These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
☐
|
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
x
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
☐
|
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Title of each class
|
|
Trading Symbol
|
|
Name of each exchange on which registered
|
|
Ordinary Shares
|
|
CSTM
|
|
New York Stock Exchange
|
|
U.S. GAAP ☐
|
|
International Financial Reporting Standards as issued by the
International Accounting Standards Board
x
|
|
Other ☐
|
|
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
•
|
We may not be able to compete successfully in the highly competitive markets in which we operate, and new competitors could emerge, which could negatively impact our share of industry sales, sales volumes and selling prices.
|
|
•
|
Aluminium may become less competitive with alternative materials, which could reduce our sales volumes, or lower our selling prices.
|
|
•
|
A significant portion of our revenue is derived from international operations, which exposes us to certain risks inherent in doing business globally.
|
|
•
|
The cyclical and seasonal nature of the metals industry, our end-use markets and our customers’ industries could adversely affect our financial condition and results of operations.
|
|
•
|
If we fail to implement or execute our business strategy, our financial condition and results of operations could be materially adversely affected.
|
|
•
|
Our failure to meet customer manufacturing and quality requirements, standards and demand, or changing market conditions could have a material adverse impact on our business, reputation and financial results.
|
|
•
|
We are dependent on a limited number of customers for a substantial portion of our sales and a failure to successfully renew or renegotiate our agreements with such customers may adversely affect our results of operations, financial condition and cash flows.
|
|
•
|
If we are unable to substantially pass on to our customers the cost of price increases of our raw materials, which may be subject to volatility, our profitability could be adversely affected.
|
|
•
|
We are dependent on a limited number of suppliers for a substantial portion of our aluminium supply and a failure to successfully renew or renegotiate our agreements with our suppliers may adversely affect our results of operations, financial condition and cash flows.
|
|
•
|
The price volatility of energy costs may adversely affect our profitability.
|
|
•
|
Disruptions or failures in our IT systems, or failure to protect our IT systems against cyber-attacks or information security breaches, could have a material adverse effect on our business and financial results.
|
|
•
|
The loss of certain key members of our management team may have a material adverse effect on our operating results.
|
|
•
|
Our level of indebtedness could limit cash flow available for our operations and capital expenditures and could adversely affect our net income, our ability to service our debt or obtain additional financing, and our business relationships.
|
|
•
|
We are a foreign private issuer under the U.S. securities laws and within the meaning of the New York Stock Exchange (“NYSE”) rules. As a result, we qualify for and rely on exemptions from certain corporate governance requirements and may rely on other exemptions available to us in the future.
|
|
•
|
Any inability of the Company to continue to benefit from French provisions applicable to registered intermediaries (“
intermédiaires inscrits
”) could adversely affect the rights of shareholders.
|
|
•
|
The other factors presented under “Item 3. Key Information-D. Risk Factors.”
|
|
A.
|
Selected Financial Data
|
|
|
|
As of and for the year ended
December 31,
|
|||||||||||||
|
(€ in millions other than per share and per ton data)
|
|
2019
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
|||||
|
Statement of income data:
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Revenue
|
|
5,907
|
|
|
5,686
|
|
|
5,237
|
|
|
4,743
|
|
|
5,153
|
|
|
Gross profit
|
|
602
|
|
|
538
|
|
|
555
|
|
|
535
|
|
|
468
|
|
|
Income / (Loss) from operations
|
|
255
|
|
|
404
|
|
|
338
|
|
|
267
|
|
|
(406
|
)
|
|
Net income / (loss) for the period
|
|
64
|
|
|
190
|
|
|
(31
|
)
|
|
(4
|
)
|
|
(552
|
)
|
|
Earnings / (loss) per share—basic
|
|
0.43
|
|
|
1.40
|
|
|
(0.28
|
)
|
|
(0.04
|
)
|
|
(5.27
|
)
|
|
Earnings / (loss) per share—diluted
|
|
0.41
|
|
|
1.37
|
|
|
(0.28
|
)
|
|
(0.04
|
)
|
|
(5.27
|
)
|
|
Weighted average number of shares outstanding (diluted)
|
|
142,645,619
|
|
|
138,145,914
|
|
|
110,164,320
|
|
|
105,500,327
|
|
|
105,097,442
|
|
|
Dividends per ordinary share (Euro)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
As of and for the year ended
December 31,
|
|||||||||||||
|
(€ in millions other than per share and per ton data)
|
|
2019
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
|||||
|
Balance sheet data:
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Total assets
|
|
4,184
|
|
|
3,901
|
|
|
3,711
|
|
|
3,787
|
|
|
3,628
|
|
|
Net (liabilities)/assets or total invested equity
|
|
(85
|
)
|
|
(114
|
)
|
|
(319
|
)
|
|
(570
|
)
|
|
(540
|
)
|
|
Share capital
|
|
3
|
|
|
3
|
|
|
3
|
|
|
2
|
|
|
2
|
|
|
Other operational and financial data (unaudited):
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Capital expenditure
(1)
|
|
271
|
|
|
277
|
|
|
276
|
|
|
355
|
|
|
350
|
|
|
Volumes (in kt)
|
|
1,589
|
|
|
1,534
|
|
|
1,482
|
|
|
1,470
|
|
|
1,478
|
|
|
Revenue per ton (€ per ton)
|
|
3,717
|
|
|
3,707
|
|
|
3,534
|
|
|
3,227
|
|
|
3,486
|
|
|
(1)
|
Represents purchases of property, plant, and equipment.
|
|
B.
|
Capitalization and Indebtedness
|
|
C.
|
Reasons for the Offer and Use of Proceeds
|
|
D.
|
Risk Factors
|
|
•
|
changes in international governmental regulations, trade restrictions and laws, including those relating to taxes, employment and repatriation of earnings;
|
|
•
|
compliance with sanctions regimes and export control laws of multiple jurisdictions;
|
|
•
|
currency exchange rate fluctuations;
|
|
•
|
tariffs and other trade barriers;
|
|
•
|
the potential for nationalization of enterprises or government policies favoring local production;
|
|
•
|
renegotiation or nullification of existing agreements;
|
|
•
|
interest rate fluctuations;
|
|
•
|
high rates of inflation;
|
|
•
|
currency restrictions and limitations on repatriation of profits;
|
|
•
|
differing protections for intellectual property and enforcement thereof;
|
|
•
|
divergent environmental laws and regulations;
|
|
•
|
uncertain political and regulatory conditions (e.g. U.K. Brexit; U.S. duties, tariffs and trade negotiations);
|
|
•
|
sustained economic downturns, social instability; and
|
|
•
|
significant supply/demand imbalances impacting our industry.
|
|
•
|
Meeting such demand may require us to make substantial capital investments to repair, maintain, upgrade, and expand our facilities and equipment. Notwithstanding our ongoing plans and investments to increase our capacity, we may not be able to expand our production capacity quickly enough to meet our customer requirements.
|
|
•
|
Our operations may experience unplanned business interruptions caused by events such as explosions, fires, inclement weather, natural disasters, accidents, equipment failure and breakdown, IT systems and process failures, electrical blackouts or outages, transportation and supply interruptions. Any such disruption at one or more of our production facilities could cause substantial losses or delays in our production capacity, increase our operating costs and have a negative financial impact on the Company and our customers. Business interruptions may also harm our reputation among actual and potential customers, and the reputation of our customers.
|
|
•
|
The qualification of our products by many of our customers can be lengthy and unpredictable as many of these customers have extensive sourcing and qualification processes, which require substantial time and financial resources, with no certainty of success or recovery of our related expenses. Failure to qualify or re-qualify our products may result in us losing such customers or customer contracts.
|
|
•
|
As we begin manufacturing processes in our new locations or for newly introduced products, we may experience difficulties, including operational and manufacturing disruptions, delays or other complications, which could adversely affect our ability to timely launch or ramp-up productions and serve our customers.
|
|
•
|
limit our ability to obtain additional financing for working capital, capital expenditures, research and development efforts, acquisitions and general corporate purposes;
|
|
•
|
make it more difficult for us to satisfy leverage and fixed charge coverage ratios required for us to incur additional indebtedness under our existing indebtedness;
|
|
•
|
make it more difficult for us to satisfy our financial obligations;
|
|
•
|
increase our vulnerability to general adverse economic and industry conditions;
|
|
•
|
require us to dedicate a substantial portion of our cash flow from operations to payments on our indebtedness, thereby reducing the availability of our cash flow to fund working capital, capital expenditures, research and development efforts and other general corporate purposes;
|
|
•
|
restrict us from making strategic acquisitions, introducing new technologies and exploiting business opportunities;
|
|
•
|
adversely affect the terms under which suppliers provide goods and services to us, and under which we supply products to our customers;
|
|
•
|
limit our flexibility in planning for, or reacting to, changes in our business and the markets in which we compete; and
|
|
•
|
place us at a competitive disadvantage compared to our competitors that have less debt.
|
|
A.
|
History and Development of the Company
|
|
B.
|
Business Overview
|
|
|
|
For the years ended December 31,
|
|||||||
|
|
|
2019
|
|
2018
|
|
2017
|
|||
|
Shipments (kT)
|
|
1,589
|
|
|
1,534
|
|
|
1,482
|
|
|
Revenue (in € millions)
|
|
5,907
|
|
|
5,686
|
|
|
5,237
|
|
|
Net income/(loss) (in € millions)
|
|
64
|
|
|
190
|
|
|
(31
|
)
|
|
Adjusted EBITDA (in € millions)
|
|
562
|
|
|
498
|
|
|
448
|
|
|
(i)
|
Focus on High Value-added Product Focus
|
|
(ii)
|
Increase Customer Connectivity
|
|
(iii)
|
Optimize Margins and Asset Utilization Through Product Portfolio Management
|
|
(iv)
|
Harvest Returns from Recent Investments
|
|
(v)
|
Strictly Control Cost and Continuously Improve
|
|
(vi)
|
Increase Financial Flexibility
|
|
|
|
Packaging & Automotive
Rolled Products
|
|
Aerospace &
Transportation
|
|
Automotive Structures &
Industry
|
|
|
|
|
|
|
|
|
|
Manufacturing Facilities
1
|
|
•
4 (France, Germany, U.S.)
|
|
•
6 (France, U.S., Switzerland)
|
|
•
18 (France, Germany, Switzerland, Czech Republic, Slovakia, Spain, U.S., Canada, Mexico, China)
|
|
Employees
|
|
•
4,000
|
|
•
4,000
|
|
•
4,800
|
|
Key Products
|
|
•
Can stock
•
Can end stock
•
Closure stock
•
Auto Body Sheet
•
Rolled products for heat exchangers
•
Specialty reflective sheet (Bright)
|
|
•
Aerospace plates, sheets and extrusions
•
Aerospace wing skins
•
Plate and sheet for transportation, industry and defense applications
|
|
•
Automotive structures
•
Other extruded products including:
•
Soft alloys
•
Hard alloys
•
Large profiles
|
|
Key Customers
|
|
•
Packaging
: AB InBev, Ball Corporation, Can-Pack, Amcor, Ardagh Group, Coca-Cola, Crown
•
Automotive
: Audi, BMW AG, Daimler AG, Groupe PSA, Valeo, Volkswagen
|
|
•
Aerospace
: Airbus, Boeing, Bombardier, Dassault
•
Transportation
,
Industry, Defense and Distribution:
Amari, Nexter Systems, Ryerson, ThyssenKrupp
|
|
•
Automotive
: Audi, BMW AG, Daimler AG, FCA Group, Ford, Porsche, Groupe PSA
•
Rail
: CAF, Hitachi, Stadler
|
|
Select Key Facilities
|
|
•
Neuf-Brisach (France)
•
Singen (Germany)
•
Muscle Shoals (Alabama, U.S.)
•
Bowling Green (Kentucky, U.S.)
|
|
•
Issoire (France)
•
Ravenswood (West Virginia, U.S.)
•
Sierre (Switzerland)
|
|
•
Gottmadingen (Germany)
•
Van Buren (Michigan, U.S.)
•
Děčín (Czech Republic)
•
Singen (Germany)
|
|
% of total Revenue
2
(for the twelve months ended December 31, 2019)
|
|
53%
|
|
24%
|
|
23%
|
|
% of Adjusted EBITDA
3
(for the twelve months ended December 31, 2019)
|
|
49%
|
|
36%
|
|
19%
|
|
1
|
Our 28 manufacturing facilities are located in 26 sites, two of which are shared between two operating segments.
|
|
2
|
Holdings & Corporate not included.
|
|
3
|
The difference between the sum of Adjusted EBITDA for our three segments and the Company’s Adjusted EBITDA is attributable to our fourth segment Holdings and Corporate which is not presented here.
|
|
(in thousand metric tons)
|
|
For the year ended
December 31,
|
|||||||
|
2019
|
|
2018
|
|
2017
|
|||||
|
Packaging rolled products
|
|
822
|
|
|
799
|
|
|
807
|
|
|
Automotive rolled products
|
|
234
|
|
|
196
|
|
|
158
|
|
|
Specialty and other thin-rolled products
|
|
41
|
|
|
44
|
|
|
43
|
|
|
Aerospace rolled products
|
|
120
|
|
|
111
|
|
|
106
|
|
|
Transportation, industry, and other rolled products
|
|
122
|
|
|
135
|
|
|
132
|
|
|
Automotive extruded products
|
|
123
|
|
|
114
|
|
|
109
|
|
|
Other extruded products
|
|
127
|
|
|
135
|
|
|
127
|
|
|
Other
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Total shipments
|
|
1,589
|
|
|
1,534
|
|
|
1,482
|
|
|
•
|
approximately 75% of operating segment volume was in packaging rolled products, which primarily includes beverage and food canstock as well as closure stock and foil stock,
|
|
•
|
approximately 21% of operating segment volume was in automotive rolled products,
|
|
•
|
and approximately 4% of operating segment volume was in specialty and other thin-rolled products, which include technologically advanced products for the industrial sector.
|
|
|
|
For the year ended December 31,
|
|||||||
|
(€ in millions, unless otherwise noted)
|
|
2019
|
|
2018
|
|
2017
|
|||
|
Packaging & Automotive Rolled Products:
|
|
|
|
|
|
|
|||
|
Segment Revenue
|
|
3,149
|
|
|
3,059
|
|
|
2,812
|
|
|
Segment Shipments (kt)
|
|
1,097
|
|
|
1,039
|
|
|
1,008
|
|
|
Segment Revenue (€/ton)
|
|
2,871
|
|
|
2,944
|
|
|
2,789
|
|
|
Segment Adjusted EBITDA
(1)
|
|
273
|
|
|
243
|
|
|
204
|
|
|
Segment Adjusted EBITDA(€/ton)
|
|
249
|
|
|
234
|
|
|
202
|
|
|
Segment Adjusted EBITDA margin
|
|
9
|
%
|
|
8
|
%
|
|
7
|
%
|
|
(1)
|
Adjusted EBITDA is not a measure defined under IFRS. Adjusted EBITDA is defined and discussed in “Item 5. Operating and Financial Review and Prospects—Segment Results.”
|
|
|
|
For the year ended December 31,
|
|||||||
|
(€ in millions, unless otherwise noted)
|
|
2019
|
|
2018
|
|
2017
|
|||
|
Aerospace & Transportation:
|
|
|
|
|
|
|
|||
|
Segment Revenue
|
|
1,462
|
|
|
1,389
|
|
|
1,335
|
|
|
Segment Shipments (kt)
|
|
242
|
|
|
246
|
|
|
238
|
|
|
Segment Revenue (€/ton)
|
|
6,041
|
|
|
5,646
|
|
|
5,618
|
|
|
Segment Adjusted EBITDA
(1)
|
|
204
|
|
|
152
|
|
|
146
|
|
|
Segment Adjusted EBITDA(€/ton)
|
|
843
|
|
|
619
|
|
|
614
|
|
|
Segment Adjusted EBITDA margin
|
|
14
|
%
|
|
11
|
%
|
|
11
|
%
|
|
(1)
|
Adjusted EBITDA is not a measure defined under IFRS. Adjusted EBITDA is defined and discussed in “Item 5. Operating and Financial Review and Prospects—Segment Results.”
|
|
|
|
For the year ended December 31,
|
|||||||
|
(€ in millions, unless otherwise noted)
|
|
2019
|
|
2018
|
|
2017
|
|||
|
Automotive Structures & Industry:
|
|
|
|
|
|
|
|||
|
Segment Revenue
|
|
1,351
|
|
|
1,290
|
|
|
1,123
|
|
|
Segment Shipments (kt)
|
|
250
|
|
|
249
|
|
|
236
|
|
|
Segment Revenue (€/ton)
|
|
5,404
|
|
|
5,181
|
|
|
4,756
|
|
|
Segment Adjusted EBITDA
(1)
|
|
106
|
|
|
125
|
|
|
120
|
|
|
Segment Adjusted EBITDA(€/ton)
|
|
423
|
|
|
502
|
|
|
510
|
|
|
Segment Adjusted EBITDA margin
|
|
8
|
%
|
|
10
|
%
|
|
11
|
%
|
|
(1)
|
Adjusted EBITDA is not a measure defined under IFRS. Adjusted EBITDA is defined and discussed in “Item 5. Operating and Financial Review and Prospects—Segment Results.”
|
|
•
|
Slabs or billets we cast from a combination of primary and recycled aluminium. The primary aluminium is typically in form of standard ingots. The recycled aluminium comes either from scrap from fabrication processes, known as recycled process material, or from recycled end products in their end of life phase, such as used beverage cans.
|
|
•
|
Slabs or billets purchased from smelters or metal trading companies.
|
|
Total European Rolled Products Consumption
Can Stock (Kt)
|
|
Total North American Rolled Products
Consumption Can Stock (Kt)
|
|
|
|
|
|
|
|
|
|
|
|
|
Source: CRU International Ltd., Aluminium Rolled Products Market Outlook November 2019
|
|
Source: CRU International Ltd., Aluminium Products Market Outlook November 2019
|
|
World’s Commercial Aircraft Fleet (thousands)
|
|
Fleet Development Driven by Passenger Demand and Aging Fleet (units)
|
|
|
|
|
|
|
|
|
|
|
|
|
Source: Boeing 2019 current market outlook
|
|
Source: Boeing 2019 current market outlook
|
|
•
|
In cases where we are able to align the price and quantity of physical aluminium purchases with that of physical aluminium sales to our customers, we enter into back-to-back arrangements with our customers.
|
|
•
|
When we are unable to align the price and quantity of physical aluminium purchases with that of physical aluminium sales to our customers, we enter into derivative financial instruments to pass through the exposure to financial institutions at the time the price is set.
|
|
•
|
For a small portion of our volumes, the aluminium we process is owned by our customers and we bear no aluminium price risk.
|
|
•
|
Primary metal from smelters or metal traders in the form of ingots, rolling slabs or extrusion billets.
|
|
•
|
Remelted metal in the form of rolling slabs or extrusion billets from external cast-houses, as an addition to our own internal cast-houses.
|
|
•
|
Production scrap from customers and scrap traders.
|
|
•
|
End-of-life scrap (e.g., used beverage cans) from customers, collectors and scrap traders.
|
|
•
|
Specific alloying elements and primary ingots from producers and metal traders.
|
|
•
|
Close interaction with key customers, including through formal partnerships or joint development teams—examples include Strongalex®, Formalex® and Surfalex®, which were developed with automotive customers (mainly Daimler and Audi) and the Fusion bottle, a drawn and ironed technology created in partnership with Ball Corporation.
|
|
•
|
Technologically advanced equipment—for example, full-size casthouse for rapid prototyping of new Airware® low density alloys, innovative joining technologies for aerospace alloys (friction stir welding), forming technologies for automotive body sheets.
|
|
•
|
Long-term partnerships with universities worldwide. For example Michigan University in the U.S., Stuttgart University in Germany or Manchester University in the United Kingdom which generate significant innovation opportunities and foster new ideas.
|
|
C.
|
Organizational Structure
|
|
D.
|
Property, Plant and Equipment
|
|
•
|
The Muscle Shoals, Alabama facility operates one of the largest and most efficient can reclamation facilities in the world. In addition, the facility utilizes multi-station electromagnetic casting, houses the widest hot line in North America and has the fastest can end stock coating line in the world. Production capabilities include body stock, tab stock, and end stock. In addition, we are producing automotive cold coils for body sheet. The capital expenditures invested in the facility were €40 million for the year ended December 31, 2019 and €44 million in the year ended December 31, 2018.
|
|
•
|
The Neuf-Brisach, France facility is an integrated aluminium rolling, finishing and recycling facility in Europe. Our investments in a can body stock slitter and recycling furnace has enabled us to secure long-term can stock contracts. Additionally, our latest investment in a new state-of-the-art automotive finishing line has further strengthened the plant’s position as a significant supplier of aluminium Auto Body Sheet in the automotive market. The capital expenditures invested in the facility were €31 million in the year ended December 31, 2019 and €32 million in the year ended December 31, 2018.
|
|
•
|
The Issoire, France facility is one of the world’s two leading aerospace plate mills based on volumes. The plant operates two Airware
®
industrial casthouses and currently uses recycling capabilities to take back scrap along the entire fabrication chain. Issoire works as an integrated platform with Ravenswood, West Virginia and Sierre, Switzerland, providing a significant competitive advantage for us as a global supplier to the aerospace industry. The capital expenditures invested in the facility were €32 million in the year ended December 31, 2019 and €32 million in the year ended December 31, 2018.
|
|
•
|
The Ravenswood, West Virginia facility has significant assets for producing aerospace plates, transportation coil and is a recognized supplier to the defense industry. The facility has stretchers and wide-coil capabilities that make it one of the few facilities in the world capable of producing plates of a size needed for the largest commercial airplanes. The capital expenditures invested in the facility were €31 million for the year ended December 31, 2019 and €28 million in the year ended December 31, 2018.
|
|
•
|
The Singen, Germany rolling plant has more than 100 years’ experience, industry leading cycle times and high-grade cold mills with special surfaces capabilities to serve automotive and other markets. The extrusion part has one of the largest extrusion presses in Europe as well as advanced and highly productive integrated automotive bumper manufacturing lines. A dedicated unit allows the production of crash management applications, battery enclosures for electric vehicles as well as other automotive structural parts ready for the OEM assembly lines. The capital expenditures invested in the facility were €38 million in the year ended December 31, 2019 and €45 million in the year ended December 31, 2018.
|
|
•
|
The Děčín, Czech Republic facility is a large extrusion facility, mainly focusing on hard alloy extrusions for automotive and industrial applications, with significant recycling capabilities. It is located near the German border, strategically positioning it to supply the German, Czech and French Tier1s and OEMs. Its integrated casthouse allows it to offer high value-add customized hard alloys to our customers. The capital expenditures invested in the facility were €13 million in the year ended December 31, 2019 and €21 million in the year ended December 31, 2018.
|
|
•
|
The Sierre, Switzerland facility is dedicated to precision plates for general engineering, aerospace plates and slabs and is a leading supplier of extruded products for high-speed train railway manufacturers and a wide range of applications. The Sierre facility includes the Steg casthouse that produces automotive, general engineering and aerospace slabs and the Chippis casthouse that has the capacity to produce non-standard billets for a wide range of extrusions. Its qualification as an aerospace plate and slabs plant increases our aerospace production capabilities. The capital expenditures invested in the facility were €15 million in the year ended December 31, 2019 and €12 million in the year ended December 31, 2018.
|
|
Operating Segment
|
|
Location
|
|
Country
|
|
Owned/
Leased
|
|
Packaging & Automotive Rolled Products
|
|
Biesheim, Neuf-Brisach
|
|
France
|
|
Owned
|
|
Packaging & Automotive Rolled Products
|
|
Singen
|
|
Germany
|
|
Owned
|
|
Packaging & Automotive Rolled Products
|
|
Muscle Shoals, AL
|
|
United States
|
|
Owned
|
|
Packaging & Automotive Rolled Products
|
|
Bowling Green, KY
|
|
United States
|
|
Owned
|
|
Aerospace & Transportation
|
|
Ravenswood, WV
|
|
United States
|
|
Owned
|
|
Aerospace & Transportation
|
|
Issoire
|
|
France
|
|
Owned
|
|
Aerospace & Transportation
|
|
Montreuil-Juigné
|
|
France
|
|
Owned
|
|
Aerospace & Transportation
|
|
Ussel
|
|
France
|
|
Owned
|
|
Aerospace & Transportation
|
|
Steg
|
|
Switzerland
|
|
Owned
|
|
Aerospace & Transportation
|
|
Sierre
|
|
Switzerland
|
|
Owned
|
|
Automotive Structures & Industry
|
|
Van Buren, MI
|
|
United States
|
|
Leased
|
|
Automotive Structures & Industry
|
|
Changchun, Jilin Province (JV)
(1)
|
|
China
|
|
Leased
|
|
Automotive Structures & Industry
|
|
Děčín
|
|
Czech Republic
|
|
Owned
|
|
Automotive Structures & Industry
|
|
Nuits-Saint-Georges
|
|
France
|
|
Owned
|
|
Automotive Structures & Industry
|
|
Burg
|
|
Germany
|
|
Owned
|
|
Automotive Structures & Industry
|
|
Crailsheim
|
|
Germany
|
|
Owned
|
|
Automotive Structures & Industry
|
|
Neckarsulm
|
|
Germany
|
|
Owned
|
|
Automotive Structures & Industry
|
|
Gottmadingen
|
|
Germany
|
|
Owned
|
|
Automotive Structures & Industry
|
|
Landau/Pfalz
|
|
Germany
|
|
Owned
|
|
Automotive Structures & Industry
|
|
Singen
|
|
Germany
|
|
Owned
|
|
Automotive Structures & Industry
|
|
Levice
|
|
Slovakia
|
|
Owned
|
|
Automotive Structures & Industry
|
|
Chippis
|
|
Switzerland
|
|
Owned
|
|
Automotive Structures & Industry
|
|
Sierre
|
|
Switzerland
|
|
Owned
|
|
Automotive Structures & Industry
|
|
White, GA
|
|
United States
|
|
Leased
|
|
Automotive Structures & Industry
|
|
Lakeshore, Ontario (JV)
(2)
|
|
Canada
|
|
Leased
|
|
Automotive Structures & Industry
|
|
San Luis Potosi
|
|
Mexico
|
|
Leased
|
|
Automotive Structures & Industry
|
|
Zilina
|
|
Slovakia
|
|
Leased
|
|
Automotive Structures & Industry
|
|
Vigo
|
|
Spain
|
|
Leased
|
|
(1)
|
Engley is a Constellium Joint Venture with Changchun Engley Auto Parts Co. Ltd.
|
|
(2)
|
Astrex is a Constellium Joint Venture with Can Art Aluminum Extrusion Inc.
|
|
Plant
|
|
Capacity
|
|
Utilization Rate
|
|
Neuf-Brisach
|
|
450 kt
|
|
95-100%
|
|
Muscle Shoals
|
|
500-550 kt
|
|
80-90%
|
|
Issoire
|
|
110 kt
|
|
90%
|
|
Ravenswood
|
|
175 kt
|
|
90%
|
|
Děčín
|
|
92 kt
|
|
78%
|
|
Singen
|
|
290-310 kt
|
|
90-95%
|
|
Sierre
|
|
70-75 kt
|
|
50%
|
|
•
|
Can packaging tends not to be highly correlated to the general economic cycle. In addition, we believe European canstock has an attractive long-term growth outlook due to ongoing trends in (i) growth in beer, soft drinks and energy drinks consumption, (ii) increasing use of cans versus glass in the beer market, and (iii) increasing penetration of aluminium in canstock at the expense of tinplate.
|
|
•
|
We believe that the aerospace industry is currently insulated from economic cycles by a combination of growth drivers. These drivers include increasing passenger traffic and the fleet replacement towards newer and more fuel efficient aircrafts. These factors have materialized in the form of historically high backlogs for the aircraft manufacturers. The combined order backlog for Boeing and Airbus represents approximately eight- to nine-years of manufacturing at current build rates.
|
|
•
|
Although the automotive industry is a cyclical industry, its demand for aluminium has been increasing in recent years. This has been triggered by a light-weighting trend for new car models and electric vehicles, which drives substitution of heavier metals in favor of aluminium.
|
|
(Euros/ton)
|
|
2019
|
|
2018
|
|
2017
|
|||
|
First Quarter
|
|
1,637
|
|
|
1,757
|
|
|
1,737
|
|
|
Second Quarter
|
|
1,595
|
|
|
1,896
|
|
|
1,736
|
|
|
Third Quarter
|
|
1,585
|
|
|
1,769
|
|
|
1,714
|
|
|
Fourth Quarter
|
|
1,583
|
|
|
1,726
|
|
|
1,786
|
|
|
Average for the year
|
|
1,600
|
|
|
1,786
|
|
|
1,743
|
|
|
(Euros/ton)
|
|
2019
|
|
2018
|
|
2017
|
|||
|
First Quarter
|
|
375
|
|
|
246
|
|
|
198
|
|
|
Second Quarter
|
|
371
|
|
|
404
|
|
|
180
|
|
|
Third Quarter
|
|
355
|
|
|
390
|
|
|
144
|
|
|
Fourth Quarter
|
|
329
|
|
|
376
|
|
|
176
|
|
|
Average for the year
|
|
357
|
|
|
354
|
|
|
175
|
|
|
(Euros/ton)
|
|
2019
|
|
2018
|
|
2017
|
|||
|
First Quarter
|
|
116
|
|
|
134
|
|
|
137
|
|
|
Second Quarter
|
|
130
|
|
|
170
|
|
|
131
|
|
|
Third Quarter
|
|
137
|
|
|
135
|
|
|
120
|
|
|
Fourth Quarter
|
|
123
|
|
|
116
|
|
|
135
|
|
|
Average for the year
|
|
127
|
|
|
139
|
|
|
131
|
|
|
•
|
In cases where we are able to align the price and quantity of physical aluminium purchases with that of physical aluminium sales to customers, we enter back-to-back arrangements with our customers.
|
|
•
|
However, when we are unable to align the price and quantity of physical aluminium purchases with that of physical aluminium sales to our customers, we enter into derivative financial instruments to pass through the exposure to financial institutions at the time the price is set.
|
|
•
|
For a small portion of our volumes, the aluminium we process is owned by our customers and we bear no aluminium price risk.
|
|
|
|
For the year ended December 31,
|
||||||||||
|
|
|
2019
|
|
2018
|
||||||||
|
|
|
(€ in millions and as a % of revenue)
|
||||||||||
|
|
|
|
|
%
|
|
|
|
%
|
||||
|
Revenue
|
|
5,907
|
|
|
100
|
%
|
|
5,686
|
|
|
100
|
%
|
|
Cost of sales
|
|
(5,305
|
)
|
|
90
|
%
|
|
(5,148
|
)
|
|
91
|
%
|
|
Gross profit
|
|
602
|
|
|
10
|
%
|
|
538
|
|
|
9
|
%
|
|
Selling and administrative expenses
|
|
(276
|
)
|
|
5
|
%
|
|
(247
|
)
|
|
4
|
%
|
|
Research and development expenses
|
|
(48
|
)
|
|
1
|
%
|
|
(40
|
)
|
|
1
|
%
|
|
Restructuring costs
|
|
(4
|
)
|
|
—
|
%
|
|
(1
|
)
|
|
—
|
%
|
|
Other gains / (losses) net
|
|
(19
|
)
|
|
—
|
%
|
|
154
|
|
|
3
|
%
|
|
Income from operations
|
|
255
|
|
|
4
|
%
|
|
404
|
|
|
7
|
%
|
|
Finance costs, net
|
|
(175
|
)
|
|
3
|
%
|
|
(149
|
)
|
|
3
|
%
|
|
Share of income / (loss) of joint ventures
|
|
2
|
|
|
—
|
%
|
|
(33
|
)
|
|
1
|
%
|
|
Income before income taxes
|
|
82
|
|
|
1
|
%
|
|
222
|
|
|
4
|
%
|
|
Income tax expense
|
|
(18
|
)
|
|
—
|
%
|
|
(32
|
)
|
|
1
|
%
|
|
Net income / (loss)
|
|
64
|
|
|
1
|
%
|
|
190
|
|
|
3
|
%
|
|
Shipment volumes (in kt)
|
|
1,589
|
|
|
n/a
|
|
|
1,534
|
|
|
n/a
|
|
|
Revenue per ton (€ per ton)
|
|
3,717
|
|
|
n/a
|
|
|
3,707
|
|
|
n/a
|
|
|
|
|
For the year ended December 31,
|
||||
|
|
|
2019
|
|
2018
|
||
|
(€ in millions)
|
|
|
|
|
||
|
Realized (losses) / gains on derivatives
|
|
(49
|
)
|
|
14
|
|
|
Unrealized gains / (losses) on derivatives at fair value through profit and loss—net
|
|
33
|
|
|
(84
|
)
|
|
Unrealized exchange gains / (losses) from the remeasurement of monetary assets and liabilities—net
|
|
—
|
|
|
—
|
|
|
Gains on pension plan amendments
|
|
1
|
|
|
36
|
|
|
(Losses) / gains on disposal
|
|
(3
|
)
|
|
186
|
|
|
Other—net
|
|
(1
|
)
|
|
2
|
|
|
Total other gains / (losses), net
|
|
(19
|
)
|
|
154
|
|
|
|
|
For the year ended December 31,
|
||||||||||
|
|
|
2018
|
|
2017
|
||||||||
|
|
|
(€ in millions and as a % of revenue)
|
||||||||||
|
|
|
|
|
%
|
|
|
|
%
|
||||
|
Revenue
|
|
5,686
|
|
|
100
|
%
|
|
5,237
|
|
|
100
|
%
|
|
Cost of sales
|
|
(5,148
|
)
|
|
91
|
%
|
|
(4,682
|
)
|
|
89
|
%
|
|
Gross profit
|
|
538
|
|
|
9
|
%
|
|
555
|
|
|
11
|
%
|
|
Selling and administrative expenses
|
|
(247
|
)
|
|
4
|
%
|
|
(247
|
)
|
|
5
|
%
|
|
Research and development expenses
|
|
(40
|
)
|
|
1
|
%
|
|
(36
|
)
|
|
1
|
%
|
|
Restructuring costs
|
|
(1
|
)
|
|
—
|
%
|
|
(4
|
)
|
|
—
|
%
|
|
Other gains net
|
|
154
|
|
|
3
|
%
|
|
70
|
|
|
1
|
%
|
|
Income from operations
|
|
404
|
|
|
7
|
%
|
|
338
|
|
|
6
|
%
|
|
Finance costs, net
|
|
(149
|
)
|
|
3
|
%
|
|
(260
|
)
|
|
5
|
%
|
|
Share of loss of joint ventures
|
|
(33
|
)
|
|
1
|
%
|
|
(29
|
)
|
|
1
|
%
|
|
Income before income taxes
|
|
222
|
|
|
4
|
%
|
|
49
|
|
|
1
|
%
|
|
Income tax expense
|
|
(32
|
)
|
|
1
|
%
|
|
(80
|
)
|
|
2
|
%
|
|
Net income / (loss)
|
|
190
|
|
|
3
|
%
|
|
(31
|
)
|
|
1
|
%
|
|
Shipment volumes (in kt)
|
|
1,534
|
|
|
n/a
|
|
|
1,482
|
|
|
n/a
|
|
|
Revenue per ton (€ per ton)
|
|
3,707
|
|
|
n/a
|
|
|
3,534
|
|
|
n/a
|
|
|
|
|
For the year ended December 31,
|
||||
|
|
|
2018
|
|
2017
|
||
|
(€ in millions)
|
|
|
|
|
||
|
Realized gains on derivatives
|
|
14
|
|
|
—
|
|
|
Unrealized (losses)/gains on derivatives at fair value through profit and loss—net
|
|
(84
|
)
|
|
57
|
|
|
Unrealized exchange (losses) from the remeasurement of monetary assets and liabilities—net
|
|
—
|
|
|
(4
|
)
|
|
Gains on pension plan amendments
|
|
36
|
|
|
20
|
|
|
Gains /(losses) on disposal
|
|
186
|
|
|
(3
|
)
|
|
Other—net
|
|
2
|
|
|
—
|
|
|
Total other gains / (losses), net
|
|
154
|
|
|
70
|
|
|
|
|
For the year ended December 31,
|
||||||||||||||||
|
|
|
2019
|
|
2018
|
|
2017
|
||||||||||||
|
|
|
(millions of € and as a % of revenue)
|
||||||||||||||||
|
P&ARP
|
|
3,149
|
|
|
53
|
%
|
|
3,059
|
|
|
54
|
%
|
|
2,812
|
|
|
54
|
%
|
|
A&T
|
|
1,462
|
|
|
24
|
%
|
|
1,389
|
|
|
23
|
%
|
|
1,335
|
|
|
25
|
%
|
|
AS&I
|
|
1,351
|
|
|
23
|
%
|
|
1,290
|
|
|
23
|
%
|
|
1,123
|
|
|
21
|
%
|
|
Holdings and Corporate
|
|
—
|
|
|
—
|
%
|
|
10
|
|
|
—
|
%
|
|
13
|
|
|
—
|
%
|
|
Inter-segment eliminations
|
|
(55
|
)
|
|
n.m.
|
|
|
(62
|
)
|
|
n.m.
|
|
|
(46
|
)
|
|
n.m.
|
|
|
Total revenue
|
|
5,907
|
|
|
100
|
%
|
|
5,686
|
|
|
100
|
%
|
|
5,237
|
|
|
100
|
%
|
|
|
|
For the year ended December 31,
|
||||||||||||||||
|
|
|
2019
|
|
2018
|
|
2017
|
||||||||||||
|
|
|
(millions of € and as a % of revenue)
|
||||||||||||||||
|
P&ARP
|
|
273
|
|
|
9
|
%
|
|
243
|
|
|
8
|
%
|
|
204
|
|
|
7
|
%
|
|
A&T
|
|
204
|
|
|
14
|
%
|
|
152
|
|
|
11
|
%
|
|
146
|
|
|
11
|
%
|
|
AS&I
|
|
106
|
|
|
8
|
%
|
|
125
|
|
|
10
|
%
|
|
120
|
|
|
11
|
%
|
|
Holdings and Corporate
|
|
(21
|
)
|
|
n.m.
|
|
|
(22
|
)
|
|
n.m.
|
|
|
(22
|
)
|
|
n.m.
|
|
|
Total Adjusted EBITDA
|
|
562
|
|
|
10
|
%
|
|
498
|
|
|
9
|
%
|
|
448
|
|
|
8
|
%
|
|
|
|
P&ARP
|
|
A&T
|
|
AS&I
|
|||
|
|
|
(millions of €)
|
|||||||
|
Adjusted EBITDA for the year ended December 31, 2018
|
|
243
|
|
|
152
|
|
|
125
|
|
|
Volume
|
|
27
|
|
|
(5
|
)
|
|
24
|
|
|
Price and product mix
|
|
(10
|
)
|
|
65
|
|
|
(1
|
)
|
|
Costs
|
|
21
|
|
|
(14
|
)
|
|
(51
|
)
|
|
Consolidation of Bowling Green
|
|
(15
|
)
|
|
—
|
|
|
—
|
|
|
Impact of IFRS 16 adoption
|
|
6
|
|
|
2
|
|
|
12
|
|
|
Foreign exchange and other
|
|
1
|
|
|
4
|
|
|
(3
|
)
|
|
Adjusted EBITDA for the year ended December 31, 2019
|
|
273
|
|
|
204
|
|
|
106
|
|
|
|
|
P&ARP
|
|
A&T
|
|
AS&I
|
|||
|
|
|
(millions of €)
|
|||||||
|
Adjusted EBITDA for the year ended December 31, 2017
|
|
204
|
|
|
146
|
|
|
120
|
|
|
Volume
|
|
14
|
|
|
14
|
|
|
14
|
|
|
Price and product mix
|
|
17
|
|
|
(2
|
)
|
|
11
|
|
|
Costs
|
|
7
|
|
|
(3
|
)
|
|
(21
|
)
|
|
Foreign exchange and other
|
|
1
|
|
|
(3
|
)
|
|
1
|
|
|
Adjusted EBITDA for the year ended December 31, 2018
|
|
243
|
|
|
152
|
|
|
125
|
|
|
|
|
For the year ended December 31,
|
|||||||
|
|
|
2019
|
|
2018
|
|
2017
|
|||
|
(€ in millions)
|
|
|
|
|
|
|
|||
|
Net income / (loss)
|
|
64
|
|
|
190
|
|
|
(31
|
)
|
|
Net income from discontinued operations
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Income tax expense
|
|
18
|
|
|
32
|
|
|
80
|
|
|
Finance costs, net
|
|
175
|
|
|
149
|
|
|
260
|
|
|
Share of loss of joint ventures
|
|
(2
|
)
|
|
33
|
|
|
29
|
|
|
Depreciation and amortization
|
|
256
|
|
|
197
|
|
|
171
|
|
|
Restructuring costs
|
|
4
|
|
|
1
|
|
|
4
|
|
|
Unrealized losses / (gains) on derivatives
|
|
(33
|
)
|
|
84
|
|
|
(57
|
)
|
|
Unrealized exchange losses / (gains) from remeasurement of monetary assets and liabilities—net
|
|
—
|
|
|
—
|
|
|
4
|
|
|
Gains on pension plan amendments
(a)
|
|
(1
|
)
|
|
(36
|
)
|
|
(20
|
)
|
|
Share-based compensation
|
|
16
|
|
|
12
|
|
|
8
|
|
|
Metal price lag
(b)
|
|
46
|
|
|
—
|
|
|
(22
|
)
|
|
Start-up and development costs
(c)
|
|
11
|
|
|
21
|
|
|
17
|
|
|
Manufacturing system and process transformation costs
|
|
—
|
|
|
—
|
|
|
2
|
|
|
(Gains) / Losses on disposals
(d)
|
|
3
|
|
|
(186
|
)
|
|
3
|
|
|
Bowling Green one-time costs related to the acquisition
(e)
|
|
5
|
|
|
—
|
|
|
—
|
|
|
Other
(f)
|
|
—
|
|
|
1
|
|
|
—
|
|
|
Adjusted EBITDA
|
|
562
|
|
|
498
|
|
|
448
|
|
|
(a)
|
For the year ended December 31, 2018, the Company amended one of its OPEB plans in the U.S., which resulted in a €36 million gain. For the year ended December 31, 2017, amendments to certain Swiss pension plans, U.S. pension plans and OPEB resulted in a €20 million net gain.
|
|
(b)
|
Metal price lag represents the financial impact of the timing difference between when aluminium prices included within Constellium revenue are established and when aluminium purchase prices included in Cost of sales are established. The Company accounts for inventory using a weighted average price basis and this adjustment aims to remove the effect of volatility in LME prices. The calculation of the Company’s metal price lag adjustment is based on an internal standardized methodology calculated at each of Constellium’s manufacturing sites and is primarily calculated as the average value of product recorded in inventory, which approximates the spot price in the market, less the average value transferred out of inventory, which is the weighted average of the metal element of cost of sales, based on the quantity sold in the period.
|
|
(c)
|
For the years ended December 31, 2019, 2018 and 2017, start-up and development costs include €11 million, €21 million and €16 million, respectively, related to new projects in our AS&I operating segment.
|
|
(d)
|
In July 2018, Constellium completed the sale of the North Building assets of its Sierre plant in Switzerland to Novelis and contributed the Sierre site shared infrastructure to a joint-venture with Novelis, in exchange for cash consideration of €200 million. This transaction also resulted in the termination of the existing lease agreement for the North Building assets which had been leased and operated by Novelis since 2005. For the year ended December 31, 2018, the transaction generated a €190 million net gain.
|
|
(e)
|
For the year ended December 2019, Bowling Green one-time costs related to the acquisition include the non-cash reversal of the inventory step-up.
|
|
(f)
|
For the year ended December 31, 2017, other includes €3 million of legal fees and lump-sum payments in connection with the renegotiation of a new 5-year collective bargaining agreement offset by accrual reversals of unused provisions related to one-time loss contingencies.
|
|
•
|
Our level of indebtedness could limit cash flow available for our operations and capital expenditures and could adversely affect our net income, our ability to service our debt or obtain additional financing, and our business relationships;
|
|
•
|
Our results of operations, cash flows and liquidity could be adversely affected if we are unable to execute on our hedging policy, if counterparties to our derivative instruments fail to honor their agreements or if we are unable to purchase derivative instruments;
|
|
•
|
Our cash flows and liquidity could be adversely affected as a result of the maturity mismatch between certain of our derivative instruments and the underlying exposure.
|
|
|
|
For the year ended December 31,
|
|||||||
|
|
|
2019
|
|
2018
|
|
2017
|
|||
|
|
|
(€ in millions)
|
|||||||
|
Net Cash Flows from / (used) in:
|
|
|
|
|
|
|
|||
|
Operating activities
|
|
447
|
|
|
66
|
|
|
160
|
|
|
Investing activities
|
|
(353
|
)
|
|
(91
|
)
|
|
(292
|
)
|
|
Financing activities
|
|
(76
|
)
|
|
(82
|
)
|
|
61
|
|
|
Net increase / (decrease) in cash and cash equivalents, excluding the effect of exchange rate changes
|
|
18
|
|
|
(107
|
)
|
|
(71
|
)
|
|
|
|
For the year ended December 31,
|
|||||||
|
|
|
2019
|
|
2018
|
|
2017
|
|||
|
|
|
(€ in millions)
|
|||||||
|
P&ARP
|
|
96
|
|
|
97
|
|
|
115
|
|
|
A&T
|
|
72
|
|
|
70
|
|
|
73
|
|
|
AS&I
|
|
97
|
|
|
105
|
|
|
83
|
|
|
Holdings and Corporate
|
|
6
|
|
|
5
|
|
|
5
|
|
|
Total capital expenditures
|
|
271
|
|
|
277
|
|
|
276
|
|
|
|
|
|
|
Cash payments due by period
|
|||||||||||
|
|
|
Total
|
|
Less
than
1 year
|
|
1-3
years
|
|
3-5
years
|
|
After 5
years
|
|||||
|
|
|
(€ in millions)
|
|||||||||||||
|
Borrowings
(1)
|
|
2,166
|
|
|
139
|
|
|
221
|
|
|
368
|
|
|
1,438
|
|
|
Interest
(2)
|
|
601
|
|
|
112
|
|
|
209
|
|
|
195
|
|
|
85
|
|
|
Derivatives relating to currencies and metal
|
|
56
|
|
|
31
|
|
|
24
|
|
|
1
|
|
|
—
|
|
|
Capital expenditures
|
|
71
|
|
|
62
|
|
|
9
|
|
|
—
|
|
|
—
|
|
|
Leases
|
|
241
|
|
|
40
|
|
|
58
|
|
|
55
|
|
|
88
|
|
|
Operating lease obligations
(3)
|
|
16
|
|
|
5
|
|
|
7
|
|
|
3
|
|
|
1
|
|
|
Total
(4)
|
|
3,151
|
|
|
389
|
|
|
528
|
|
|
622
|
|
|
1,612
|
|
|
(1)
|
Borrowings include our Pan-U.S. ABL Facility which is considered short-term in nature and is included in the category “Less than 1 year.”
|
|
(2)
|
Interests accrue under the May 2014 Notes denominated in U.S. dollars at a rate of 5.750% per annum, under the May 2014 Notes denominated in euros at a rate of 4.625% per annum, under the February 2017 Notes at a rate of 6.625% per annum, under the November 2017 Notes denominated in U.S. dollars at a rate of 5.875%, per annum, and under the November 2017 Notes denominated in euros at a rate of 4.250% per annum.
|
|
(3)
|
Operating leases relate to buildings, machinery and equipment leased under short term leases or low-value asset leases.
|
|
(4)
|
Estimating when pension and other post-employment obligations will require settlement is not practicable and therefore these have not been included in the Contractual Obligations table above.
|
|
A.
|
Directors and Senior Management
|
|
Name
|
|
Age
|
|
Position
|
|
Date of Appointment
|
|
Current Term
|
|
Richard B. Evans
|
|
72
|
|
Chairman
|
|
January 5, 2011
|
|
2019-2022
|
|
Guy Maugis
|
|
66
|
|
Director
|
|
January 5, 2011
|
|
2019-2020
|
|
Philippe Guillemot
|
|
60
|
|
Director
|
|
May 21, 2013
|
|
2019-2020
|
|
Werner P. Paschke
|
|
69
|
|
Director
|
|
May 21, 2013
|
|
2019-2021
|
|
Michiel Brandjes
|
|
65
|
|
Director
|
|
June 11, 2014
|
|
2019-2021
|
|
Peter F. Hartman
|
|
70
|
|
Director
|
|
June 11, 2014
|
|
2019-2020
|
|
John Ormerod
|
|
70
|
|
Director
|
|
June 11, 2014
|
|
2019-2021
|
|
Lori A. Walker
|
|
62
|
|
Director
|
|
June 11, 2014
|
|
2019-2022
|
|
Martha Brooks
|
|
60
|
|
Director
|
|
June 15, 2016
|
|
2019-2022
|
|
Jean-Marc Germain
|
|
53
|
|
Director and CEO
|
|
June 15, 2016
|
|
2017-2020
|
|
Stéphanie Frachet
|
|
42
|
|
Director
|
|
May 24, 2018
|
|
2019-2022
|
|
Name
|
|
Age
|
|
Title
|
|
|
Jean-Marc Germain
|
|
53
|
|
|
Chief Executive Officer
|
|
Peter R. Matt
|
|
57
|
|
|
Executive Vice President and Chief Financial Officer
|
|
Peter Basten
|
|
44
|
|
|
President, Packaging and Automotive Rolled Products business unit
|
|
Ingrid Joerg
|
|
50
|
|
|
President, Aerospace and Transportation business unit
|
|
Paul Warton
|
|
58
|
|
|
President, Automotive Structures and Industry business unit
|
|
Jack Clark
|
|
60
|
|
|
Senior Vice President Manufacturing Excellence and Chief Technical Officer
|
|
Philip Ryan Jurkovic
|
|
48
|
|
|
Senior Vice President and Chief Human Resources Officer
|
|
Nicolas Brun
|
|
53
|
|
|
Senior Vice President, Public Affairs, Communications and Sustainability
|
|
Jeremy Leach
|
|
57
|
|
|
Senior Vice President and Group General Counsel
|
|
B.
|
Compensation
|
|
Name
|
|
Annual
Director
Fees
|
|
Attendance/Membership Fees
|
|
Equity
Award
April 1,
2019
(1)
|
|
Equity
Award
August 14, 2019
(2)
|
|
Total
|
||||||||||
|
Richard B. Evans
|
|
€
|
96,500
|
|
|
€
|
56,500
|
|
|
€
|
44,505
|
|
|
€
|
40,100
|
|
|
€
|
237,605
|
|
|
Guy Maugis
|
|
€
|
69,000
|
|
|
€
|
20,000
|
|
|
€
|
35,604
|
|
|
€
|
31,189
|
|
|
€
|
155,793
|
|
|
Philippe Guillemot
(3)
|
|
€
|
65,000
|
|
|
€
|
9,000
|
|
|
€
|
35,604
|
|
|
€
|
31,189
|
|
|
€
|
140,793
|
|
|
Michiel Brandjes
|
|
€
|
65,000
|
|
|
€
|
14,000
|
|
|
€
|
35,604
|
|
|
€
|
31,189
|
|
|
€
|
145,793
|
|
|
Werner P. Paschke
|
|
€
|
72,500
|
|
|
€
|
18,000
|
|
|
€
|
35,604
|
|
|
€
|
31,189
|
|
|
€
|
157,293
|
|
|
Peter F. Hartman
|
|
€
|
69,000
|
|
|
€
|
16,000
|
|
|
€
|
35,604
|
|
|
€
|
31,189
|
|
|
€
|
151,793
|
|
|
John Ormerod
|
|
€
|
65,000
|
|
|
€
|
25,000
|
|
|
€
|
35,604
|
|
|
€
|
31,189
|
|
|
€
|
156,793
|
|
|
Lori A. Walker
|
|
€
|
65,000
|
|
|
€
|
29,000
|
|
|
€
|
35,604
|
|
|
€
|
31,189
|
|
|
€
|
160,793
|
|
|
Martha Brooks
|
|
€
|
65,000
|
|
|
€
|
30,000
|
|
|
€
|
35,604
|
|
|
€
|
31,189
|
|
|
€
|
161,793
|
|
|
Stéphanie Frachet
(4)
|
|
€
|
—
|
|
|
€
|
—
|
|
|
€
|
—
|
|
|
€
|
—
|
|
|
€
|
—
|
|
|
Total
|
|
€
|
632,000
|
|
|
€
|
217,500
|
|
|
€
|
329,337
|
|
|
€
|
289,612
|
|
|
€
|
1,468,449
|
|
|
(1)
|
The amount reported in this column represents the grant date fair value of RSU awards granted on April 1, 2019, computed in accordance with IFRS 2. On April 1, 2019, Mr. Evans was granted 6,266 RSUs and each of the other non-executive directors, except for Ms. Frachet, was granted 5,013 RSUs. 50% of the RSUs (“April Tranche I”) granted on April 1, 2019 will vest on the earlier of (i) April 1, 2020 or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service. 50% of the RSUs (“April Tranche II”) granted on April 1, 2019 will vest on the earlier of (i) April 1, 2021 or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service. Amounts have been converted to Euros based on an exchange rate of 0.8901 Dollars to Euros to reflect the equivalent of $ 50,000 for the Chairman and $ 40,000 for each other non-executive director, except for Ms. Frachet. See also Note 31 of the Consolidated Financial Statements.
|
|
(2)
|
The amount reported in this column represents the grant date fair value of the RSU awards granted on August 14, 2019, computed in accordance with IFRS 2. Mr. Evans was granted 3,797 RSUs and each of the other non-executive directors, except for Ms. Frachet, was granted 2,954 RSUs. 50% of the RSUs (“August Tranche I”) granted on August 14, 2019 will vest on the earlier of (i) August 14, 2020 or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service. 50% of the RSUs (“August Tranche II”) granted on August 14, 2019 will vest on the earlier of (i) August 14, 2021 or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service. Amounts have been converted to Euros based on an exchange rate of 0.8911 Dollars to Euros to reflect the equivalent of $45,000 for the Chairman and $35,000 for each other non-executive director, except for Ms. Frachet. See also Note 31 of the Consolidated Financial Statements.
|
|
(3)
|
Mr. Guillemot resigned as a non-executive director effective December 13, 2019.
|
|
(4)
|
Ms. Frachet did not receive any fees for her services.
|
|
•
|
$500,000 Chairman of the Board
|
|
•
|
$250,000 Other non-executive directors
|
|
Name
|
|
Base Salary
Paid
|
|
Bonus EPA
Paid
|
|
Equity
Awards
(1)
|
|
Pension
(2)
|
|
Other
Compensation
(3)
|
|
Total
(4)
|
||||||||||||
|
Jean-Marc Germain
|
|
€
|
959,288
|
|
|
€
|
1,259,908
|
|
|
€
|
4,095,081
|
|
|
€
|
22,514
|
|
|
€
|
221,436
|
|
|
€
|
6,558,227
|
|
|
Other Executive Officers
|
|
€
|
2,148,159
|
|
|
€
|
2,033,260
|
|
|
€
|
3,330,613
|
|
|
€
|
196,157
|
|
|
€
|
172,868
|
|
|
€
|
7,881,057
|
|
|
(1)
|
The amount reported as Equity Awards represents the grant date fair value of the awards granted in 2019, computed in accordance with IFRS 2. Jean-Marc Germain was granted the following in April 2019: (a) 291,219 performance-based restricted stock units (“PSUs”) (which can become a maximum of 582,438 shares); and (b) 148,557 RSUs. Our other executive officers listed were granted, in the aggregate, 236,854 PSUs (which can become a maximum of 473,708) and 120,825 RSUs. The PSUs vest on the third anniversary of the date of grant, subject to continued service and certain market-related performance conditions being satisfied, and have a vesting range of 0-200%. RSUs vest 100% on the third anniversary of the date of grant, subject to continued service. See hereafter “2019 Long-Term Incentive Plan” for description of market-related performance conditions. See also Note 31 of the Consolidated Financial Statements for more information.
|
|
(2)
|
Pension represents amounts contributed by the Company during the 2019 fiscal year to the U.S. and Swiss governments as part of the employer overall pension requirements apportioned to the base salary of these individuals.
|
|
(3)
|
Other compensation for Jean-Marc Germain includes car allowance, parking and premium for health, life and long-term disability insurance as well as non-qualified restoration contributions under the Constellium US Holdings I, LLC U.S. Non-qualified Deferred Compensation and Restoration Plan (new in 2019, see below). Other compensation for Ms. Joerg as well as for Messrs. Matt, Warton and Basten includes flights (including for family members), car allowance, lunch allowance, tax and medical services, relocation and premiums for life and long-term disability insurance.
|
|
(4)
|
The total remuneration paid to such executive officers, including Mr. Germain and Mr. Matt, during our 2019 fiscal year amounted to €7,013,590, consisting of (a) an aggregate base salary of €3,107,447, (b) aggregate short-term incentive compensation of €3,293,168, and (c) aggregate other compensation in an amount equal to €394,304. The total amount contributed to the value of the pensions for such executive officers was €218,671.
|
|
•
|
400% of base salary CEO
|
|
•
|
200% of base salary CFO and Business Unit Presidents
|
|
•
|
100% of base salary Other executive officers
|
|
•
|
Financial Objectives — 70%
|
|
•
|
EHS Objective — 10%
|
|
•
|
Individual Objectives — 20%
|
|
•
|
Financial Objectives: The payout ranged from 0% to 183%
|
|
•
|
EHS Objective: The payout ranged from 0% to 200%;
|
|
•
|
Individual Objectives: The payout ranged from 0% to 150%. The payout for Mr. Germain was 125%.
|
|
•
|
the human resources and remuneration committee no longer has the power to make awards of any type;
|
|
•
|
the Board of Directors has exclusive power to make awards that are to be settled with shares;
|
|
•
|
the Board of Directors has exclusive power to make awards to the Company’s CEO and other executive corporate officers (mandataires sociaux dirigeants), if any, irrespective of the form of settlement; and
|
|
•
|
the Company’s senior management has exclusive power to make awards that are cash-settled (other than to the Company’s CEO and other executive corporate officers (mandataires sociaux dirigeants), if any).
|
|
•
|
which directors, officers, employees and consultants are to be granted awards;
|
|
•
|
the type of award that is granted;
|
|
•
|
the number of our ordinary shares subject to the awards; and
|
|
•
|
the terms and conditions of such awards, consistent with the Constellium 2013 Equity Plan.
|
|
•
|
grants be made by the Board of Directors only, and only pursuant to an authorization of the shareholders which may not have a validity of more than 38 months;
|
|
•
|
no such shareholder authorization may exceed 10% of share capital;
|
|
•
|
only officers and employees are eligible to receive share-settled awards (as described above under “Eligibility”); and
|
|
•
|
persons holding more than 10% of the share capital prior to grant or as a result of the grant are ineligible.
|
|
•
|
If the Constellium TSR is below the average of the two 25th percentile TSRs of the Comparator Group, no PSUs will vest.
|
|
•
|
If the Constellium TSR is at the average of the two 25th percentile TSRs of the Comparator Group, 25% of the target PSUs will vest.
|
|
•
|
If the Constellium TSR is at the average of the two median TSRs of the Comparator Group, 100% of the target PSUs will vest.
|
|
•
|
If the Constellium TSR is between the average of the two 25th percentile TSRs and the average of the two median TSRs of the Comparator Group, then the number of PSUs will be determined by linear interpolation on a straight line basis.
|
|
•
|
If the Constellium TSR is at or above the average of the two 75th percentile TSRs of the Comparator Group, 200% of the target PSUs will vest.
|
|
•
|
If the Constellium TSR is between the average of the two median TSRs and the average of the two 75th percentile TSRs of the Comparator Group, then the number of PSUs will be determined by linear interpolation on a straight line basis.
|
|
•
|
If the Constellium TSR is negative, the number of PSUs that vest will be capped at 100% of target.
|
|
C.
|
Board Practices
|
|
•
|
our financial reporting process and internal control system;
|
|
•
|
the integrity of our consolidated financial statements;
|
|
•
|
the independence, qualifications and performance of our independent registered public accounting firm;
|
|
•
|
the performance of our internal audit function; and
|
|
•
|
our compliance with legal, ethical and regulatory matters.
|
|
•
|
to review, evaluate and make recommendations to the full Board regarding our compensation policies and establish performance-based incentives that support our long-term goals, objectives and interests;
|
|
•
|
to review and approve the compensation of our Chief Executive Officer, all employees who report directly to our Chief Executive Officer and other members of our senior management;
|
|
•
|
to review and approve the departure conditions of employees who reported directly to our CEO and who have left Constellium;
|
|
•
|
to review and approve compensation structure and level of any new employee who reports directly to our CEO;
|
|
•
|
to review and make recommendations to the Board with respect to our incentive compensation plans and equity-based compensation plans;
|
|
•
|
to set and review the compensation of and reimbursement policies for members of the Board;
|
|
•
|
to provide oversight concerning selection of officers, management succession planning, expense accounts, indemnification and insurance matters, and separation packages; and
|
|
•
|
to provide regular reports to the Board and take such other actions as are necessary and consistent with our Articles of Association.
|
|
•
|
to establish criteria for Board and committee membership and recommend to our Board proposed nominees for election to the Board and for membership on committees of our Board; and
|
|
•
|
to make recommendations to our Board regarding board governance matters and practices; and
|
|
•
|
to review conflicts of interest, related party matters and director independence.
|
|
•
|
the Company’s policies, practices and programs with respect to the management of EHS affairs, including sustainability;
|
|
•
|
the adequacy of the Company’s policies, practices and programs for ensuring compliance with EHS laws and regulations; and
|
|
•
|
any significant EHS litigation and regulatory proceedings in which the Company is or may become involved.
|
|
D.
|
Employees
|
|
E.
|
Share Ownership
|
|
A.
|
Major Shareholders
|
|
Name of beneficial owner
|
|
Number of
ordinary
shares
|
|
|
|
Beneficial
ownership
percentage
|
||
|
Caisse des Dépôts (f/k/a Caisse des Dépôts et Consignations),
Bpifrance Participations S.A., Bpifrance S.A. (f/k/a BPI-Groupe), EPIC Bpifrance (f/k/a EPIC BPI-Groupe)
|
|
16,393,903
|
|
|
(1)
|
|
11.9
|
%
|
|
T. Rowe Price Associates, Inc.
|
|
9,840,684
|
|
|
(2)
|
|
7.1
|
%
|
|
Directors and Senior Management
|
|
|
|
|
|
|
||
|
Richard B. Evans
|
|
236,219
|
|
|
(3)
|
|
*
|
|
|
Guy Maugis
|
|
22,799
|
|
|
(4)
|
|
*
|
|
|
Philippe Guillemot
|
|
23,957
|
|
|
(5)
|
|
*
|
|
|
Werner P. Paschke
|
|
102,382
|
|
|
(6)
|
|
*
|
|
|
Michiel Brandjes
|
|
34,748
|
|
|
(7)
|
|
*
|
|
|
Peter F. Hartman
|
|
24,570
|
|
|
(8)
|
|
*
|
|
|
John Ormerod
|
|
26,435
|
|
|
(9)
|
|
*
|
|
|
Lori A. Walker
|
|
24,274
|
|
|
(10)
|
|
*
|
|
|
Martha Brooks
|
|
28,642
|
|
|
(11)
|
|
*
|
|
|
Stéphanie Frachet
|
|
—
|
|
|
(12)
|
|
*
|
|
|
Jean-Marc Germain
|
|
355,000
|
|
|
(13)
|
|
|
|
|
Peter R. Matt
|
|
213,382
|
|
|
(14)
|
|
*
|
|
|
Ingrid Joerg
|
|
140,840
|
|
|
(15)
|
|
*
|
|
|
Paul Warton
|
|
166,276
|
|
|
(16)
|
|
*
|
|
|
Peter Basten
|
|
174,150
|
|
|
(17)
|
|
*
|
|
|
*
|
Represents beneficial ownership of less than 1%.
|
|
(1)
|
This information is based on a Schedule 13D/A filed with the SEC on November 8, 2017. Bpifrance Participations S.A. (f/k/a Fonds Stratégique d'Investissement, “Bpifrance”) is a French public investment fund specializing in the business of equity financing via direct investments or fund and a wholly owned subsidiary of Bpifrance S.A., a French financial institution (“Bpifrance S.A.”). Caisse des Dépôts (“CDC”) and EPIC Bpifrance (“EPIC”) each hold 50% of the share capital of Bpifrance S.A. and jointly control Bpifrance S.A. CDC is principally engaged in the business of long-term investments. EPIC is principally engaged in the business of banking finance. Bpifrance holds directly 16,393,903 ordinary shares of the Company. As of the date hereof, neither Bpifrance S.A., CDC nor EPIC holds any ordinary shares
|
|
(2)
|
This information is based on a Schedule 13G filed with the SEC on February 14, 2020 reporting beneficial ownership as of December 31, 2019. T.Rowe Price Associates, Inc. has sole dispositive power with respect to 9,840,684 ordinary shares and sole voting power with respect to 2,287,839 ordinary shares.
|
|
(3)
|
Consists of 236,219 ordinary shares held indirectly by Mr. Evans through the Evans Family Inter Vivos Revocable Trust. Excludes the remaining portions of previous grants: 3,133 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 2,074 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) May 25, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 1,899 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 3,133 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2021 or (ii) the date of the annual general meeting of shareholders of that year; and 1,898 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2021 or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service.
|
|
(4)
|
Consists of 22,799 ordinary shares held directly by Mr. Maugis. Excludes the remaining portions of previous grants: 2,507 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 1,660 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) May 25, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 2,506 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2021 or (ii) the date of the annual general meeting of shareholders of that year; and 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2021 or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service.
|
|
(5)
|
Consists of 23,957 ordinary shares held directly by Mr. Guillemot. Excludes the remaining unvested portions of grants which were canceled due to the resignation of Mr. Guillemot effective December 13, 2019.
|
|
(6)
|
Consists of 102,382 ordinary shares held directly by Mr. Paschke. Excludes the remaining portions of previous grants: 2,507 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 1,660 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) May 25, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 2,506 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2021 or (ii) the date of the annual general meeting of shareholders of that year; and 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2021 or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service.
|
|
(7)
|
Consists of 34,748 ordinary shares held directly by Mr. Brandjes. Excludes the remaining portions of previous grants: 2,507 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 1,660 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) May 25, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 2,506 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2021 or (ii) the date of the annual general meeting of shareholders of that year; and 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2021 or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service.
|
|
(8)
|
Consists of 24,570 ordinary shares held directly by Mr. Hartman. Excludes the remaining portions of previous grants: 2,507 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 1,660 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) May 25, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 2,506 ordinary shares underlying unvested RSUs that will vest on the earlier of
|
|
(9)
|
Consists of 26,435 ordinary shares held by Mr. Ormerod. Excludes the remaining portions of previous grants: 2,507 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 1,660 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) May 25, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 2,506 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2021 or (ii) the date of the annual general meeting of shareholders of that year; and 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2021 or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service.
|
|
(10)
|
Consists of 24,274 ordinary shares held directly by Ms. Walker. Excludes the remaining portions of previous grants: 2,507 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 1,660 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) May 25, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 2,506 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2021 or (ii) the date of the annual general meeting of shareholders of that year; and 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2021 or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service.
|
|
(11)
|
Consists of 28,642 ordinary shares held directly by Ms. Brooks. Excludes the remaining portions of previous grants: 2,507 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 1,660 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) May 25, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2020 or (ii) the date of the annual general meeting of shareholders of that year; 2,506 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2021 or (ii) the date of the annual general meeting of shareholders of that year; and 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2021 or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service.
|
|
(12)
|
No ordinary shares are held directly by Ms. Frachet and no RSUs or PSUs were granted in 2019.
|
|
(13)
|
Consists of 355,000 ordinary shares held directly by Mr. Germain. Excludes the remaining portions of previous grants: 216,943 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on July 31, 2020, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; 110,667 ordinary shares underlying unvested RSUs that will vest on July 31, 2020, subject to continued service; 197,531 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on May 25, 2021, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; 100,765 ordinary shares underlying unvested RSUs that will vest on May 25, 2021, subject to continued service; 291,219 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 1, 2022, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 148,557 ordinary shares underlying unvested RSUs that will vest on April 1, 2022, subject to continued service.
|
|
(14)
|
Consists of 213,382 ordinary shares held directly by Mr. Matt. Excludes the remaining portions of previous grants: 71,946 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on July 31, 2020, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; 36,701 ordinary shares underlying unvested RSUs that will vest on July 31, 2020, subject to continued service; 67,901 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on May 25, 2021, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; 34,638 ordinary shares underlying unvested RSUs that will vest on May 25, 2021, subject to continued service; 99,847 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 1, 2022, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 50,934 ordinary shares underlying unvested RSUs that will vest on April 1, 2022, subject to continued service.
|
|
(15)
|
Consists of 140,840 ordinary shares held directly by Ms. Joerg. Excludes the remaining portions of previous grants: 47,214 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on July 31, 2020, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; 24,085 ordinary shares underlying unvested RSUs that will vest on July 31, 2020, subject to continued service; 34,462 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on May 25, 2021, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; 17,580 ordinary shares underlying unvested RSUs that will vest on May 25, 2021, subject to continued service; 45,669 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 1, 2022, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 23,297 ordinary shares underlying unvested RSUs that will vest on April 1, 2022, subject to continued service.
|
|
(16)
|
Consists of 166,276 ordinary shares held directly by Mr. Warton. Excludes the remaining portions of previous grants: 42,170 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on July 31, 2020, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; 21,512 ordinary shares underlying unvested RSUs that will vest on July 31, 2020, subject to continued service; 34,462 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on May 25, 2021, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; 17,580 ordinary shares underlying unvested RSUs that will vest on May 25, 2021, subject to continued service; 45,669 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 1, 2022, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 23,297 ordinary shares underlying unvested RSUs that will vest on April 1, 2022, subject to continued service.
|
|
(17)
|
Consists of 174,150 ordinary shares held directly by Mr. Basten. Excludes the remaining portions of previous grants: 31,485 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on July 31, 2020, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; 16,061 ordinary shares underlying unvested RSUs that will vest on July 31, 2020, subject to continued service; 34,462 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on May 25, 2021, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; 17,580 ordinary shares underlying unvested RSUs that will vest on May 25, 2021, subject to continued service; 45,669 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 1, 2022, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 23,297 ordinary shares underlying unvested RSUs that will vest on April 1, 2022, subject to continued service.
|
|
B.
|
Related Party Transactions
|
|
C.
|
Interests of Experts and Counsel
|
|
A.
|
Consolidated Statements and Other Financial Information
|
|
B.
|
Significant Changes
|
|
A.
|
Offer and Listing Details
|
|
B.
|
Plan of Distribution
|
|
C.
|
Markets
|
|
D.
|
Selling Shareholders
|
|
E.
|
Dilution
|
|
F.
|
Expenses of the Issue
|
|
A.
|
Share Capital
|
|
B.
|
Memorandum and Articles of Association
|
|
•
|
on November 3, 2017 the Company issued 25,000,000 Class A ordinary shares, each with a nominal value of €0.02;
|
|
•
|
on November 3, 2017 the Company issued 3,750,000 Class A ordinary shares, each with a nominal value of €0.02;
|
|
•
|
on November 15, 2017 the Company issued 25,000 Class A ordinary shares, each with a nominal value of €0.02;
|
|
•
|
on March 28, 2018 the Company issued 34,580 Class A ordinary shares, each with a nominal value of €0.02;
|
|
•
|
on May 17, 2018 the Company issued 80,000 Class A ordinary shares, each with a nominal value of €0.02;
|
|
•
|
on June 20, 2018 the Company issued 68,136 Class A ordinary shares, each with a nominal value of €0.02;
|
|
•
|
on August 6, 2018 the Company issued 50,000 Class A ordinary shares, each with a nominal value of €0.02; and
|
|
•
|
on November 15, 2018 the Company issued 1,256,055 Class A ordinary shares, each with a nominal value of €0.02;
|
|
•
|
on March 28, 2019 the Company issued 645,732 Class A ordinary shares, each with a nominal value of €0.02;
|
|
•
|
on May 29, 2019 the Company issued 144,691 Class A ordinary shares, each with a nominal value of €0.02;
|
|
•
|
on June 15, 2019 the Company issued 27,204 Class A ordinary shares, each with a nominal value of €0.02;
|
|
•
|
on August 7, 2019 the Company issued 534,256 Class A ordinary shares, each with a nominal value of €0.02; and
|
|
•
|
on November 18, 2019 the Company issued 516,141 Class A ordinary shares, each with a nominal value of €0.02.
|
|
C.
|
Material Contracts
|
|
•
|
Employment Agreements and Benefit Plans
. See “Item 6. Directors, Senior Management and Employees—E. Share Ownership” for a description of the material terms of our employment agreements and benefits plans.
|
|
•
|
Amended and Restated Shareholders Agreement
. See “Item 7. Major Shareholders and Related Party Transactions” for a description of material terms of this contract.
|
|
•
|
Notes, Pan-U.S. ABL Facility, French Inventory Facility and Factoring Agreements
. As disclosed below.
|
|
•
|
Metal Supply Agreement
. As disclosed below.
|
|
D.
|
Exchange Controls
|
|
E.
|
Taxation
|
|
•
|
distributions in cash or in kind, deemed and constructive distributions and repayments of paid-in capital not recognized for Dutch dividend withholding tax purposes;
|
|
•
|
liquidation proceeds, proceeds of redemption of ordinary shares or, generally, consideration for the repurchase of ordinary shares by us in excess of the average paid-in capital of those ordinary shares recognized for Dutch dividend withholding tax purposes;
|
|
•
|
the nominal value of ordinary shares issued to a shareholder or an increase of the nominal value of ordinary shares, as the case may be, to the extent that it does not appear that a contribution to the capital recognized for Dutch dividend withholding tax purposes was made or will be made; and
|
|
•
|
partial repayment of paid-in capital, recognized for Dutch dividend withholding tax purposes, if and to the extent that there are net profits (zuivere winst), within the meaning of the Dutch Dividend Withholding Tax Act 1965 (Wet op de dividendbelasting 1965), unless the general meeting of shareholders has resolved in advance to make such a repayment and provided that the nominal value of the ordinary shares concerned has been reduced by a corresponding amount by way of an amendment of our articles of association.
|
|
•
|
transactions on shares of the Company realized on the NYSE;
|
|
•
|
over the counter sales of ordinary shares of the Company published on the market or communicated to the regulator in application of the MIF Directive or foreign provisions equivalent to the MIF Directive, provided that they are not evidenced by a written agreement; and
|
|
•
|
over the counter transactions carried out on ordinary shares of the Company in connection with transactions that are the subject of the same publishing or communication obligations, provided that they are not evidenced by a written agreement.
|
|
F.
|
Dividends and Paying Agents
|
|
G.
|
Statement of Experts
|
|
H.
|
Documents on Display
|
|
I.
|
Subsidiary Information
|
|
•
|
Note 2—Summary of Significant Accounting Policies—2.6— Principles governing the preparation of the Consolidated Financial Statements— Financial Instruments; and
|
|
•
|
|
|
A.
|
Material Modifications to the Rights of Security Holders
|
|
B.
|
Use of Proceeds
|
|
A.
|
Disclosure Controls and Procedures
|
|
B.
|
Management’s Annual Report on Internal Control over Financial Reporting
|
|
C.
|
Attestation report of the registered public accounting firm.
|
|
D.
|
Changes in Internal Control over Financial Reporting
|
|
|
|
For the year ended December 31,
|
||||
|
|
|
2019
|
|
2018
|
||
|
|
|
(€ in thousands)
|
||||
|
Audit fees
|
|
3,948
|
|
|
4,048
|
|
|
Audit-related fees
|
|
448
|
|
|
224
|
|
|
Tax fees
|
|
202
|
|
|
276
|
|
|
All other fees
|
|
2
|
|
|
3
|
|
|
Total
(1)
|
|
4,600
|
|
|
4,551
|
|
|
•
|
Audit Committee
-The Board’s audit committee is responsible for selecting our statutory auditors and making a recommendation to our Board regarding the terms of their compensation. As required by French law, the actual appointment of the statutory auditors has to be made by the shareholders at a general meeting of the shareholders. Such appointment was made at our last shareholders' meeting held on November 25, 2019 and became effective on December 12, 2019.
|
|
•
|
Committee Powers
-While the NYSE Listed Company Manual empowers board committees with decision-making authority that can be delegated by a company’s board, under French law, committees of the Company recommend to the full Board, which will be the decision-making body (not its committees).
|
|
•
|
Executive Sessions/Communications with Independent Directors
-French law does not require for our independent directors to meet regularly without management, nor does it require the independent directors to meet alone in executive session at least once a year, as required by the NYSE Listed Company Manual. However, if our independent directors decide to engage in either or both of these activities, they will be permitted to do so. In practice, our independent directors regularly meet among themselves for discussions, but we do not expect them to be under any requirement to do so under our Articles of Association or French law. In addition, French law does not require a method for interested parties to communicate with our independent directors.
|
|
•
|
Equity Compensation Plans
-French law requires shareholder approval at a general meeting of the shareholders to adopt an equity compensation plan, which is consistent with the shareholder vote required by the NYSE Listed Company Manual. It is common practice after obtaining such shareholder approval for the shareholders of a French company to then delegate to such company’s board the authority to decide on the specific terms of the granting of equity compensation, within the limits of the shareholders’ authorization. The shareholders of the Company at the general meeting held on November 25, 2019 voted on such an authorization (effective as of December 12, 2019) to delegate such authority to the Board, and going forward we expect our Board to perform such functions for the Company.
|
|
•
|
Corporate Governance Guidelines
-A Board Internal Charter is required by the NYSE Listed Company Manual for U.S. companies listed on the NYSE that would set forth certain corporate governance practices of a listed company’s board. Our Board Internal Charter after the Transfer covers all items required by the NYSE Listed Company Manual subject to certain differences set forth by French law, particularly with respect to Committee powers (as described above) and conflict of interest transactions (as described below).
|
|
•
|
Conflicts of Interest
-Pursuant to French law and the Articles of Association, any agreement (directly or through an intermediary) between the Company and any director of the Company that is not entered into (i) in the ordinary course of business and (ii) under normal terms and conditions will be subject to the prior authorization of the Board, excluding the participation and vote of the interested director. As required by French law, any such agreement will also be subject to approval at the next ordinary shareholders’ meeting (by a simple majority, excluding the vote of interested persons). If the transaction has not been pre-approved by the Board, it can be nullified if it has prejudicial consequences for the Company. If it is not approved by the shareholders, interested directors may be held liable for any prejudicial consequences for the Company of the unapproved transaction; such transaction will nevertheless remain valid, unless it is nullified in case of fraud. The foregoing requirements also apply to agreements between the Company and another entity if one of the Company’s directors is an owner, a general partner, manager, director, general manager, member of the executive or supervisory board of the other entity, as well as to agreements in which one of the Company’s directors has an indirect interest. Aside from the foregoing requirements, there are no specific provisions prohibiting conflicted directors to participate or vote at a Board meeting. However, as a general rule under French law, directors must act in the interest of the Company.
|
|
•
|
their voting instructions will be transmitted to the Company via the French Intermediary, acting as intermediary for the account of all shareholders registered on the U.S. Register, in accordance with articles L. 228-1 et seq. of the French Commercial Code;
|
|
•
|
the French Record Date will be set;
|
|
•
|
an additional record date will be fixed for all shareholders registered on the U.S. Register, which date will be the 25th day before the meeting (the “U.S. Mailing Record Date”); and
|
|
•
|
shareholders who purchase shares between the U.S. Mailing Record Date and the French Record Date will be entitled to participate and vote at the shareholders’ meeting as long as they continue to be shareholders on the French Record Date. However, given the short time between the French Record Date and the shareholders’ meeting date, shareholders as of the French Record Date may not have received the notices and information received by shareholders holding shares registered on the U.S. Register as of the U.S. Mailing Record Date. To the extent that shareholders as of the U.S. Mailing Record Date have sent voting instructions and sold or otherwise transferred their shares as of the French Record Date, such voting instructions will be invalidated or modified by the Company, as the case may be, in accordance with articles R. 225-85 and R. 225-86 of the French Commercial Code.
|
|
•
|
one or several shareholders holding at least 5% of the share capital, or
|
|
•
|
any interested party or the workers committee in cases of urgency.
|
|
•
|
With a view to distributing within one year of their repurchase the relevant shares to employees or managers under a profit-sharing, restricted free share or share option plan, not to exceed 10% of the share capital;
|
|
•
|
In payment or in exchange for assets acquired by the company within two years of their repurchase, not to exceed 5% of the share capital;
|
|
•
|
To sell the relevant shares to any shareholders willing to purchase them as part of a process organized by the company within five years, not to exceed 10% of the share capital.
|
|
•
|
the approval of the board of directors; and
|
|
•
|
the approval by a two-thirds majority of the votes held by the shareholders present, represented by proxy or voting by mail at the relevant meeting, or in the case of a legal merger (fusion) with a non-EU company, approval of all the shareholders of the company.
|
|
4.1
|
|
|
|
|
|
4.2
|
|
|
|
|
|
4.3
|
|
|
|
|
|
4.4
|
|
|
|
|
|
4.5
|
|
|
|
|
|
4.6
|
|
|
|
|
|
4.7
|
|
|
|
|
|
4.8
|
|
|
|
|
|
4.9
|
|
|
|
|
|
4.10
|
|
|
|
|
|
4.11
|
|
|
|
|
|
4.12
|
|
|
|
|
|
4.12.1
|
|
|
|
|
|
4.13
|
|
|
|
|
|
4.14
|
|
|
|
|
|
4.15
|
|
|
|
|
|
4.16
|
|
|
|
|
|
4.17
|
|
|
|
|
|
4.17.2
|
|
|
|
|
|
4.18
|
|
|
|
|
|
4.19
|
|
|
|
|
|
4.20
|
|
|
|
|
|
4.21
|
|
|
|
|
|
4.22
|
|
|
|
|
|
4.23
|
|
|
|
|
|
4.24
|
|
|
|
|
|
4.25
|
|
|
|
|
|
4.26
|
|
|
|
|
|
4.27
|
|
|
|
|
|
4.28
|
|
|
|
|
|
4.29
|
|
|
|
|
|
4.30
|
|
|
|
|
|
4.31
|
|
|
|
|
|
4.32
|
|
|
|
|
|
4.33
|
|
|
|
|
|
4.34
|
|
|
|
|
|
4.35
|
|
|
|
|
|
4.36
|
|
|
|
|
|
4.37
|
|
|
|
|
|
4.38
|
|
|
|
|
|
4.39
|
|
|
|
|
|
4.40
|
|
|
|
|
|
4.41
|
|
|
|
|
|
4.42
|
|
|
|
|
|
4.43
|
|
|
|
|
|
4.43.1
|
|
|
|
|
|
4.44
|
|
|
|
|
|
4.45
|
|
|
|
|
|
4.45.1
|
|
|
|
|
|
4.46
|
|
|
|
|
|
4.46.1
|
|
|
|
|
|
4.46.2
|
|
|
|
|
|
4.47
|
|
|
|
|
|
4.48
|
|
|
|
|
|
4.48.1
|
|
|
|
|
|
10.1
|
|
|
|
|
|
10.2
|
|
|
|
|
|
10.3
|
|
|
|
|
|
10.4
|
|
|
|
|
|
10.5
|
|
|
|
|
|
10.6
|
|
|
|
|
|
10.7
|
|
|
|
|
|
10.8
|
|
|
|
|
|
10.8.1
|
|
|
|
|
|
10.8.2
|
|
|
|
|
|
10.9
|
|
|
|
|
|
10.9.1
|
|
|
|
|
|
10.9.2
|
|
|
|
|
|
10.9.3
|
|
|
|
|
|
10.10
|
|
|
|
|
|
10.10.1
|
|
|
|
|
|
10.11
|
|
|
|
|
|
10.11.1
|
|
|
|
|
|
10.12
|
|
|
|
|
|
10.12.1
|
|
|
|
|
|
10.12.2
|
|
|
|
|
|
10.13
|
|
|
|
|
|
10.13.1
|
|
|
|
|
|
10.13.2
|
|
|
|
|
|
10.14
|
|
|
|
|
|
10.15
|
|
|
|
|
|
10.15.1
|
|
|
|
|
|
10.15.2
|
|
|
|
|
|
10.15.3
|
|
|
|
|
|
10.16
|
|
|
|
|
|
10.17
|
|
|
|
|
|
10.18
|
|
|
|
|
|
10.19
|
|
|
|
|
|
10.20
|
|
|
|
|
|
10.22
|
|
|
|
|
|
10.23
|
|
|
|
|
|
10.24
|
|
|
|
|
|
10.24.1
|
|
|
|
|
|
10.25
|
|
|
|
|
|
10.25.1
|
|
|
|
|
|
10.25.2
|
|
|
|
|
|
10.25.3
|
|
|
|
|
|
10.25.4
|
|
|
|
|
|
10.25.5
|
|
|
|
|
|
10.25.6
|
|
|
|
|
|
10.28
|
|
|
|
|
|
10.29
|
|
|
|
|
|
10.30
|
|
|
|
|
|
10.30.1
|
|
|
|
|
|
10.30.2
|
|
|
|
|
|
10.30.3
|
|
|
|
|
|
10.30.4
|
|
|
|
|
|
10.30.5
|
|
|
|
|
|
10.30.6
|
|
|
|
|
|
10.31
|
|
|
|
|
|
10.32
|
|
|
|
|
|
10.33
|
|
|
|
|
|
12.1
|
|
|
|
|
|
12.2
|
|
|
|
|
|
13.1
|
|
|
|
|
|
13.2
|
|
|
|
|
|
15.1
|
|
|
|
|
|
15.2
|
|
|
|
|
|
21.1
|
|
|
|
|
|
101.INS
|
XBRL Instance Document**
|
|
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document**
|
|
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document**
|
|
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document**
|
|
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document**
|
|
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document**
|
|
CONSTELLIUM SE
|
||
|
|
|
|
|
By:
|
/s/ Jean-Marc Germain
|
|
|
|
Name:
|
Jean-Marc Germain
|
|
|
Title:
|
Chief Executive Officer
|
|
(in millions of Euros)
|
|
Notes
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Revenue
|
|
4
|
|
5,907
|
|
|
5,686
|
|
|
5,237
|
|
|
Cost of sales
|
|
|
|
(5,305
|
)
|
|
(5,148
|
)
|
|
(4,682
|
)
|
|
Gross profit
|
|
|
|
602
|
|
|
538
|
|
|
555
|
|
|
Selling and administrative expenses
|
|
|
|
(276
|
)
|
|
(247
|
)
|
|
(247
|
)
|
|
Research and development expenses
|
|
|
|
(48
|
)
|
|
(40
|
)
|
|
(36
|
)
|
|
Restructuring costs
|
|
|
|
(4
|
)
|
|
(1
|
)
|
|
(4
|
)
|
|
Other gains / (losses) - net
|
|
9
|
|
(19
|
)
|
|
154
|
|
|
70
|
|
|
Income from operations
|
|
|
|
255
|
|
|
404
|
|
|
338
|
|
|
Finance costs - net
|
|
11
|
|
(175
|
)
|
|
(149
|
)
|
|
(260
|
)
|
|
Share of income / (loss) of joint-ventures
|
|
19
|
|
2
|
|
|
(33
|
)
|
|
(29
|
)
|
|
Income before income tax
|
|
|
|
82
|
|
|
222
|
|
|
49
|
|
|
Income tax expense
|
|
12
|
|
(18
|
)
|
|
(32
|
)
|
|
(80
|
)
|
|
Net income / (loss)
|
|
|
|
64
|
|
|
190
|
|
|
(31
|
)
|
|
Income attributable to:
|
|
|
|
|
|
|
|
|
|||
|
Equity holders of Constellium
|
|
|
|
59
|
|
|
188
|
|
|
(31
|
)
|
|
Non-controlling interests
|
|
|
|
5
|
|
|
2
|
|
|
—
|
|
|
Net income / (loss)
|
|
|
|
64
|
|
|
190
|
|
|
(31
|
)
|
|
(in Euros per share)
|
|
Notes
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Basic
|
|
13
|
|
0.43
|
|
|
1.40
|
|
|
(0.28
|
)
|
|
Diluted
|
|
13
|
|
0.41
|
|
|
1.37
|
|
|
(0.28
|
)
|
|
(in millions of Euros)
|
|
Notes
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Net income / (loss)
|
|
|
|
64
|
|
|
190
|
|
|
(31
|
)
|
|
Other comprehensive income / (loss)
|
|
|
|
|
|
|
|
|
|||
|
Items that will not be reclassified subsequently to the consolidated income statement
|
|
|
|
|
|
|
|
|
|||
|
Remeasurement on post-employment benefit obligations
|
|
|
|
(61
|
)
|
|
24
|
|
|
12
|
|
|
Income tax on remeasurement on post-employment benefit obligations
|
|
|
|
13
|
|
|
(6
|
)
|
|
(8
|
)
|
|
Items that may be reclassified subsequently to the consolidated income statement
|
|
|
|
|
|
|
|
|
|||
|
Cash flow hedges
|
|
24
|
|
(8
|
)
|
|
(25
|
)
|
|
46
|
|
|
Net investment hedges
|
|
24
|
|
4
|
|
|
(4
|
)
|
|
—
|
|
|
Income tax on hedges
|
|
20
|
|
2
|
|
|
8
|
|
|
(15
|
)
|
|
Currency translation differences
|
|
|
|
1
|
|
|
10
|
|
|
(20
|
)
|
|
Other comprehensive (loss) / income
|
|
|
|
(49
|
)
|
|
7
|
|
|
15
|
|
|
Total comprehensive income / (loss)
|
|
|
|
15
|
|
|
197
|
|
|
(16
|
)
|
|
Attributable to:
|
|
|
|
|
|
|
|
|
|||
|
Equity holders of Constellium
|
|
|
|
10
|
|
|
195
|
|
|
(15
|
)
|
|
Non-controlling interests
|
|
|
|
5
|
|
|
2
|
|
|
(1
|
)
|
|
Total comprehensive income / (loss)
|
|
|
|
15
|
|
|
197
|
|
|
(16
|
)
|
|
(in millions of Euros)
|
|
Notes
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||
|
Assets
|
|
|
|
|
|
|
||
|
Current assets
|
|
|
|
|
|
|
||
|
Cash and cash equivalents
|
|
14
|
|
184
|
|
|
164
|
|
|
Trade receivables and other
|
|
15
|
|
474
|
|
|
587
|
|
|
Inventories
|
|
16
|
|
670
|
|
|
660
|
|
|
Other financial assets
|
|
23
|
|
22
|
|
|
30
|
|
|
|
|
|
|
1,350
|
|
|
1,441
|
|
|
Non-current assets
|
|
|
|
|
|
|
||
|
Property, plant and equipment
|
|
17
|
|
2,056
|
|
|
1,666
|
|
|
Goodwill
|
|
18
|
|
455
|
|
|
422
|
|
|
Intangible assets
|
|
18
|
|
70
|
|
|
70
|
|
|
Investments accounted for under the equity method
|
|
19
|
|
1
|
|
|
1
|
|
|
Deferred income tax assets
|
|
20
|
|
185
|
|
|
163
|
|
|
Trade receivables and other
|
|
15
|
|
60
|
|
|
64
|
|
|
Other financial assets
|
|
23
|
|
7
|
|
|
74
|
|
|
|
|
|
|
2,834
|
|
|
2,460
|
|
|
Total Assets
|
|
|
|
4,184
|
|
|
3,901
|
|
|
Liabilities
|
|
|
|
|
|
|
||
|
Current liabilities
|
|
|
|
|
|
|
||
|
Trade payables and other
|
|
21
|
|
999
|
|
|
968
|
|
|
Borrowings
|
|
22
|
|
201
|
|
|
57
|
|
|
Other financial liabilities
|
|
23
|
|
35
|
|
|
60
|
|
|
Income tax payable
|
|
|
|
14
|
|
|
8
|
|
|
Provisions
|
|
26
|
|
23
|
|
|
46
|
|
|
|
|
|
|
1,272
|
|
|
1,139
|
|
|
Non-current liabilities
|
|
|
|
|
|
|
||
|
Trade payables and other
|
|
21
|
|
21
|
|
|
27
|
|
|
Borrowings
|
|
22
|
|
2,160
|
|
|
2,094
|
|
|
Other financial liabilities
|
|
23
|
|
23
|
|
|
29
|
|
|
Pension and other post-employment benefit obligations
|
|
25
|
|
670
|
|
|
610
|
|
|
Provisions
|
|
26
|
|
99
|
|
|
94
|
|
|
Deferred income tax liabilities
|
|
20
|
|
24
|
|
|
22
|
|
|
|
|
|
|
2,997
|
|
|
2,876
|
|
|
Total Liabilities
|
|
|
|
4,269
|
|
|
4,015
|
|
|
Equity
|
|
|
|
|
|
|
||
|
Share capital
|
|
28
|
|
3
|
|
|
3
|
|
|
Share premium
|
|
28
|
|
420
|
|
|
420
|
|
|
Retained deficit and other reserves
|
|
|
|
(519
|
)
|
|
(545
|
)
|
|
Equity attributable to equity holders of Constellium
|
|
|
|
(96
|
)
|
|
(122
|
)
|
|
Non controlling interests
|
|
|
|
11
|
|
|
8
|
|
|
Total Equity
|
|
|
|
(85
|
)
|
|
(114
|
)
|
|
Total Equity and Liabilities
|
|
|
|
4,184
|
|
|
3,901
|
|
|
(in millions of Euros)
|
|
Share capital
|
|
Share premium
|
|
Re-
measurement |
|
Cash flow hedges and net investment hedges
|
|
Foreign currency translation reserve
|
|
Other reserves
|
|
Retained losses
|
|
Total Equity holders of Constellium
|
|
Non-controlling interests
|
|
Total equity
|
||||||||||
|
At January 1, 2019
|
|
3
|
|
|
420
|
|
|
(129
|
)
|
|
(8
|
)
|
|
3
|
|
|
37
|
|
|
(448
|
)
|
|
(122
|
)
|
|
8
|
|
|
(114
|
)
|
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
59
|
|
|
59
|
|
|
5
|
|
|
64
|
|
|
Other comprehensive (loss) / income
|
|
—
|
|
|
—
|
|
|
(48
|
)
|
|
(2
|
)
|
|
1
|
|
|
—
|
|
|
—
|
|
|
(49
|
)
|
|
—
|
|
|
(49
|
)
|
|
Total comprehensive (loss) / income
|
|
—
|
|
|
—
|
|
|
(48
|
)
|
|
(2
|
)
|
|
1
|
|
|
—
|
|
|
59
|
|
|
10
|
|
|
5
|
|
|
15
|
|
|
Transactions with equity holders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based compensation
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
16
|
|
|
—
|
|
|
16
|
|
|
—
|
|
|
16
|
|
|
Transactions with non-controlling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
(2
|
)
|
|
At December 31, 2019
|
|
3
|
|
|
420
|
|
|
(177
|
)
|
|
(10
|
)
|
|
4
|
|
|
53
|
|
|
(389
|
)
|
|
(96
|
)
|
|
11
|
|
|
(85
|
)
|
|
(in millions of Euros)
|
|
Share capital
|
|
Share premium
|
|
Re-
measurement |
|
Cash flow hedges and net investment hedges
|
|
Foreign currency translation reserve
|
|
Other reserves
|
|
Retained losses
|
|
Total Equity holders of Constellium
|
|
Non-controlling interests
|
|
Total equity
|
||||||||||
|
At January 1, 2018
|
|
3
|
|
|
420
|
|
|
(147
|
)
|
|
13
|
|
|
(7
|
)
|
|
25
|
|
|
(634
|
)
|
|
(327
|
)
|
|
8
|
|
|
(319
|
)
|
|
Change in accounting policies
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
(2
|
)
|
|
—
|
|
|
(2
|
)
|
|
At January 1, 2018, restated
|
|
3
|
|
|
420
|
|
|
(147
|
)
|
|
13
|
|
|
(7
|
)
|
|
25
|
|
|
(636
|
)
|
|
(329
|
)
|
|
8
|
|
|
(321
|
)
|
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
188
|
|
|
188
|
|
|
2
|
|
|
190
|
|
|
Other comprehensive income / (loss)
|
|
—
|
|
|
—
|
|
|
18
|
|
|
(21
|
)
|
|
10
|
|
|
—
|
|
|
—
|
|
|
7
|
|
|
—
|
|
|
7
|
|
|
Total comprehensive income / (loss)
|
|
—
|
|
|
—
|
|
|
18
|
|
|
(21
|
)
|
|
10
|
|
|
—
|
|
|
188
|
|
|
195
|
|
|
2
|
|
|
197
|
|
|
Transactions with equity holders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share issuance
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Share-based compensation
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12
|
|
|
—
|
|
|
12
|
|
|
—
|
|
|
12
|
|
|
Transactions with non-controlling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
(2
|
)
|
|
At December 31, 2018
|
|
3
|
|
|
420
|
|
|
(129
|
)
|
|
(8
|
)
|
|
3
|
|
|
37
|
|
|
(448
|
)
|
|
(122
|
)
|
|
8
|
|
|
(114
|
)
|
|
(in millions of Euros)
|
|
Share capital
|
|
Share premium
|
|
Re-
measurement |
|
Cash flow hedges
|
|
Foreign currency translation reserve
|
|
Other reserves
|
|
Retained losses
|
|
Total Equity holders of Constellium
|
|
Non-controlling interests
|
|
Total equity
|
||||||||||
|
At January 1, 2017
|
|
2
|
|
|
162
|
|
|
(151
|
)
|
|
(18
|
)
|
|
12
|
|
|
17
|
|
|
(603
|
)
|
|
(579
|
)
|
|
9
|
|
|
(570
|
)
|
|
Net loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(31
|
)
|
|
(31
|
)
|
|
—
|
|
|
(31
|
)
|
|
Other comprehensive income / (loss)
|
|
—
|
|
|
—
|
|
|
4
|
|
|
31
|
|
|
(19
|
)
|
|
—
|
|
|
—
|
|
|
16
|
|
|
(1
|
)
|
|
15
|
|
|
Total comprehensive income / (loss)
|
|
—
|
|
|
—
|
|
|
4
|
|
|
31
|
|
|
(19
|
)
|
|
—
|
|
|
(31
|
)
|
|
(15
|
)
|
|
(1
|
)
|
|
(16
|
)
|
|
Transactions with equity holders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share issuance
|
|
1
|
|
|
258
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
259
|
|
|
—
|
|
|
259
|
|
|
Share-based compensation
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8
|
|
|
—
|
|
|
8
|
|
|
—
|
|
|
8
|
|
|
Transactions with non-controlling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
At December 31, 2017
|
|
3
|
|
|
420
|
|
|
(147
|
)
|
|
13
|
|
|
(7
|
)
|
|
25
|
|
|
(634
|
)
|
|
(327
|
)
|
|
8
|
|
|
(319
|
)
|
|
(in millions of Euros)
|
|
Notes
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Net income / (loss)
|
|
|
|
64
|
|
|
190
|
|
|
(31
|
)
|
|
Adjustments
|
|
|
|
|
|
|
|
|
|||
|
Depreciation and amortization
|
|
17, 18
|
|
256
|
|
|
197
|
|
|
171
|
|
|
Finance costs - net
|
|
11
|
|
175
|
|
|
149
|
|
|
260
|
|
|
Income tax expense
|
|
12
|
|
18
|
|
|
32
|
|
|
80
|
|
|
Share of (income) / loss of joint-ventures
|
|
19
|
|
(2
|
)
|
|
33
|
|
|
29
|
|
|
Unrealized (gains) / losses on derivatives - net and from remeasurement of monetary assets and liabilities - net
|
|
|
|
(33
|
)
|
|
86
|
|
|
(54
|
)
|
|
Losses / (gains) on disposal
|
|
9
|
|
3
|
|
|
(186
|
)
|
|
3
|
|
|
Other - net
|
|
|
|
16
|
|
|
14
|
|
|
7
|
|
|
Interest paid
|
|
|
|
(158
|
)
|
|
(129
|
)
|
|
(185
|
)
|
|
Income tax paid
|
|
|
|
(6
|
)
|
|
(23
|
)
|
|
(18
|
)
|
|
Change in trade working capital
|
|
|
|
|
|
|
|
|
|||
|
Inventories
|
|
|
|
57
|
|
|
(9
|
)
|
|
(99
|
)
|
|
Trade receivables
|
|
|
|
104
|
|
|
(145
|
)
|
|
(91
|
)
|
|
Trade payables
|
|
|
|
(31
|
)
|
|
(27
|
)
|
|
124
|
|
|
Margin calls
|
|
|
|
5
|
|
|
(5
|
)
|
|
—
|
|
|
Change in provisions and pension obligations
|
|
|
|
(25
|
)
|
|
(58
|
)
|
|
(24
|
)
|
|
Other working capital
|
|
|
|
4
|
|
|
(53
|
)
|
|
(12
|
)
|
|
Net cash flows from operating activities
|
|
|
|
447
|
|
|
66
|
|
|
160
|
|
|
Purchases of property, plant and equipment
|
|
5
|
|
(271
|
)
|
|
(277
|
)
|
|
(276
|
)
|
|
Acquisition of subsidiaries net of cash acquired
|
|
|
|
(83
|
)
|
|
—
|
|
|
—
|
|
|
Proceeds from disposals, net of cash
|
|
|
|
2
|
|
|
200
|
|
|
2
|
|
|
Equity contribution and loan to joint ventures
|
|
|
|
—
|
|
|
(24
|
)
|
|
(41
|
)
|
|
Other investing activities
|
|
|
|
(1
|
)
|
|
10
|
|
|
23
|
|
|
Net cash flows used in investing activities
|
|
|
|
(353
|
)
|
|
(91
|
)
|
|
(292
|
)
|
|
Net proceeds received from issuance of shares
|
|
|
|
—
|
|
|
—
|
|
|
259
|
|
|
Proceeds from issuance of Senior Notes
|
|
22
|
|
—
|
|
|
—
|
|
|
1,440
|
|
|
Repayment of Senior Notes
|
|
22
|
|
(100
|
)
|
|
—
|
|
|
(1,559
|
)
|
|
Lease repayments
|
|
22
|
|
(86
|
)
|
|
(15
|
)
|
|
(13
|
)
|
|
Proceeds / (repayments) from revolving credit facilities and other loans
|
|
22
|
|
109
|
|
|
(68
|
)
|
|
29
|
|
|
Payment of deferred financing costs and exit fees
|
|
|
|
—
|
|
|
—
|
|
|
(118
|
)
|
|
Transactions with non-controlling interests
|
|
|
|
(4
|
)
|
|
—
|
|
|
—
|
|
|
Other financing activities
|
|
|
|
5
|
|
|
1
|
|
|
23
|
|
|
Net cash flows (used in) / from financing activities
|
|
|
|
(76
|
)
|
|
(82
|
)
|
|
61
|
|
|
Net increase / (decrease) in cash and cash equivalents
|
|
|
|
18
|
|
|
(107
|
)
|
|
(71
|
)
|
|
Cash and cash equivalents - beginning of year
|
|
|
|
164
|
|
|
269
|
|
|
347
|
|
|
Effect of exchange rate changes on cash and cash equivalents
|
|
|
|
2
|
|
|
2
|
|
|
(7
|
)
|
|
Cash and cash equivalents - end of year
|
|
14
|
|
184
|
|
|
164
|
|
|
269
|
|
|
(in millions of Euros)
|
|
Carrying amount
December 31, 2018 |
|
IFRS16 impact
|
|
Carrying amount
January 1, 2019 |
|||
|
Property, plant and equipment
|
|
1,666
|
|
|
102
|
|
|
1,768
|
|
|
Borrowings
|
|
(2,151
|
)
|
|
(102
|
)
|
|
(2,253
|
)
|
|
Foreign exchange rate for 1 Euro
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
||||||||||||
|
|
Average rate
|
|
Closing rate
|
|
Average rate
|
|
Closing rate
|
|
Average rate
|
|
Closing rate
|
|||||||
|
U.S. Dollars
|
USD
|
1.1193
|
|
|
1.1234
|
|
|
1.1798
|
|
|
1.1450
|
|
|
1.1273
|
|
|
1.1993
|
|
|
Swiss Francs
|
CHF
|
1.1121
|
|
|
1.0854
|
|
|
1.1546
|
|
|
1.1269
|
|
|
1.1103
|
|
|
1.1702
|
|
|
Czech Koruna
|
CZK
|
25.6698
|
|
|
25.4080
|
|
|
25.6452
|
|
|
25.7240
|
|
|
26.3151
|
|
|
25.5349
|
|
|
–
|
It is technically feasible to complete the intangible asset so that it will be available for use;
|
|
–
|
Management intends to complete and use the intangible asset;
|
|
–
|
There is an ability to use the intangible asset;
|
|
–
|
It can be demonstrated how the intangible asset will generate probable future economic benefits;
|
|
–
|
Adequate technical, financial and other resources to complete the development and use or sell the intangible asset are available; and
|
|
–
|
The expenditure attributable to the intangible asset during its development can be reliably measured.
|
|
–
|
Buildings
10
–
50
years;
|
|
–
|
Machinery and equipment
3
–
40
years;
|
|
–
|
Vehicles
5
–
8
years.
|
|
–
|
Technology
20
years;
|
|
–
|
Customer relationships
25
years;
|
|
–
|
Software
3
–
5
years.
|
|
i.
|
Classification and measurement
|
|
•
|
Financial assets
|
|
i.
|
Assets at amortized cost are comprised of other receivables, non-current loans receivable and current loans receivable in the Consolidated Statement of Financial Position. They are held within a business model whose objective is to hold assets in order to collect contractual cash flows provided they give rise to cash flows that are ‘solely payments of principal and interest’ on the principal amount outstanding. They are carried at amortized cost using the effective interest rate method, less any impairment. They are classified as current or non-current assets based on their maturity date.
|
|
ii.
|
Assets at fair value through OCI are comprised of trade receivables in the Consolidated Statement of Financial Position. The business model is to maintain liquidity for the Group, should the need arise, which leads to sales through factoring agreements that are more than infrequent and significant in value. Therefore, trade receivables are managed under an objective that results in both collecting the contractual cash flows and selling the receivables to the factors. The portfolio of trade receivables is therefore classified as measured at fair value through OCI. Foreign exchange revaluation and impairment losses or reversals are recognized in profit or loss and computed in the same manner as for financial assets measured at amortized cost. The remaining fair value changes are recognized in OCI. Upon derecognition, the cumulative fair value change recognized in OCI is recycled to profit or loss. These assets are classified as current or non-current assets based on their maturity date.
|
|
iii.
|
Assets at fair value through profit or loss are comprised of derivatives except when designated as hedging instruments in a hedging relationship that qualifies for hedge accounting in accordance with IAS 39, ‘Financial instruments’. Financial assets carried at fair value through profit or loss are initially recognized at fair value and transaction costs are expensed in the Consolidated Income Statement.
|
|
•
|
Financial liabilities
|
|
ii.
|
Impairment of financial assets
|
|
iii.
|
Offsetting financial instruments
|
|
(in millions of Euros)
|
|
Fair Value
|
|
|
Cash and cash equivalents
|
|
4
|
|
|
Trade receivables and other
|
|
49
|
|
|
Inventories
|
|
65
|
|
|
Property, plant and equipment
|
|
165
|
|
|
Deferred tax assets
|
|
3
|
|
|
Trade payables and other
|
|
(41
|
)
|
|
Borrowings
|
|
(75
|
)
|
|
Net asset acquired at fair value
|
|
170
|
|
|
Goodwill
|
|
24
|
|
|
Total Consideration
|
|
194
|
|
|
(in millions of Euros)
|
|
Year ended
December 31, 2019 |
|
Year ended
December 31, 2018 |
|
Year ended
December 31, 2017 |
|||
|
Packaging rolled products
|
|
2,172
|
|
|
2,245
|
|
|
2,146
|
|
|
Automotive rolled products
|
|
816
|
|
|
636
|
|
|
483
|
|
|
Specialty and other thin-rolled products
|
|
151
|
|
|
169
|
|
|
176
|
|
|
Aerospace rolled products
|
|
863
|
|
|
773
|
|
|
760
|
|
|
Transportation, Industry and other rolled products
|
|
557
|
|
|
566
|
|
|
541
|
|
|
Automotive extruded products
|
|
797
|
|
|
714
|
|
|
614
|
|
|
Other extruded products
|
|
551
|
|
|
573
|
|
|
504
|
|
|
Other
|
|
—
|
|
|
10
|
|
|
13
|
|
|
Total Revenue
|
|
5,907
|
|
|
5,686
|
|
|
5,237
|
|
|
(in millions of Euros)
|
|
Year ended
December 31, 2019 |
|
Year ended
December 31, 2018 |
|
Year ended
December 31, 2017 |
|||
|
France
|
|
563
|
|
|
554
|
|
|
557
|
|
|
Germany
|
|
1,260
|
|
|
1,339
|
|
|
1,217
|
|
|
United Kingdom
|
|
194
|
|
|
175
|
|
|
188
|
|
|
Switzerland
|
|
68
|
|
|
77
|
|
|
123
|
|
|
Other Europe
|
|
1,078
|
|
|
1,038
|
|
|
940
|
|
|
United States
|
|
2,175
|
|
|
1,897
|
|
|
1,691
|
|
|
Canada
|
|
89
|
|
|
107
|
|
|
78
|
|
|
Asia and Other Pacific
|
|
277
|
|
|
300
|
|
|
270
|
|
|
All Other
|
|
203
|
|
|
199
|
|
|
173
|
|
|
Total Revenue
|
|
5,907
|
|
|
5,686
|
|
|
5,237
|
|
|
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||||||||||||||||||||
|
(in millions of Euros)
|
|
Segment revenue
|
|
Inter-segment elimination
|
|
External revenue
|
|
Segment revenue
|
|
Inter-segment elimination
|
|
External revenue
|
|
Segment revenue
|
|
Inter-segment elimination
|
|
External revenue
|
|||||||||
|
P&ARP
|
|
3,149
|
|
|
(10
|
)
|
|
3,139
|
|
|
3,059
|
|
|
(9
|
)
|
|
3,050
|
|
|
2,812
|
|
|
(7
|
)
|
|
2,805
|
|
|
A&T
|
|
1,462
|
|
|
(42
|
)
|
|
1,420
|
|
|
1,389
|
|
|
(50
|
)
|
|
1,339
|
|
|
1,335
|
|
|
(34
|
)
|
|
1,301
|
|
|
AS&I
|
|
1,351
|
|
|
(3
|
)
|
|
1,348
|
|
|
1,290
|
|
|
(3
|
)
|
|
1,287
|
|
|
1,123
|
|
|
(5
|
)
|
|
1,118
|
|
|
Holdings & Corporate (A)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
10
|
|
|
—
|
|
|
10
|
|
|
13
|
|
|
—
|
|
|
13
|
|
|
Total
|
|
5,962
|
|
|
(55
|
)
|
|
5,907
|
|
|
5,748
|
|
|
(62
|
)
|
|
5,686
|
|
|
5,283
|
|
|
(46
|
)
|
|
5,237
|
|
|
(A)
|
For the years ended
December 31, 2018
and
2017
, the Holdings & Corporate segment included revenue from supplying metal to third parties.
|
|
(in millions of Euros)
|
|
Notes
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
P&ARP
|
|
|
|
273
|
|
|
243
|
|
|
204
|
|
|
A&T
|
|
|
|
204
|
|
|
152
|
|
|
146
|
|
|
AS&I
|
|
|
|
106
|
|
|
125
|
|
|
120
|
|
|
Holdings & Corporate
|
|
|
|
(21
|
)
|
|
(22
|
)
|
|
(22
|
)
|
|
Adjusted EBITDA
|
|
|
|
562
|
|
|
498
|
|
|
448
|
|
|
Metal price lag (A)
|
|
|
|
(46
|
)
|
|
—
|
|
|
22
|
|
|
Start-up and development costs (B)
|
|
|
|
(11
|
)
|
|
(21
|
)
|
|
(17
|
)
|
|
Manufacturing system and process transformation costs
|
|
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
Bowling Green one-time costs related to the acquisition (C)
|
|
|
|
(5
|
)
|
|
—
|
|
|
—
|
|
|
Share based compensation costs
|
|
|
|
(16
|
)
|
|
(12
|
)
|
|
(8
|
)
|
|
Gains on pensions plan amendments (D)
|
|
25
|
|
1
|
|
|
36
|
|
|
20
|
|
|
Depreciation and amortization
|
|
17,18
|
|
(256
|
)
|
|
(197
|
)
|
|
(171
|
)
|
|
Restructuring costs
|
|
|
|
(4
|
)
|
|
(1
|
)
|
|
(4
|
)
|
|
Unrealized gains / (losses) on derivatives
|
|
9
|
|
33
|
|
|
(84
|
)
|
|
57
|
|
|
Unrealized exchange (losses) / gains from the remeasurement of monetary assets and liabilities – net
|
|
9
|
|
—
|
|
|
—
|
|
|
(4
|
)
|
|
(Losses) / gains on disposals (E)
|
|
9
|
|
(3
|
)
|
|
186
|
|
|
(3
|
)
|
|
Other (F)
|
|
|
|
—
|
|
|
(1
|
)
|
|
—
|
|
|
Income from operations
|
|
|
|
255
|
|
|
404
|
|
|
338
|
|
|
Finance costs - net
|
|
11
|
|
(175
|
)
|
|
(149
|
)
|
|
(260
|
)
|
|
Share of income / (loss) of joint-ventures
|
|
19
|
|
2
|
|
|
(33
|
)
|
|
(29
|
)
|
|
Income before income tax
|
|
|
|
82
|
|
|
222
|
|
|
49
|
|
|
Income tax expense
|
|
12
|
|
(18
|
)
|
|
(32
|
)
|
|
(80
|
)
|
|
Net income / (loss)
|
|
|
|
64
|
|
|
190
|
|
|
(31
|
)
|
|
(A)
|
Metal price lag represents the financial impact of the timing difference between when aluminium prices included within Constellium Revenues are established and when aluminium purchase prices included in Cost of sales are established. The Group accounts for inventory using a weighted average price basis and this adjustment aims to remove the effect of volatility in LME prices. The calculation of the Group metal price lag adjustment is based on an internal standardized methodology calculated at each of Constellium’s manufacturing sites and is primarily calculated as the average value of product recorded in inventory, which approximates the spot price in the market, less the average value transferred out of inventory, which is the weighted average of the metal element of cost of sales, based on the quantity sold in the year.
|
|
(B)
|
For the years ended
December 31, 2019
,
2018
and
2017
, start-up and development costs include
€11 million
,
€21 million
and
€16 million
, respectively, related to new projects in our AS&I operating segment.
|
|
(C)
|
For the year ended
December 31, 2019
, Bowling Green one-time costs related to the acquisition include the non-cash reversal of the inventory step-up.
|
|
(D)
|
For the year ended
December 31, 2018
, the Group amended one of its OPEB plans in the U.S., which resulted in a
€36 million
gain. For the year ended
December 31, 2017
, amendments to certain Swiss pension plans, U.S. pension plans and OPEB resulted in a
€20 million
gain.
|
|
(E)
|
In July 2018, Constellium completed the sale of the North Building assets of its Sierre plant in Switzerland to Novelis and contributed the Sierre site shared infrastructure to a joint-venture with Novelis, in exchange for cash consideration of
€200 million
. This transaction also resulted in the termination of the existing lease agreement for the North Building assets which had been leased and operated by Novelis since 2005. For the year ended
December 31, 2018
, the transaction generated a
€190 million
net gain (See
NOTE 32 - Subsidiaries and Operating Segments
).
|
|
(F)
|
For the year ended
December 31, 2017
, other includes
€3 million
of legal fees and lump-sum payments in connection with the renegotiation of a new
5
-year collective bargaining agreement offset by accrual reversals of unused provisions related to one-time loss contingencies.
|
|
(in millions of Euros)
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
P&ARP
|
|
(96
|
)
|
|
(97
|
)
|
|
(115
|
)
|
|
A&T
|
|
(72
|
)
|
|
(70
|
)
|
|
(73
|
)
|
|
AS&I
|
|
(97
|
)
|
|
(105
|
)
|
|
(83
|
)
|
|
Holdings & Corporate
|
|
(6
|
)
|
|
(5
|
)
|
|
(5
|
)
|
|
Capital expenditures
|
|
(271
|
)
|
|
(277
|
)
|
|
(276
|
)
|
|
(in millions of Euros)
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||
|
P&ARP
|
|
1,951
|
|
|
1,791
|
|
|
A&T
|
|
856
|
|
|
831
|
|
|
AS&I
|
|
703
|
|
|
544
|
|
|
Holdings & Corporate
|
|
276
|
|
|
304
|
|
|
Segment assets
|
|
3,786
|
|
|
3,470
|
|
|
Deferred income tax assets
|
|
185
|
|
|
163
|
|
|
Cash and cash equivalents
|
|
184
|
|
|
164
|
|
|
Other financial assets
|
|
29
|
|
|
104
|
|
|
Total Assets
|
|
4,184
|
|
|
3,901
|
|
|
(in millions of Euros)
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||
|
United States
|
|
926
|
|
|
740
|
|
|
France
|
|
656
|
|
|
613
|
|
|
Germany
|
|
250
|
|
|
181
|
|
|
Czech Republic
|
|
106
|
|
|
84
|
|
|
Other
|
|
118
|
|
|
48
|
|
|
Total
|
|
2,056
|
|
|
1,666
|
|
|
(in millions of Euros)
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Raw materials and consumables used
|
|
(3,535
|
)
|
|
(3,561
|
)
|
|
(3,197
|
)
|
|
Employee benefit expenses
|
|
(1,038
|
)
|
|
(927
|
)
|
|
(907
|
)
|
|
Energy costs
|
|
(162
|
)
|
|
(140
|
)
|
|
(138
|
)
|
|
Sub-contractors
|
|
(100
|
)
|
|
(92
|
)
|
|
(99
|
)
|
|
Freight out costs
|
|
(156
|
)
|
|
(143
|
)
|
|
(124
|
)
|
|
Professional fees
|
|
(97
|
)
|
|
(74
|
)
|
|
(77
|
)
|
|
Lease expenses
|
|
(13
|
)
|
|
(31
|
)
|
|
(27
|
)
|
|
Depreciation and amortization
|
|
(256
|
)
|
|
(197
|
)
|
|
(171
|
)
|
|
Other operating expenses
|
|
(276
|
)
|
|
(271
|
)
|
|
(229
|
)
|
|
Other gains / (losses) - net
|
|
(19
|
)
|
|
154
|
|
|
70
|
|
|
Total operating expenses
|
|
(5,652
|
)
|
|
(5,282
|
)
|
|
(4,899
|
)
|
|
(in millions of Euros)
|
|
Notes
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Wages and salaries
|
|
|
|
(994
|
)
|
|
(889
|
)
|
|
(872
|
)
|
|
Pension costs - defined benefit plans
|
|
25
|
|
(19
|
)
|
|
(20
|
)
|
|
(21
|
)
|
|
Other post-employment benefits
|
|
25
|
|
(9
|
)
|
|
(6
|
)
|
|
(6
|
)
|
|
Share-based compensation
|
|
31
|
|
(16
|
)
|
|
(12
|
)
|
|
(8
|
)
|
|
Total employee benefit expenses
|
|
|
|
(1,038
|
)
|
|
(927
|
)
|
|
(907
|
)
|
|
(in millions of Euros)
|
|
Notes
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Realized (losses) / gains on derivatives (A)
|
|
|
|
(49
|
)
|
|
14
|
|
|
—
|
|
|
Unrealized gains / (losses) on derivatives at fair value through profit and loss - net (A)
|
|
5
|
|
33
|
|
|
(84
|
)
|
|
57
|
|
|
Unrealized exchange losses from the remeasurement of monetary assets and liabilities - net
|
|
5
|
|
—
|
|
|
—
|
|
|
(4
|
)
|
|
Gains on pension plan amendments (B)
|
|
25
|
|
1
|
|
|
36
|
|
|
20
|
|
|
(Losses) / gains on disposal (C)
|
|
|
|
(3
|
)
|
|
186
|
|
|
(3
|
)
|
|
Other
|
|
|
|
(1
|
)
|
|
2
|
|
|
—
|
|
|
Total other gains / (losses) - net
|
|
|
|
(19
|
)
|
|
154
|
|
|
70
|
|
|
(A)
|
Realized gains and losses are related to derivatives entered into with the purpose of mitigating exposure to volatility in foreign currencies and commodity prices. Unrealized gains and losses are related to derivatives that do not qualify for hedge accounting.
|
|
(B)
|
For the year ended
December 31, 2018
, the Group amended one of its OPEB plans in the U.S., which resulted in a
€36 million
gain. For the year ended
December 31, 2017
, amendments to certain Swiss pension plans, U.S. pension plans and OPEB resulted in a
€20 million
gain.
|
|
(C)
|
In July 2018, Constellium completed the sale of the North Building assets of its Sierre plant in Switzerland to Novelis and contributed the Sierre site shared infrastructure to a joint-venture with Novelis, in exchange for cash consideration of
€200 million
. This transaction also resulted in the termination of the existing lease agreement for the North Building assets which had been leased and operated by Novelis since 2005. For the year ended
December 31, 2018
, the transaction generated a
€190 million
net gain (See
NOTE 32 - Subsidiaries and Operating Segments
).
|
|
(in millions of Euros)
|
|
Notes
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Included in Revenue
|
|
24
|
|
(7
|
)
|
|
2
|
|
|
2
|
|
|
Included in Cost of sales
|
|
|
|
1
|
|
|
2
|
|
|
(4
|
)
|
|
Included in Other gains / (losses) - net
|
|
|
|
9
|
|
|
7
|
|
|
(4
|
)
|
|
Total
|
|
|
|
3
|
|
|
11
|
|
|
(6
|
)
|
|
Realized exchange gains / (losses) on foreign currency derivatives - net
|
|
24
|
|
1
|
|
|
11
|
|
|
(15
|
)
|
|
Unrealized gains / (losses) on foreign currency derivatives - net
|
|
24
|
|
1
|
|
|
(3
|
)
|
|
17
|
|
|
Exchange gains / (losses) from the remeasurement of monetary assets and liabilities - net
|
|
|
|
1
|
|
|
3
|
|
|
(8
|
)
|
|
Total
|
|
|
|
3
|
|
|
11
|
|
|
(6
|
)
|
|
(in millions of Euros)
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||
|
Foreign currency translation reserve at January 1
|
|
3
|
|
|
(7
|
)
|
|
Effect of currency translation differences
|
|
1
|
|
|
10
|
|
|
Foreign currency translation reserve at December 31
|
|
4
|
|
|
3
|
|
|
(in millions of Euros)
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Interest received
|
|
—
|
|
|
7
|
|
|
7
|
|
|
Finance income
|
|
—
|
|
|
7
|
|
|
7
|
|
|
Interest expense on borrowings (A)
|
|
(124
|
)
|
|
(118
|
)
|
|
(147
|
)
|
|
Expenses on factoring arrangements
|
|
(19
|
)
|
|
(18
|
)
|
|
(16
|
)
|
|
Interest expense on leases
|
|
(13
|
)
|
|
(5
|
)
|
|
(3
|
)
|
|
Net loss on settlement of debt (B)
|
|
—
|
|
|
—
|
|
|
(91
|
)
|
|
Realized and unrealized gains / (losses) on debt derivatives at fair value (C)
|
|
13
|
|
|
28
|
|
|
(79
|
)
|
|
Realized and unrealized exchange (losses) / gains on financing activities - net (C)
|
|
(3
|
)
|
|
(22
|
)
|
|
91
|
|
|
Interest cost on pension and other benefits
|
|
(16
|
)
|
|
(15
|
)
|
|
(17
|
)
|
|
Other finance expenses (D)
|
|
(16
|
)
|
|
(10
|
)
|
|
(12
|
)
|
|
Capitalized borrowing costs (E)
|
|
3
|
|
|
4
|
|
|
7
|
|
|
Finance expenses
|
|
(175
|
)
|
|
(156
|
)
|
|
(267
|
)
|
|
Finance costs - net
|
|
(175
|
)
|
|
(149
|
)
|
|
(260
|
)
|
|
(A)
|
For the year ended
December 31, 2019
, the Group incurred mainly (i)
€115 million
of interest related to Constellium SE Senior Notes and (ii)
€7 million
of interest expense and fees related to the Muscle Shoals and Ravenswood ABL Facility (“Pan-U.S. ABL”). For the year ended
December 31, 2018
, the Group incurred (i)
€113 million
of interest related to Constellium SE Senior Notes, (ii)
€4 million
of interest expense and fees related to the Pan US ABL.
|
|
(B)
|
For the year ended
December 31, 2017
, net loss on settlement of debt related to (i) the Muscle Shoals Senior Notes redemption in February 2017 for
€13 million
and (ii) the Constellium SE Senior Notes redemption in November 2017 for
€78 million
. The total exit fees incurred and paid related to refinancings in
2017
amounted to
€88 million
.
|
|
(C)
|
The Group hedges the dollar exposure relating to the principal of its Constellium SE U.S. Dollar Senior Notes, for the portion that has not been used to finance directly or indirectly U.S. Dollar functional currency entities. Changes in the fair value of these hedging derivatives are recognized within Finance costs – net in the Consolidated Income Statement and largely offset the unrealized results related to Constellium SE U.S. Dollar Senior Notes revaluation.
|
|
(D)
|
For the year ended
December 31, 2018
, other finance expenses include a
€6 million
net loss resulting from the modification of our loan to Constellium-UACJ ABS LLC in February 2018.
|
|
(E)
|
Borrowing costs directly attributable to the construction of assets are capitalized. The capitalization rate was
6%
for the years ended
December 31, 2019
,
2018
and
2017
.
|
|
(in millions of Euros)
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Current tax expense
|
|
(32
|
)
|
|
(30
|
)
|
|
(26
|
)
|
|
Deferred tax expense
|
|
14
|
|
|
(2
|
)
|
|
(54
|
)
|
|
Total income tax expense
|
|
(18
|
)
|
|
(32
|
)
|
|
(80
|
)
|
|
(in millions of Euros)
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Income before income tax
|
|
82
|
|
|
222
|
|
|
49
|
|
|
Composite statutory income tax rate applicable by tax jurisdiction
|
|
30.3
|
%
|
|
24.1
|
%
|
|
31.9
|
%
|
|
Income tax expense calculated at composite statutory tax rate applicable by tax jurisdiction
|
|
(25
|
)
|
|
(53
|
)
|
|
(16
|
)
|
|
Tax effect of:
|
|
|
|
|
|
|
|||
|
Changes in recognized and unrecognized deferred tax assets (A)
|
|
(10
|
)
|
|
30
|
|
|
(61
|
)
|
|
Change in tax laws and rates (B)
|
|
21
|
|
|
—
|
|
|
(11
|
)
|
|
Other
|
|
(4
|
)
|
|
(9
|
)
|
|
8
|
|
|
Income tax expense
|
|
(18
|
)
|
|
(32
|
)
|
|
(80
|
)
|
|
Effective income tax rate
|
|
22
|
%
|
|
14
|
%
|
|
163
|
%
|
|
(A)
|
For the year ended December 31, 2018, changes mainly relate to non-recurring transactions, especially the gain on the sale of the North Building of the Sierre plant and termination of an existing lease agreement, that generated a significant taxable profit compensated by the use of previously unrecognized tax losses carried forward. For the year ended December 31, 2017, changes mainly relate to unrecognized tax losses carried forward.
|
|
(B)
|
For the year ended December 31, 2019, the change in tax laws and rates relates mainly to the application of the Swiss Federal Tax Reform voted in May 2019 and enacted in the Canton where one of our entities is located. For the year ended December 31, 2017, the change in tax laws and rates relates mainly to the decrease in the U.S. income tax rate from
40%
to
27%
for
€16 million
and to the gradual decrease in the French tax rate to
25.82%
starting 2022.
|
|
(in millions of Euros)
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Earnings attributable to equity holders of the parent used to calculate basic and diluted earnings per share
|
|
59
|
|
|
188
|
|
|
(31
|
)
|
|
(number of shares)
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Weighted average number of ordinary shares used to calculate basic earnings per share
|
|
136,856,978
|
|
|
134,761,736
|
|
|
110,164,320
|
|
|
Effect of other dilutive potential ordinary shares (A)
|
|
5,788,641
|
|
|
3,384,178
|
|
|
—
|
|
|
Weighted average number of ordinary shares used to calculate diluted earnings per share
|
|
142,645,619
|
|
|
138,145,914
|
|
|
110,164,320
|
|
|
(A)
|
For the year ended
December 31, 2017
there were
3,291,875
potential ordinary shares that could have a dilutive impact but were considered antidilutive due to negative earnings.
|
|
(in Euro per share)
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Basic
|
|
0.43
|
|
|
1.40
|
|
|
(0.28
|
)
|
|
Diluted
|
|
0.41
|
|
|
1.37
|
|
|
(0.28
|
)
|
|
(in millions of Euros)
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||
|
Cash in bank and on hand
|
|
184
|
|
|
164
|
|
|
Total Cash and cash equivalent
|
|
184
|
|
|
164
|
|
|
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||||||||
|
(in millions of Euros)
|
|
Non-current
|
|
Current
|
|
Non-current
|
|
Current
|
||||
|
Trade receivables - gross
|
|
—
|
|
|
395
|
|
|
—
|
|
|
483
|
|
|
Impairment
|
|
—
|
|
|
(2
|
)
|
|
—
|
|
|
(2
|
)
|
|
Total trade receivables - net
|
|
—
|
|
|
393
|
|
|
—
|
|
|
481
|
|
|
Income tax receivables
|
|
35
|
|
|
22
|
|
|
28
|
|
|
43
|
|
|
Other taxes
|
|
—
|
|
|
35
|
|
|
—
|
|
|
33
|
|
|
Contract assets
|
|
16
|
|
|
2
|
|
|
28
|
|
|
2
|
|
|
Prepaid expenses
|
|
1
|
|
|
8
|
|
|
1
|
|
|
12
|
|
|
Other
|
|
8
|
|
|
14
|
|
|
7
|
|
|
16
|
|
|
Total other receivables
|
|
60
|
|
|
81
|
|
|
64
|
|
|
106
|
|
|
Total trade receivables and other
|
|
60
|
|
|
474
|
|
|
64
|
|
|
587
|
|
|
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||||||||
|
(in millions of Euros)
|
|
Non-current
|
|
Current
|
|
Non-current
|
|
Current
|
||||
|
Unbilled tooling costs
|
|
16
|
|
|
—
|
|
|
26
|
|
|
—
|
|
|
Other
|
|
—
|
|
|
2
|
|
|
2
|
|
|
2
|
|
|
Total Contract assets
|
|
16
|
|
|
2
|
|
|
28
|
|
|
2
|
|
|
(in millions of Euros)
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||
|
Not past due
|
|
380
|
|
|
453
|
|
|
1 – 30 days past due
|
|
10
|
|
|
23
|
|
|
31 – 60 days past due
|
|
3
|
|
|
2
|
|
|
61 – 90 days past due
|
|
—
|
|
|
2
|
|
|
Greater than 90 days past due
|
|
—
|
|
|
1
|
|
|
Total trade receivables - net
|
|
393
|
|
|
481
|
|
|
(in millions of Euros)
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||
|
Euro
|
|
126
|
|
|
177
|
|
|
U.S. Dollar
|
|
251
|
|
|
284
|
|
|
Swiss franc
|
|
3
|
|
|
4
|
|
|
Other currencies
|
|
13
|
|
|
16
|
|
|
Total trade receivables - net
|
|
393
|
|
|
481
|
|
|
•
|
€463 million
(
December 31, 2018
:
€446 million
) have been derecognized from the Consolidated Statement of Financial Position as the Group transferred substantially all of the associated risks and rewards to the factor;
|
|
•
|
€111 million
(
December 31, 2018
:
€155 million
) were recognized on the Consolidated Statement of Financial Position.
|
|
(in millions of Euros)
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||
|
Finished goods
|
|
203
|
|
|
165
|
|
|
Work in progress
|
|
321
|
|
|
347
|
|
|
Raw materials
|
|
106
|
|
|
112
|
|
|
Stores and supplies
|
|
74
|
|
|
67
|
|
|
Inventories write down
|
|
(34
|
)
|
|
(31
|
)
|
|
Total inventories
|
|
670
|
|
|
660
|
|
|
(in millions of Euros)
|
|
Notes
|
|
Land and Property Rights
|
|
Buildings
|
|
Machinery and Equipment
|
|
Construction Work in Progress
|
|
Other
|
|
Total
|
||||||
|
Net balance at December 31, 2018
|
|
|
|
18
|
|
|
217
|
|
|
1,227
|
|
|
194
|
|
|
10
|
|
|
1,666
|
|
|
IFRS 16 application
|
|
|
|
—
|
|
|
82
|
|
|
17
|
|
|
—
|
|
|
3
|
|
|
102
|
|
|
Net balance at January 1, 2019
|
|
|
|
18
|
|
|
299
|
|
|
1,244
|
|
|
194
|
|
|
13
|
|
|
1,768
|
|
|
Property, plant and equipment acquired through business combination
|
|
3
|
|
—
|
|
|
40
|
|
|
120
|
|
|
4
|
|
|
1
|
|
|
165
|
|
|
Additions
|
|
|
|
1
|
|
|
22
|
|
|
81
|
|
|
245
|
|
|
3
|
|
|
352
|
|
|
Disposals
|
|
|
|
—
|
|
|
—
|
|
|
(5
|
)
|
|
—
|
|
|
—
|
|
|
(5
|
)
|
|
Depreciation expense
|
|
|
|
—
|
|
|
(27
|
)
|
|
(208
|
)
|
|
—
|
|
|
(11
|
)
|
|
(246
|
)
|
|
Transfer during the year
|
|
|
|
—
|
|
|
28
|
|
|
203
|
|
|
(242
|
)
|
|
11
|
|
|
—
|
|
|
Effects of changes in foreign exchange rates
|
|
|
|
—
|
|
|
4
|
|
|
16
|
|
|
2
|
|
|
—
|
|
|
22
|
|
|
Net balance at December 31, 2019
|
|
|
|
19
|
|
|
366
|
|
|
1,451
|
|
|
203
|
|
|
17
|
|
|
2,056
|
|
|
Cost
|
|
|
|
35
|
|
|
527
|
|
|
2,407
|
|
|
213
|
|
|
46
|
|
|
3,228
|
|
|
Less accumulated depreciation and impairment
|
|
|
|
(16
|
)
|
|
(161
|
)
|
|
(956
|
)
|
|
(10
|
)
|
|
(29
|
)
|
|
(1,172
|
)
|
|
Net balance at December 31, 2019
|
|
|
|
19
|
|
|
366
|
|
|
1,451
|
|
|
203
|
|
|
17
|
|
|
2,056
|
|
|
(in millions of Euros)
|
|
Land and Property Rights
|
|
Buildings
|
|
Machinery and Equipment
|
|
Construction Work in Progress
|
|
Other
|
|
Total
|
||||||
|
Net balance at January 1, 2018
|
|
14
|
|
|
206
|
|
|
1,089
|
|
|
198
|
|
|
10
|
|
|
1,517
|
|
|
Additions
|
|
1
|
|
|
5
|
|
|
98
|
|
|
195
|
|
|
4
|
|
|
303
|
|
|
Disposals
|
|
—
|
|
|
—
|
|
|
(6
|
)
|
|
—
|
|
|
—
|
|
|
(6
|
)
|
|
Depreciation expense
|
|
(4
|
)
|
|
(13
|
)
|
|
(161
|
)
|
|
—
|
|
|
(6
|
)
|
|
(184
|
)
|
|
Transfer during the year
|
|
6
|
|
|
16
|
|
|
181
|
|
|
(202
|
)
|
|
2
|
|
|
3
|
|
|
Effects of changes in foreign exchange rates
|
|
1
|
|
|
3
|
|
|
26
|
|
|
3
|
|
|
—
|
|
|
33
|
|
|
Net balance at December 31, 2018
|
|
18
|
|
|
217
|
|
|
1,227
|
|
|
194
|
|
|
10
|
|
|
1,666
|
|
|
Cost
|
|
33
|
|
|
349
|
|
|
2,000
|
|
|
200
|
|
|
35
|
|
|
2,617
|
|
|
Less accumulated depreciation and impairment
|
|
(15
|
)
|
|
(132
|
)
|
|
(773
|
)
|
|
(6
|
)
|
|
(25
|
)
|
|
(951
|
)
|
|
Net balance at December 31, 2018
|
|
18
|
|
|
217
|
|
|
1,227
|
|
|
194
|
|
|
10
|
|
|
1,666
|
|
|
(in millions of Euros)
|
|
Buildings
|
|
Machinery and Equipment
|
|
Other
|
|
Total
|
||||
|
Net balance at December 31, 2018
|
|
24
|
|
|
53
|
|
|
—
|
|
|
77
|
|
|
IFRS 16 application (A)
|
|
82
|
|
|
17
|
|
|
3
|
|
|
102
|
|
|
Net balance at January 1, 2019
|
|
106
|
|
|
70
|
|
|
3
|
|
|
179
|
|
|
Additions
|
|
20
|
|
|
21
|
|
|
2
|
|
|
43
|
|
|
Disposals
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Depreciation expense
|
|
(11
|
)
|
|
(18
|
)
|
|
(2
|
)
|
|
(31
|
)
|
|
Transfer during the period
|
|
—
|
|
|
(3
|
)
|
|
—
|
|
|
(3
|
)
|
|
Effects of changes in foreign exchange rates
|
|
1
|
|
|
1
|
|
|
—
|
|
|
2
|
|
|
Net balance at December 31, 2019
|
|
116
|
|
|
71
|
|
|
3
|
|
|
190
|
|
|
Cost
|
|
134
|
|
|
113
|
|
|
5
|
|
|
252
|
|
|
Less accumulated depreciation and impairment
|
|
(18
|
)
|
|
(42
|
)
|
|
(2
|
)
|
|
(62
|
)
|
|
Net balance at December 31, 2019
|
|
116
|
|
|
71
|
|
|
3
|
|
|
190
|
|
|
(A)
|
The IFRS 16 application included assets acquired through finance leases reclassified as right-of-use assets of
€77 million
and operating leases recognized as right-of-use assets of
€102 million
at January 1, 2019.
|
|
(in millions of Euros)
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Cost of sales
|
|
(237
|
)
|
|
(184
|
)
|
|
(160
|
)
|
|
Selling and administrative expenses
|
|
(13
|
)
|
|
(9
|
)
|
|
(8
|
)
|
|
Research and development expenses
|
|
(6
|
)
|
|
(4
|
)
|
|
(3
|
)
|
|
Total
|
|
(256
|
)
|
|
(197
|
)
|
|
(171
|
)
|
|
(in millions of Euros)
|
|
Notes
|
|
Goodwill
|
|
Technology
|
|
Computer Software
|
|
Customer relationships
|
|
Work in Progress
|
|
Other
|
|
Total intangible assets (excluding goodwill)
|
|||||||
|
Net balance at January 1, 2019
|
|
|
|
422
|
|
|
22
|
|
|
18
|
|
|
15
|
|
|
13
|
|
|
2
|
|
|
70
|
|
|
Intangible assets acquired through business combination
|
|
3
|
|
24
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Additions
|
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|
—
|
|
|
8
|
|
|
—
|
|
|
9
|
|
|
Amortization expense
|
|
|
|
—
|
|
|
(1
|
)
|
|
(8
|
)
|
|
(1
|
)
|
|
—
|
|
|
—
|
|
|
(10
|
)
|
|
Transfer during the year
|
|
|
|
—
|
|
|
—
|
|
|
7
|
|
|
—
|
|
|
(7
|
)
|
|
—
|
|
|
—
|
|
|
Effects of changes in foreign exchange rates
|
|
|
|
9
|
|
|
—
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|
Net balance at December 31, 2019
|
|
|
|
455
|
|
|
21
|
|
|
19
|
|
|
14
|
|
|
14
|
|
|
2
|
|
|
70
|
|
|
Cost
|
|
|
|
455
|
|
|
87
|
|
|
73
|
|
|
39
|
|
|
16
|
|
|
2
|
|
|
217
|
|
|
Less accumulated depreciation and impairment
|
|
|
|
—
|
|
|
(66
|
)
|
|
(54
|
)
|
|
(25
|
)
|
|
(2
|
)
|
|
—
|
|
|
(147
|
)
|
|
Net balance at December 31, 2019
|
|
|
|
455
|
|
|
21
|
|
|
19
|
|
|
14
|
|
|
14
|
|
|
2
|
|
|
70
|
|
|
(in millions of Euros)
|
|
Goodwill
|
|
Technology
|
|
Computer Software
|
|
Customer relationships
|
|
Work in Progress
|
|
Other
|
|
Total intangible assets (excluding goodwill)
|
|||||||
|
Net balance at January 1, 2018
|
|
403
|
|
|
24
|
|
|
18
|
|
|
15
|
|
|
9
|
|
|
2
|
|
|
68
|
|
|
Additions
|
|
—
|
|
|
—
|
|
|
2
|
|
|
—
|
|
|
8
|
|
|
1
|
|
|
11
|
|
|
Amortization expense
|
|
—
|
|
|
(3
|
)
|
|
(8
|
)
|
|
(1
|
)
|
|
—
|
|
|
(1
|
)
|
|
(13
|
)
|
|
Transfer during the year
|
|
—
|
|
|
—
|
|
|
5
|
|
|
—
|
|
|
(5
|
)
|
|
—
|
|
|
—
|
|
|
Effects of changes in foreign exchange rates
|
|
19
|
|
|
1
|
|
|
1
|
|
|
1
|
|
|
1
|
|
|
—
|
|
|
4
|
|
|
Net balance at December 31, 2018
|
|
422
|
|
|
22
|
|
|
18
|
|
|
15
|
|
|
13
|
|
|
2
|
|
|
70
|
|
|
Cost
|
|
422
|
|
|
84
|
|
|
65
|
|
|
39
|
|
|
13
|
|
|
3
|
|
|
204
|
|
|
Less accumulated depreciation and impairment
|
|
—
|
|
|
(62
|
)
|
|
(47
|
)
|
|
(24
|
)
|
|
—
|
|
|
(1
|
)
|
|
(134
|
)
|
|
Net balance at December 31, 2018
|
|
422
|
|
|
22
|
|
|
18
|
|
|
15
|
|
|
13
|
|
|
2
|
|
|
70
|
|
|
–
|
Discount rates used represent the current market assessment of the risks specific to the P&ARP operating segment taking into consideration the time value of money and the risks associated with the underlying assets.
|
|
–
|
The growth rates used to extrapolate cash-flows beyond the forecast year were developed internally and are consistent with external sources of information.
|
|
–
|
Discount rate: an increase in the discount rate by
5%
would result in the recoverable value equaling the carrying value.
|
|
–
|
Perpetual growth rate: a decrease in the perpetual growth rate by
9%
would result in the recoverable value equaling the carrying value.
|
|
(in millions of Euros)
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
||
|
At January 1
|
|
1
|
|
|
1
|
|
|
Group share in loss
|
|
—
|
|
|
(33
|
)
|
|
Reclassified to non-current other financial assets (A)
|
|
—
|
|
|
33
|
|
|
At December 31
|
|
1
|
|
|
1
|
|
|
(A)
|
At December 31, 2018, the loan to Constellium-UACJ ABS LLC was, in substance, part of Constellium’s investment in the joint-venture. Thus, Constellium’s accumulated share of the losses of joint-ventures, in excess of the initial investment, was recognized against other financial assets for a cumulative amount of
€49 million
at December 31, 2018, of which
€33 million
was recognized during the year ended December 31, 2018.
|
|
|
|
|
|
Group share of joint venture’s net assets
|
|
Group share of joint venture’s profit/ (loss)
|
|||||||||
|
(in millions of Euros)
|
|
% interest
|
|
At December 31, 2019
|
|
At December 31, 2018
|
|
At December 31, 2019
|
|
At December 31, 2018
|
|||||
|
Constellium-UACJ ABS LLC
|
|
51.00
|
%
|
|
—
|
|
|
(49
|
)
|
|
—
|
|
|
(33
|
)
|
|
Rhenaroll S.A. (A)
|
|
49.85
|
%
|
|
1
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
Group share
|
|
|
|
1
|
|
|
(48
|
)
|
|
—
|
|
|
(33
|
)
|
|
|
Reclassified to non-current other financial assets
|
|
|
|
—
|
|
|
49
|
|
|
—
|
|
|
—
|
|
|
|
Investment in joint venture
|
|
|
|
1
|
|
|
1
|
|
|
—
|
|
|
(33
|
)
|
|
|
(A)
|
The Group holds a
49.85%
interest in a joint venture named Rhenaroll S.A. (located in Biesheim, France), specialized in the chrome-plating, grinding and repairing of rolling mills’ roll and rollers. Rhenaroll S.A. is a private company with no quoted market price available for its shares. The investment is included in P&ARP segment assets.
|
|
(in millions of Euros)
|
|
At December 31, 2018
|
|
|
Current assets
|
|
|
|
|
Cash and cash equivalents
|
|
8
|
|
|
Trade receivables and other
|
|
49
|
|
|
Inventories
|
|
68
|
|
|
Non-current assets
|
|
|
|
|
Property, plant and equipment
|
|
166
|
|
|
Intangible assets
|
|
—
|
|
|
Total Assets
|
|
291
|
|
|
Current liabilities
|
|
|
|
|
Trade payables and other
|
|
79
|
|
|
Borrowings (A)
|
|
36
|
|
|
Non-current liabilities
|
|
|
|
|
Borrowings (A)
|
|
271
|
|
|
Equity
|
|
(95
|
)
|
|
Total Equity and Liabilities
|
|
291
|
|
|
(A)
|
In February 2018, the shareholders had agreed to modify the terms of their loan to Constellium-UACJ ABS LLC by reducing the interest rate and extending the maturity to March 31, 2023.
|
|
(in millions of Euros)
|
|
Year ended December 31, 2018
|
|
|
Revenue
|
|
262
|
|
|
Cost of sales
|
|
(309
|
)
|
|
Selling and administrative expenses
|
|
(10
|
)
|
|
Loss from operations
|
|
(57
|
)
|
|
Finance costs (A)
|
|
(7
|
)
|
|
Net loss
|
|
(64
|
)
|
|
(A)
|
Finance costs include a
€11 million
gain related to the shareholders’ loan modification for the year ended December 31, 2018.
|
|
(in millions of Euros)
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||
|
Deferred income tax assets
|
|
185
|
|
|
163
|
|
|
Deferred income tax liabilities
|
|
(24
|
)
|
|
(22
|
)
|
|
Net deferred income tax assets
|
|
161
|
|
|
141
|
|
|
(in millions of Euros)
|
|
At January 1, 2019
|
|
Acquisitions
|
|
Recognized in
|
|
FX and reclassifications
|
|
At December 31, 2019
|
||||||||
|
|
|
|
|
|
|
Profit or loss
|
|
OCI
|
|
|
|
|
||||||
|
Long-term assets
|
|
(94
|
)
|
|
1
|
|
|
(3
|
)
|
|
—
|
|
|
(3
|
)
|
|
(99
|
)
|
|
Inventories
|
|
5
|
|
|
—
|
|
|
2
|
|
|
—
|
|
|
1
|
|
|
8
|
|
|
Pensions
|
|
116
|
|
|
—
|
|
|
(4
|
)
|
|
13
|
|
|
2
|
|
|
127
|
|
|
Derivative valuation
|
|
12
|
|
|
—
|
|
|
(8
|
)
|
|
2
|
|
|
—
|
|
|
6
|
|
|
Tax losses carried forward (A)
|
|
61
|
|
|
—
|
|
|
27
|
|
|
—
|
|
|
(13
|
)
|
|
75
|
|
|
Other (B)
|
|
41
|
|
|
2
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|
44
|
|
|
Total
|
|
141
|
|
|
3
|
|
|
14
|
|
|
15
|
|
|
(12
|
)
|
|
161
|
|
|
(A)
|
The reclassifications resulted primarily from the adoption of IFRIC 23.
|
|
(B)
|
Other results mainly from non-deductible provisions and interest.
|
|
(in millions of Euros)
|
|
At January 1, 2018
|
|
Recognized in
|
|
FX
|
|
At December 31, 2018
|
|||||||
|
|
|
|
|
Profit or loss
|
|
OCI
|
|
|
|
|
|||||
|
Long-term assets
|
|
(76
|
)
|
|
(15
|
)
|
|
—
|
|
|
(3
|
)
|
|
(94
|
)
|
|
Inventories
|
|
4
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
5
|
|
|
Pensions
|
|
130
|
|
|
(12
|
)
|
|
(7
|
)
|
|
5
|
|
|
116
|
|
|
Derivative valuation
|
|
(20
|
)
|
|
22
|
|
|
8
|
|
|
2
|
|
|
12
|
|
|
Tax losses carried forward
|
|
78
|
|
|
(13
|
)
|
|
—
|
|
|
(4
|
)
|
|
61
|
|
|
Other (A)
|
|
23
|
|
|
15
|
|
|
—
|
|
|
3
|
|
|
41
|
|
|
Total
|
|
139
|
|
|
(2
|
)
|
|
1
|
|
|
3
|
|
|
141
|
|
|
(A)
|
Other results mainly from non-deductible provisions and interest.
|
|
(in millions of Euros)
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||
|
Expiring within 5 years
|
|
(2
|
)
|
|
(45
|
)
|
|
Expiring after 5 years and limited
|
|
(62
|
)
|
|
(89
|
)
|
|
Unlimited
|
|
(20
|
)
|
|
(19
|
)
|
|
Tax losses
|
|
(84
|
)
|
|
(153
|
)
|
|
Long-term assets
|
|
(104
|
)
|
|
(107
|
)
|
|
Pensions
|
|
(20
|
)
|
|
(18
|
)
|
|
Other
|
|
(51
|
)
|
|
(43
|
)
|
|
Deductible temporary differences
|
|
(175
|
)
|
|
(168
|
)
|
|
Total
|
|
(259
|
)
|
|
(321
|
)
|
|
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||||||||
|
(in millions of Euros)
|
|
Non-current
|
|
Current
|
|
Non-current
|
|
Current
|
||||
|
Trade payables
|
|
—
|
|
|
711
|
|
|
—
|
|
|
685
|
|
|
Fixed assets payables
|
|
—
|
|
|
43
|
|
|
—
|
|
|
30
|
|
|
Employees' entitlements
|
|
—
|
|
|
171
|
|
|
—
|
|
|
160
|
|
|
Taxes payable other than income tax
|
|
—
|
|
|
14
|
|
|
—
|
|
|
16
|
|
|
Contract liabilities and other liabilities to customers
|
|
6
|
|
|
54
|
|
|
9
|
|
|
68
|
|
|
Other payables
|
|
15
|
|
|
6
|
|
|
18
|
|
|
9
|
|
|
Total Other
|
|
21
|
|
|
288
|
|
|
27
|
|
|
283
|
|
|
Total Trade payables and other
|
|
21
|
|
|
999
|
|
|
27
|
|
|
968
|
|
|
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||||||||
|
(in millions of Euros)
|
|
Non-current
|
|
Current
|
|
Non-current
|
|
Current
|
||||
|
Deferred tooling revenue
|
|
2
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Advance payment from customers
|
|
2
|
|
|
5
|
|
|
7
|
|
|
9
|
|
|
Unrecognized variable consideration (A)
|
|
2
|
|
|
46
|
|
|
2
|
|
|
57
|
|
|
Other
|
|
—
|
|
|
3
|
|
|
—
|
|
|
2
|
|
|
Total contract liabilities and other liabilities to customers
|
|
6
|
|
|
54
|
|
|
9
|
|
|
68
|
|
|
(A)
|
Unrecognized variable consideration consists of expected volume rebates, discounts, incentives, refunds penalties and price concessions.
|
|
(in millions of Euros)
|
|
December 31, 2019
|
|
December 31, 2018
|
|||||||||||||||||||||
|
|
|
Nominal Value in Currency
|
|
Nominal rate
|
|
Effective rate
|
|
Nominal Value In Euros
|
|
(Arrangement fees)
|
|
Accrued interests
|
|
Carrying value
|
|
Carrying value
|
|||||||||
|
Secured Pan-U.S. ABL (due 2022) (A)
|
|
$
|
142
|
|
|
Floating
|
|
|
4.2
|
%
|
|
127
|
|
|
—
|
|
|
—
|
|
|
127
|
|
|
—
|
|
|
Secured Inventory Based Facility (due 2021) (B)
|
|
—
|
|
|
Floating
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
Senior Unsecured Notes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Constellium SE
(Issued May 2014, due 2024) |
|
$
|
400
|
|
|
5.75
|
%
|
|
6.26
|
%
|
|
356
|
|
|
(3
|
)
|
|
2
|
|
|
355
|
|
|
348
|
|
|
Constellium SE
(Issued May 2014, due 2021) |
|
€
|
200
|
|
|
4.63
|
%
|
|
5.16
|
%
|
|
200
|
|
|
(1
|
)
|
|
1
|
|
|
200
|
|
|
300
|
|
|
Constellium SE
(Issued February 2017, due 2025) |
|
$
|
650
|
|
|
6.63
|
%
|
|
7.13
|
%
|
|
579
|
|
|
(10
|
)
|
|
13
|
|
|
582
|
|
|
568
|
|
|
Constellium SE
(Issued November 2017, due 2026) |
|
$
|
500
|
|
|
5.88
|
%
|
|
6.26
|
%
|
|
445
|
|
|
(6
|
)
|
|
10
|
|
|
449
|
|
|
440
|
|
|
Constellium SE
(Issued November 2017, due 2026) |
|
€
|
400
|
|
|
4.25
|
%
|
|
4.57
|
%
|
|
400
|
|
|
(6
|
)
|
|
6
|
|
|
400
|
|
|
399
|
|
|
Unsecured Revolving Credit Facility (due 2021) (C)
|
|
—
|
|
|
Floating
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
Lease liabilities
|
|
|
|
|
|
|
|
187
|
|
|
—
|
|
|
1
|
|
|
188
|
|
|
73
|
|
||||
|
Other loans (D)
|
|
|
|
|
|
|
|
59
|
|
|
—
|
|
|
1
|
|
|
60
|
|
|
23
|
|
||||
|
Total Borrowings
|
|
|
|
|
|
|
|
2,353
|
|
|
(26
|
)
|
|
34
|
|
|
2,361
|
|
|
2,151
|
|
||||
|
Of which non-current
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,160
|
|
|
2,094
|
|
|||||||
|
Of which current
|
|
|
|
|
|
|
|
|
|
|
|
|
|
201
|
|
|
57
|
|
|||||||
|
(A)
|
On February 20, 2019, the Pan-U.S. ABL was amended to include Bowling Green and increased to
$350 million
. The Pan-U.S. ABL was increased to
$400 million
on May 10, 2019.
|
|
(B)
|
On March 15, 2019, the French secured Inventory Based Facility maturity was extended to 2021.
|
|
(C)
|
The Unsecured Revolving Credit Facility has a
€7 million
borrowing base and is provided by Bpifrance Financement, a related party.
|
|
(D)
|
Other loans include
€36 million
of financial liabilities relating to the sale and leaseback of assets that were considered to be financing arrangements in substance.
|
|
(in millions of Euros)
|
|
Notes
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
||
|
At December 31, prior period
|
|
|
|
2,151
|
|
|
2,127
|
|
|
IFRS 16 application
|
|
|
|
102
|
|
|
—
|
|
|
At January 1
|
|
|
|
2,253
|
|
|
2,127
|
|
|
Cash flows
|
|
|
|
|
|
|
||
|
Repayment of Senior Notes (A)
|
|
|
|
(100
|
)
|
|
—
|
|
|
Proceeds / (repayments) from revolving credit facilities and other loans
|
|
|
|
109
|
|
|
(68
|
)
|
|
Lease repayments
|
|
|
|
(86
|
)
|
|
(15
|
)
|
|
Non-cash changes
|
|
|
|
|
|
|
||
|
Borrowings assumed through business combination
|
|
3
|
|
75
|
|
|
—
|
|
|
Movement in interests accrued or capitalized
|
|
|
|
1
|
|
|
12
|
|
|
New leases and other loans
|
|
|
|
75
|
|
|
28
|
|
|
Deferred arrangement fees, step-up amortization and other
|
|
|
|
5
|
|
|
2
|
|
|
Effects of changes in foreign exchange rates
|
|
|
|
29
|
|
|
65
|
|
|
At December 31
|
|
|
|
2,361
|
|
|
2,151
|
|
|
(A)
|
On August 8, 2019,
€100 million
of the
€300 million
outstanding aggregate principal amount of the
4.63%
Senior Notes due 2021 were redeemed.
|
|
(in millions of Euros)
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||
|
U.S. Dollar
|
|
1,597
|
|
|
1,408
|
|
|
Euro
|
|
746
|
|
|
726
|
|
|
Other currencies
|
|
18
|
|
|
17
|
|
|
Total borrowings
|
|
2,361
|
|
|
2,151
|
|
|
|
|
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||||||||||||||||||||
|
(in millions of Euros)
|
|
Notes
|
|
At amortized cost
|
|
At Fair Value through Profit and loss
|
|
At Fair Value through OCI
|
|
Total
|
|
At amortized cost
|
|
At Fair Value through Profit and loss
|
|
At Fair Value through OCI
|
|
Total
|
||||||||
|
Cash and cash equivalents
|
|
14
|
|
184
|
|
|
—
|
|
|
—
|
|
|
184
|
|
|
164
|
|
|
—
|
|
|
—
|
|
|
164
|
|
|
Trade receivables
|
|
15
|
|
—
|
|
|
—
|
|
|
393
|
|
|
393
|
|
|
—
|
|
|
—
|
|
|
481
|
|
|
481
|
|
|
Other financial assets
|
|
|
|
—
|
|
|
29
|
|
|
—
|
|
|
29
|
|
|
74
|
|
|
30
|
|
|
—
|
|
|
104
|
|
|
Total
|
|
|
|
184
|
|
|
29
|
|
|
393
|
|
|
606
|
|
|
238
|
|
|
30
|
|
|
481
|
|
|
749
|
|
|
|
|
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||||||||||||||||||||
|
(in millions of Euros)
|
|
Notes
|
|
At amortized cost
|
|
At Fair Value through Profit and loss
|
|
At Fair Value through OCI
|
|
Total
|
|
At amortized cost
|
|
At Fair Value through Profit and loss
|
|
At Fair Value through OCI
|
|
Total
|
||||||||
|
Trade payables and fixed assets payables
|
|
21
|
|
754
|
|
|
—
|
|
|
—
|
|
|
754
|
|
|
715
|
|
|
—
|
|
|
—
|
|
|
715
|
|
|
Borrowings
|
|
22
|
|
2,361
|
|
|
—
|
|
|
—
|
|
|
2,361
|
|
|
2,151
|
|
|
—
|
|
|
—
|
|
|
2,151
|
|
|
Other financial liabilities
|
|
|
|
—
|
|
|
44
|
|
|
14
|
|
|
58
|
|
|
—
|
|
|
79
|
|
|
10
|
|
|
89
|
|
|
Total
|
|
|
|
3,115
|
|
|
44
|
|
|
14
|
|
|
3,173
|
|
|
2,866
|
|
|
79
|
|
|
10
|
|
|
2,955
|
|
|
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||||||||||||||
|
(in millions of Euros)
|
|
Non-current
|
|
Current
|
|
Total
|
|
Non-current
|
|
Current
|
|
Total
|
||||||
|
Derivatives
|
|
7
|
|
|
22
|
|
|
29
|
|
|
7
|
|
|
23
|
|
|
30
|
|
|
Aluminium and premium future contracts
|
|
1
|
|
|
8
|
|
|
9
|
|
|
2
|
|
|
7
|
|
|
9
|
|
|
Energy future contracts
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Other future contracts
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Currency commercial contracts
|
|
5
|
|
|
12
|
|
|
17
|
|
|
3
|
|
|
12
|
|
|
15
|
|
|
Currency net debt derivatives
|
|
1
|
|
|
2
|
|
|
3
|
|
|
2
|
|
|
4
|
|
|
6
|
|
|
Loans (A)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
67
|
|
|
2
|
|
|
69
|
|
|
Margin call
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5
|
|
|
5
|
|
|
Other financial assets
|
|
7
|
|
|
22
|
|
|
29
|
|
|
74
|
|
|
30
|
|
|
104
|
|
|
Derivatives
|
|
23
|
|
|
35
|
|
|
58
|
|
|
29
|
|
|
60
|
|
|
89
|
|
|
Aluminium and premium future contracts
|
|
4
|
|
|
10
|
|
|
14
|
|
|
6
|
|
|
38
|
|
|
44
|
|
|
Energy future contracts
|
|
—
|
|
|
1
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Other future contracts
|
|
2
|
|
|
4
|
|
|
6
|
|
|
5
|
|
|
3
|
|
|
8
|
|
|
Currency commercial contracts
|
|
12
|
|
|
16
|
|
|
28
|
|
|
7
|
|
|
12
|
|
|
19
|
|
|
Net investment hedge
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4
|
|
|
4
|
|
|
Currency net debt derivatives
|
|
5
|
|
|
4
|
|
|
9
|
|
|
11
|
|
|
3
|
|
|
14
|
|
|
Other financial liabilities
|
|
23
|
|
|
35
|
|
|
58
|
|
|
29
|
|
|
60
|
|
|
89
|
|
|
(A)
|
At December 31, 2018, Loans corresponds to a loan facility to Constellium-UACJ ABS LLC (See
|
|
•
|
Level 1 valuation is based on a quoted price (unadjusted) in active markets for identical financial instruments. Level 1 includes aluminium, copper and zinc futures that are traded on the LME.
|
|
•
|
Level 2 valuation is based on inputs other than quoted prices included within Level 1 that are observable for the assets or liabilities, either directly (i.e. prices) or indirectly (i.e. derived from prices). Level 2 includes foreign exchange derivatives;
|
|
•
|
Level 3 valuation is based on inputs for the asset or liability that are not based on observable market data (unobservable inputs). Trade receivables are classified as a Level 3 measurement under the fair value hierarchy.
|
|
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||||||||||||||||||||
|
(in millions of Euros)
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
|
Other financial assets - derivatives
|
|
8
|
|
|
21
|
|
|
—
|
|
|
29
|
|
|
9
|
|
|
21
|
|
|
—
|
|
|
30
|
|
|
Other financial liabilities - derivatives
|
|
19
|
|
|
39
|
|
|
—
|
|
|
58
|
|
|
50
|
|
|
39
|
|
|
—
|
|
|
89
|
|
|
•
|
Transaction exposures, which include:
|
|
◦
|
Commercial transactions related to forecasted sales and purchases and on-balance sheet receivables/payables resulting from such transactions;
|
|
◦
|
Financing transactions, related to external and internal net debt;
|
|
•
|
Translation exposures, which relate to net investments in foreign entities that are converted in Euros in the Consolidated Financial Statements.
|
|
Forward derivative sales
|
|
Maturity Year
|
|
Less than 1 year
|
|
Over 1 year
|
||
|
USD/EUR
|
|
2020-2024
|
|
446
|
|
|
157
|
|
|
EUR/CHF
|
|
2020-2023
|
|
79
|
|
|
35
|
|
|
Other currencies
|
|
2020
|
|
10
|
|
|
—
|
|
|
Forward derivative purchases
|
|
Maturity Year
|
|
Less than 1 year
|
|
Over 1 year
|
||
|
USD/EUR
|
|
2020-2024
|
|
473
|
|
|
77
|
|
|
EUR/CHF
|
|
2020-2024
|
|
130
|
|
|
61
|
|
|
EUR/CZK
|
|
2020
|
|
81
|
|
|
—
|
|
|
Other currencies
|
|
2020
|
|
2
|
|
|
—
|
|
|
(in millions of Euros)
|
|
Notes
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Derivatives that do not qualify for hedge accounting
|
|
|
|
|
|
|
|
|
|||
|
Included in Other gains / (losses) - net
|
|
|
|
|
|
|
|
|
|||
|
Realized gains / (losses) on foreign currency derivatives - net
|
|
10
|
|
7
|
|
|
7
|
|
|
(16
|
)
|
|
Unrealized gains / (losses) on foreign currency derivatives - net (A)
|
|
10
|
|
2
|
|
|
(1
|
)
|
|
16
|
|
|
Derivatives that qualify for hedge accounting
|
|
|
|
|
|
|
|
|
|||
|
Included in Revenue
|
|
|
|
|
|
|
|
|
|||
|
Realized (losses) / gains on foreign currency derivatives - net
|
|
10
|
|
(6
|
)
|
|
4
|
|
|
1
|
|
|
Unrealized (losses) / gains on foreign currency derivatives - net
|
|
10
|
|
(1
|
)
|
|
(2
|
)
|
|
1
|
|
|
Included in Other gains / (losses) - net
|
|
|
|
|
|
|
|
|
|||
|
Realized gains / (losses) in ineffective portion of derivatives
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Included in Other comprehensive income / (loss)
|
|
|
|
|
|
|
|
|
|||
|
Unrealized (losses) / gains on foreign currency derivatives - net
|
|
|
|
(15
|
)
|
|
(23
|
)
|
|
48
|
|
|
Gains / (losses) reclassified from cash flow hedge reserve to Consolidated Income Statement
|
|
|
|
7
|
|
|
(2
|
)
|
|
(2
|
)
|
|
(A)
|
Gains or losses on the hedging instruments are expected to offset losses or gains on the underlying hedged forecasted sales that will be reflected in future years when these sales are recognized.
|
|
(in millions of Euros)
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Derivatives
|
|
|
|
|
|
|
|
||
|
Included in Finance costs - net
|
|
|
|
|
|
|
|
||
|
Realized gains / (losses) on foreign currency derivatives - net
|
|
9
|
|
|
5
|
|
|
31
|
|
|
Unrealized gains / (losses) on foreign currency derivatives - net
|
|
4
|
|
|
23
|
|
|
(110
|
)
|
|
Total
|
|
13
|
|
|
28
|
|
|
(79
|
)
|
|
(in millions of Euros)
|
|
Effect on profit before tax
|
|
Effect on pretax equity
|
||
|
Trade receivables
|
|
2
|
|
|
—
|
|
|
Trade payables
|
|
(1
|
)
|
|
—
|
|
|
Derivatives on commercial transaction (A)
|
|
(4
|
)
|
|
(23
|
)
|
|
Commercial transaction exposure
|
|
(3
|
)
|
|
(23
|
)
|
|
Cash in Bank and intercompany loans
|
|
120
|
|
|
—
|
|
|
Borrowings
|
|
(153
|
)
|
|
—
|
|
|
Derivatives on financing transaction
|
|
33
|
|
|
—
|
|
|
Financing transaction exposure
|
|
—
|
|
|
—
|
|
|
Total
|
|
(3
|
)
|
|
(23
|
)
|
|
(A)
|
Gains or losses on the hedging instruments are expected to offset losses or gains on the underlying hedged forecasted sales that will be reflected in future years when these sales are recognized. The impact on pretax equity (
€23 million
) relates to derivatives hedging future sales spread from 2020 to 2022 which are designated as cash flow hedges.
|
|
(in millions of Euros)
|
|
Effect on profit before tax
|
|
Effect on pretax equity
|
||
|
10% strengthening U.S. Dollar/Euro
|
|
(4
|
)
|
|
16
|
|
|
(in millions of Euros)
|
|
Maturity
|
|
Less than 1 year
|
|
Over 1 year
|
||
|
Aluminium
|
|
2020-2023
|
|
283
|
|
|
33
|
|
|
Premium
|
|
2020-2021
|
|
11
|
|
|
2
|
|
|
Copper
|
|
2020-2022
|
|
10
|
|
|
7
|
|
|
Silver
|
|
2020-2021
|
|
6
|
|
|
—
|
|
|
Zinc
|
|
2020-2022
|
|
9
|
|
|
9
|
|
|
Natural gas
|
|
2020-2021
|
|
5
|
|
|
2
|
|
|
(in millions of Euros)
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Derivatives
|
|
|
|
|
|
|
|||
|
Included in Other gains / (losses) - net
|
|
|
|
|
|
|
|||
|
Realized (losses) / gains on commodity derivatives - net
|
|
(56
|
)
|
|
7
|
|
|
16
|
|
|
Unrealized gains / (losses) on commodity derivatives - net
|
|
31
|
|
|
(83
|
)
|
|
41
|
|
|
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||||||||
|
|
|
Number of financial counterparties (A)
|
|
Exposure (in millions of Euros)
|
|
Number of financial counterparties (A)
|
|
Exposure (in millions of Euros)
|
||||
|
Rated Aa or better
|
|
2
|
|
|
83
|
|
|
2
|
|
|
22
|
|
|
Rated A
|
|
9
|
|
|
81
|
|
|
8
|
|
|
110
|
|
|
Rated Baa
|
|
3
|
|
|
5
|
|
|
2
|
|
|
4
|
|
|
Total
|
|
14
|
|
|
169
|
|
|
12
|
|
|
136
|
|
|
(A)
|
Financial Counterparties for which the Group’s exposure is below
€0.25 million
have been excluded from the analysis.
|
|
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||||||||||||||
|
(in millions of Euros)
|
|
Less than 1 year
|
|
Between 1- 5 years
|
|
Over 5 years
|
|
Less than 1 year
|
|
Between 1 - 5 years
|
|
Over 5 years
|
||||||
|
Financial assets
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Net debt derivatives
|
|
3
|
|
|
4
|
|
|
—
|
|
|
5
|
|
|
12
|
|
|
—
|
|
|
Net cash flows from derivative assets related to currencies and commodities
|
|
21
|
|
|
9
|
|
|
—
|
|
|
22
|
|
|
12
|
|
|
—
|
|
|
Total
|
|
24
|
|
|
13
|
|
|
—
|
|
|
27
|
|
|
24
|
|
|
—
|
|
|
|
|
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||||||||||||||
|
(in millions of Euros)
|
|
Notes
|
|
Less than 1 year
|
|
Between 1 - 5 years
|
|
After 5 years
|
|
Less than 1 year
|
|
Between 1 - 5 Years
|
|
After 5 years
|
||||||
|
Financial liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Borrowings (A)
|
|
|
|
139
|
|
|
589
|
|
|
1,438
|
|
|
6
|
|
|
315
|
|
|
1,754
|
|
|
Leases
|
|
|
|
40
|
|
|
113
|
|
|
88
|
|
|
20
|
|
|
50
|
|
|
16
|
|
|
Interest (B)
|
|
|
|
112
|
|
|
404
|
|
|
85
|
|
|
114
|
|
|
422
|
|
|
173
|
|
|
Net debt derivatives
|
|
|
|
4
|
|
|
—
|
|
|
—
|
|
|
3
|
|
|
4
|
|
|
—
|
|
|
Net cash flows from derivative liabilities related to currencies and commodities
|
|
|
|
31
|
|
|
25
|
|
|
—
|
|
|
56
|
|
|
35
|
|
|
—
|
|
|
Trade payables and other (excluding contract liabilities)
|
|
21
|
|
945
|
|
|
15
|
|
|
—
|
|
|
900
|
|
|
18
|
|
|
—
|
|
|
Total
|
|
|
|
1,271
|
|
|
1,146
|
|
|
1,611
|
|
|
1,079
|
|
|
794
|
|
|
1,927
|
|
|
(A)
|
Borrowings include the Pan-U.S. ABL facility, which is considered short-term in nature and is included in the category “Less than 1 year”.
|
|
(B)
|
Interest disclosed is an undiscounted forecast interest amount and excludes interest on leases.
|
|
(in millions of Euros)
|
|
0.50% increase in
discount rates |
|
0.50% decrease in
discount rates |
||
|
France
|
|
(10
|
)
|
|
10
|
|
|
Germany
|
|
(9
|
)
|
|
11
|
|
|
Switzerland
|
|
(25
|
)
|
|
26
|
|
|
United States
|
|
(32
|
)
|
|
35
|
|
|
Total sensitivity on Defined Benefit Obligations
|
|
(76
|
)
|
|
82
|
|
|
|
||||||||||||
|
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||||||||
|
|
|
Rate of increase in salaries
|
|
Rate of increase in pensions
|
|
Discount rate
|
|
Rate of increase in salaries
|
|
Rate of increase in pensions
|
|
Discount rate
|
|
Switzerland
|
|
1.50%
|
|
—
|
|
0.15%
|
|
1.50%
|
|
—
|
|
0.80%
|
|
US
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
Hourly pension
|
|
2.20%
|
|
—
|
|
3.15% - 3.25%
|
|
2.20%
|
|
—
|
|
4.40% - 4.45%
|
|
Salaried pension
|
|
3.80%
|
|
—
|
|
3.25%
|
|
3.80%
|
|
—
|
|
4.45%
|
|
OPEB (A)
|
|
3.80%
|
|
—
|
|
3.20% - 3.40%
|
|
3.80%
|
|
—
|
|
4.40% - 4.55%
|
|
Other benefits
|
|
3.80%
|
|
—
|
|
3.00% - 3.20%
|
|
3.80%
|
|
—
|
|
4.25% - 4.40%
|
|
France
|
|
1.50% - 3.50%
|
|
2.00%
|
|
—
|
|
1.50% - 2.50%
|
|
2.00%
|
|
—
|
|
Retirements
|
|
—
|
|
—
|
|
0.95%
|
|
—
|
|
—
|
|
1.65%
|
|
Other benefits
|
|
—
|
|
—
|
|
0.80%
|
|
—
|
|
—
|
|
1.35%
|
|
Germany
|
|
2.75%
|
|
1.70%
|
|
1.00%
|
|
2.75%
|
|
1.70%
|
|
1.70%
|
|
(A)
|
The other main financial assumptions used for the OPEB (healthcare plans, which are predominantly in the U.S.) were:
|
|
•
|
Medical trend rate: pre 65:
6.40%
starting in
2020
decreasing gradually to
4.50%
until 2026 and stable onwards and post 65:
5.60%
starting in 2020 decreasing gradually to
4.50%
until 2026 and stable onwards, and
|
|
•
|
Claims costs are based on individual company experience.
|
|
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||||||||||||||
|
(in millions of Euros)
|
|
Pension Benefits
|
|
Other Benefits
|
|
Total
|
|
Pension Benefits
|
|
Other Benefits
|
|
Total
|
||||||
|
Present value of funded obligation
|
|
768
|
|
|
—
|
|
|
768
|
|
|
674
|
|
|
—
|
|
|
674
|
|
|
Fair value of plan assets
|
|
(445
|
)
|
|
—
|
|
|
(445
|
)
|
|
(380
|
)
|
|
—
|
|
|
(380
|
)
|
|
Deficit of funded plans
|
|
323
|
|
|
—
|
|
|
323
|
|
|
294
|
|
|
—
|
|
|
294
|
|
|
Present value of unfunded obligation
|
|
127
|
|
|
220
|
|
|
347
|
|
|
115
|
|
|
201
|
|
|
316
|
|
|
Net liability arising from defined benefit obligation
|
|
450
|
|
|
220
|
|
|
670
|
|
|
409
|
|
|
201
|
|
|
610
|
|
|
|
|
At December 31, 2019
|
|||||||||||||
|
|
|
Defined benefit obligations
|
|
Plan Assets
|
|
Net defined benefit liability
|
|||||||||
|
(in millions of Euros)
|
|
Pension benefits
|
|
Other benefits
|
|
Total
|
|
||||||||
|
At January 1, 2019
|
|
789
|
|
|
201
|
|
|
990
|
|
|
(380
|
)
|
|
610
|
|
|
Included in the Consolidated Income Statement
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Current service cost
|
|
17
|
|
|
7
|
|
|
24
|
|
|
—
|
|
|
24
|
|
|
Interest cost / (income)
|
|
18
|
|
|
8
|
|
|
26
|
|
|
(10
|
)
|
|
16
|
|
|
Past service cost
|
|
(2
|
)
|
|
1
|
|
|
(1
|
)
|
|
—
|
|
|
(1
|
)
|
|
Immediate recognition of gains / (losses) arising over the year
|
|
—
|
|
|
2
|
|
|
2
|
|
|
—
|
|
|
2
|
|
|
Administration expenses
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2
|
|
|
2
|
|
|
Included in the Statement of Comprehensive Income / (Loss)
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Remeasurements due to:
|
|
|
|
|
|
|
|
|
|
|
|||||
|
—actual return less interest on plan assets
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(54
|
)
|
|
(54
|
)
|
|
—changes in financial assumptions
|
|
101
|
|
|
25
|
|
|
126
|
|
|
—
|
|
|
126
|
|
|
—changes in demographic assumptions
|
|
(2
|
)
|
|
(2
|
)
|
|
(4
|
)
|
|
—
|
|
|
(4
|
)
|
|
—experience losses
|
|
(3
|
)
|
|
(6
|
)
|
|
(9
|
)
|
|
—
|
|
|
(9
|
)
|
|
Effects of changes in foreign exchange rates
|
|
16
|
|
|
3
|
|
|
19
|
|
|
(11
|
)
|
|
8
|
|
|
Included in the Consolidated Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Benefits paid
|
|
(43
|
)
|
|
(20
|
)
|
|
(63
|
)
|
|
38
|
|
|
(25
|
)
|
|
Contributions by the Group
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(25
|
)
|
|
(25
|
)
|
|
Contributions by the plan participants
|
|
4
|
|
|
1
|
|
|
5
|
|
|
(5
|
)
|
|
—
|
|
|
At December 31, 2019
|
|
895
|
|
|
220
|
|
|
1,115
|
|
|
(445
|
)
|
|
670
|
|
|
|
|
At December 31, 2018
|
|||||||||||||
|
|
|
Defined benefit obligations
|
|
Plan Assets
|
|
Net defined benefit liability
|
|||||||||
|
(in millions of Euros)
|
|
Pension benefits
|
|
Other benefits
|
|
Total
|
|
||||||||
|
At January 1, 2018
|
|
801
|
|
|
250
|
|
|
1,051
|
|
|
(387
|
)
|
|
664
|
|
|
Included the Consolidated Income Statement
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Current service cost
|
|
18
|
|
|
6
|
|
|
24
|
|
|
—
|
|
|
24
|
|
|
Interest cost / (income)
|
|
16
|
|
|
8
|
|
|
24
|
|
|
(9
|
)
|
|
15
|
|
|
Past service cost
|
|
—
|
|
|
(36
|
)
|
|
(36
|
)
|
|
—
|
|
|
(36
|
)
|
|
Immediate recognition of gains / (losses) arising over the year
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Administration expenses
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2
|
|
|
2
|
|
|
Included in the Statement of Comprehensive Income / (Loss)
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Remeasurements due to:
|
|
|
|
|
|
|
|
|
|
|
|||||
|
—actual return less interest on plan assets
|
|
—
|
|
|
—
|
|
|
—
|
|
|
26
|
|
|
26
|
|
|
—changes in financial assumptions
|
|
(30
|
)
|
|
(15
|
)
|
|
(45
|
)
|
|
—
|
|
|
(45
|
)
|
|
—changes in demographic assumptions
|
|
(5
|
)
|
|
(1
|
)
|
|
(6
|
)
|
|
—
|
|
|
(6
|
)
|
|
—experience losses
|
|
(1
|
)
|
|
(2
|
)
|
|
(3
|
)
|
|
—
|
|
|
(3
|
)
|
|
Effects of changes in foreign exchange rates
|
|
22
|
|
|
9
|
|
|
31
|
|
|
(16
|
)
|
|
15
|
|
|
Included in the Consolidated Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Benefits paid
|
|
(35
|
)
|
|
(19
|
)
|
|
(54
|
)
|
|
31
|
|
|
(23
|
)
|
|
Contributions by the Group
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(23
|
)
|
|
(23
|
)
|
|
Contributions by the plan participants
|
|
3
|
|
|
1
|
|
|
4
|
|
|
(4
|
)
|
|
—
|
|
|
At December 31, 2018
|
|
789
|
|
|
201
|
|
|
990
|
|
|
(380
|
)
|
|
610
|
|
|
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||||||||||||||
|
(in millions of Euros)
|
|
Defined benefit obligations
|
|
Plan assets
|
|
Net defined benefit liability
|
|
Defined benefit obligations
|
|
Plan assets
|
|
Net defined benefit liability
|
||||||
|
France
|
|
161
|
|
|
(3
|
)
|
|
158
|
|
|
151
|
|
|
(3
|
)
|
|
148
|
|
|
Germany
|
|
144
|
|
|
(1
|
)
|
|
143
|
|
|
136
|
|
|
(1
|
)
|
|
135
|
|
|
Switzerland
|
|
299
|
|
|
(214
|
)
|
|
85
|
|
|
251
|
|
|
(178
|
)
|
|
73
|
|
|
United States
|
|
510
|
|
|
(227
|
)
|
|
283
|
|
|
451
|
|
|
(198
|
)
|
|
253
|
|
|
Other countries
|
|
1
|
|
|
—
|
|
|
1
|
|
|
1
|
|
|
—
|
|
|
1
|
|
|
Total
|
|
1,115
|
|
|
(445
|
)
|
|
670
|
|
|
990
|
|
|
(380
|
)
|
|
610
|
|
|
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||||||||||||||
|
(in millions of Euros)
|
|
Quoted in an active market
|
|
Unquoted in an active market
|
|
Total
|
|
Quoted in an active market
|
|
Unquoted in an active market
|
|
Total
|
||||||
|
Cash & cash equivalents
|
|
5
|
|
|
—
|
|
|
5
|
|
|
6
|
|
|
—
|
|
|
6
|
|
|
Equities
|
|
119
|
|
|
51
|
|
|
170
|
|
|
95
|
|
|
40
|
|
|
135
|
|
|
Bonds
|
|
92
|
|
|
115
|
|
|
207
|
|
|
71
|
|
|
110
|
|
|
181
|
|
|
Property
|
|
14
|
|
|
37
|
|
|
51
|
|
|
10
|
|
|
33
|
|
|
43
|
|
|
Other
|
|
—
|
|
|
12
|
|
|
12
|
|
|
5
|
|
|
10
|
|
|
15
|
|
|
Total fair value of plan assets
|
|
230
|
|
|
215
|
|
|
445
|
|
|
187
|
|
|
193
|
|
|
380
|
|
|
(in millions of Euros)
|
|
Estimated benefits payments
|
|
|
Year ended December 31,
|
|
|
|
|
2020
|
|
54
|
|
|
2021
|
|
51
|
|
|
2022
|
|
52
|
|
|
2023
|
|
53
|
|
|
2024
|
|
58
|
|
|
2025 to 2029
|
|
289
|
|
|
(in millions of Euros)
|
|
Notes
|
|
Close down and environmental remediation costs
|
|
Restructuring
costs |
|
Legal claims
and other costs |
|
Total
|
||||
|
At January 1, 2019
|
|
|
|
83
|
|
|
3
|
|
|
54
|
|
|
140
|
|
|
IFRIC 23 application
|
|
2
|
|
—
|
|
|
—
|
|
|
(20
|
)
|
|
(20
|
)
|
|
Allowance
|
|
|
|
1
|
|
|
2
|
|
|
6
|
|
|
9
|
|
|
Amounts used
|
|
|
|
(2
|
)
|
|
(1
|
)
|
|
(4
|
)
|
|
(7
|
)
|
|
Unused amounts reversed
|
|
|
|
(1
|
)
|
|
—
|
|
|
(4
|
)
|
|
(5
|
)
|
|
Unwinding of discounts
|
|
|
|
4
|
|
|
—
|
|
|
—
|
|
|
4
|
|
|
Effects of changes in foreign exchange rates
|
|
|
|
2
|
|
|
—
|
|
|
—
|
|
|
2
|
|
|
Transfer
|
|
|
|
3
|
|
|
—
|
|
|
(4
|
)
|
|
(1
|
)
|
|
At December 31, 2019
|
|
|
|
90
|
|
|
4
|
|
|
28
|
|
|
122
|
|
|
Current
|
|
|
|
7
|
|
|
2
|
|
|
14
|
|
|
23
|
|
|
Non-Current
|
|
|
|
83
|
|
|
2
|
|
|
14
|
|
|
99
|
|
|
Total Provisions
|
|
|
|
90
|
|
|
4
|
|
|
28
|
|
|
122
|
|
|
(in millions of Euros)
|
|
Notes
|
|
Close down and environmental remediation costs
|
|
Restructuring
costs |
|
Legal claims
and other costs |
|
Total
|
||||
|
At January 1, 2018
|
|
|
|
81
|
|
|
5
|
|
|
67
|
|
|
153
|
|
|
Transfer from provision to contract liability
|
|
|
|
—
|
|
|
—
|
|
|
(23
|
)
|
|
(23
|
)
|
|
Allowance
|
|
|
|
3
|
|
|
1
|
|
|
15
|
|
|
19
|
|
|
Amounts used
|
|
|
|
(2
|
)
|
|
(2
|
)
|
|
(4
|
)
|
|
(8
|
)
|
|
Unused amounts reversed
|
|
|
|
—
|
|
|
(1
|
)
|
|
(6
|
)
|
|
(7
|
)
|
|
Unwinding of discounts
|
|
|
|
(1
|
)
|
|
—
|
|
|
—
|
|
|
(1
|
)
|
|
Effects of changes in foreign exchange rates
|
|
|
|
2
|
|
|
—
|
|
|
1
|
|
|
3
|
|
|
Transfer
|
|
|
|
—
|
|
|
—
|
|
|
4
|
|
|
4
|
|
|
At December 31, 2018
|
|
|
|
83
|
|
|
3
|
|
|
54
|
|
|
140
|
|
|
Current
|
|
|
|
5
|
|
|
1
|
|
|
40
|
|
|
46
|
|
|
Non-Current
|
|
|
|
78
|
|
|
2
|
|
|
14
|
|
|
94
|
|
|
Total Provisions
|
|
|
|
83
|
|
|
3
|
|
|
54
|
|
|
140
|
|
|
(in millions of Euros)
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||
|
Litigation (A)
|
|
21
|
|
|
45
|
|
|
Disease claims (B)
|
|
4
|
|
|
4
|
|
|
Other
|
|
3
|
|
|
5
|
|
|
Total Provisions for legal claims and other costs
|
|
28
|
|
|
54
|
|
|
(A)
|
The decrease in provisions for litigation is mainly explained by the
€20 million
reclassification upon the adoption of IFRIC 23.
|
|
(B)
|
Since the early 1990s, certain activities of the Group’s businesses have been subject to claims and lawsuits in France relating to occupational diseases resulting from alleged asbestos exposure, such as mesothelioma and asbestosis. It is not uncommon for the investigation and resolution of such claims to go on over many years as the latency period for acquiring such diseases is typically between
25
and
40
years. For any such claim, it is up to the social security authorities in each jurisdiction to determine if a claim qualifies as an occupational illness claim. If so determined, the Group must settle the case or defend its position in court. At
December 31, 2019
,
seven
cases in which gross negligence is alleged (“faute inexcusable”) remain outstanding (
six
at
December 31, 2018
), the average amount per claim being less than
€0.1 million
. The average settlement amount per claim in
2019
and
2018
was less than
€0.1 million
. It is not anticipated that the resolution of such litigation and proceedings will have a material effect on the future results from continuing operations, financial position, or cash flows of the Group.
|
|
|
|
|
|
(in millions of Euros)
|
|||||
|
|
|
Number of shares
|
|
Share capital
|
|
Share premium
|
|||
|
At January 1, 2019
|
|
135,999,394
|
|
|
3
|
|
|
420
|
|
|
New shares issued (A)
|
|
1,868,024
|
|
|
—
|
|
|
—
|
|
|
At December 31, 2019
|
|
137,867,418
|
|
|
3
|
|
|
420
|
|
|
(A)
|
Constellium SE issued and granted
1,868,024
ordinary shares to certain employees related to share-based compensation plans.
|
|
(in millions of Euros)
|
|
At December 31, 2019
|
|
|
Less than 1 year
|
|
5
|
|
|
1 to 5 years
|
|
10
|
|
|
More than 5 years
|
|
1
|
|
|
Total non-cancellable lease minimum payments
|
|
16
|
|
|
(in millions of Euros)
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||
|
Computer Software
|
|
2
|
|
|
1
|
|
|
Property, plant and equipment
|
|
89
|
|
|
123
|
|
|
Total tangible and intangible asset commitments
|
|
91
|
|
|
124
|
|
|
–
|
Short term employee benefits include their base salary plus bonus;
|
|
–
|
Directors’ fees include annual director fees, Board and committees’ attendance fees;
|
|
–
|
Share-based compensation includes the portion of the IFRS 2 expense as allocated to key management;
|
|
–
|
Post-employment benefits mainly include pension costs;
|
|
–
|
Termination benefits include departure costs.
|
|
(in millions of Euros)
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Short-term employee benefits
|
|
9
|
|
|
9
|
|
|
8
|
|
|
Directors' fees
|
|
1
|
|
|
1
|
|
|
1
|
|
|
Share-based compensation
|
|
10
|
|
|
6
|
|
|
4
|
|
|
Post-employments benefits
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Termination benefits
|
|
—
|
|
|
—
|
|
|
1
|
|
|
Employer social contribution
|
|
1
|
|
|
1
|
|
|
1
|
|
|
Total
|
|
21
|
|
|
17
|
|
|
15
|
|
|
•
|
A vesting condition under which the beneficiaries must be continuously employed by the Company through the end of the vesting period (
3 years
); and
|
|
•
|
For PSUs granted in 2016, a performance condition, contingent on the Total Stockholder Return (TSR) performance of Constellium over the measurement periods compared to the TSR of a specified group of peer companies. PSUs will ultimately vest, depending on the TSR performance at each testing period, based on a vesting multiplier in a range from
0%
to
300%
;
|
|
•
|
For PSUs granted from 2017 to 2019, a performance condition, contingent on the Total Stockholder Return (TSR) performance of Constellium shares over the vesting period compared to the TSR of specified indices. PSUs will ultimately vest based on a vesting multiplier which ranges from
0%
to
200%
.
|
|
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
||
|
Fair value at grant date (in euros)
|
|
10.44
|
|
|
15.31
|
|
|
Share price at grant date (in euros)
|
|
7.1
|
|
|
10.27
|
|
|
Dividend yield
|
|
—
|
|
|
—
|
|
|
Expected volatility (A)
|
|
52
|
%
|
|
75
|
%
|
|
Risk-free interest rate (US government bond yield)
|
|
2.29
|
%
|
|
2.6
|
%
|
|
Model used
|
|
Monte Carlo
|
|
|
Monte Carlo
|
|
|
(A)
|
Volatilities for the Company and companies included in indices were estimated based on observed historical volatilities over period equal to PSU vesting period.
|
|
|
|
Performance-Based RSU
|
|
Restricted Stock Units
|
|
Equity Award Plans
|
|||||||||||||||
|
|
|
Potential Shares
|
|
Weighted-Average Grant-Date Fair Value per Share
|
|
Potential Shares
|
|
Weighted-Average Grant-Date Fair Value per Share
|
|
Potential Shares
|
|
Weighted-Average Grant-Date Fair Value per Share
|
|||||||||
|
At January 1, 2018
|
|
3,257,840
|
|
|
€
|
8.56
|
|
|
944,500
|
|
|
€
|
7.76
|
|
|
95,340
|
|
|
€
|
5.20
|
|
|
Granted
|
|
701,109
|
|
|
€
|
15.31
|
|
|
595,687
|
|
|
€
|
10.23
|
|
|
30,709
|
|
|
€
|
10.27
|
|
|
Over-performance
|
|
633,670
|
|
|
€
|
7.28
|
|
|
—
|
|
|
€
|
—
|
|
|
—
|
|
|
€
|
—
|
|
|
Vested
|
|
(1,265,635
|
)
|
|
€
|
7.09
|
|
|
(155,000
|
)
|
|
€
|
10.83
|
|
|
(68,136
|
)
|
|
€
|
4.85
|
|
|
Forfeited
|
|
(241,820
|
)
|
|
€
|
8.40
|
|
|
(72,663
|
)
|
|
€
|
8.57
|
|
|
—
|
|
|
€
|
—
|
|
|
At December 31, 2018
|
|
3,085,164
|
|
|
€
|
10.45
|
|
|
1,312,524
|
|
|
€
|
8.47
|
|
|
57,913
|
|
|
€
|
8.31
|
|
|
Granted (A)
|
|
1,028,342
|
|
|
€
|
10.44
|
|
|
899,926
|
|
|
€
|
7.10
|
|
|
73,799
|
|
|
€
|
8.39
|
|
|
Over-performance (B)
|
|
248,230
|
|
|
€
|
8.94
|
|
|
—
|
|
|
€
|
—
|
|
|
—
|
|
|
€
|
—
|
|
|
Vested
|
|
(1,758,062
|
)
|
|
€
|
7.97
|
|
|
(106,000
|
)
|
|
€
|
4.55
|
|
|
(42,559
|
)
|
|
€
|
7.60
|
|
|
Forfeited (C)
|
|
(84,380
|
)
|
|
€
|
8.02
|
|
|
(39,947
|
)
|
|
€
|
8.31
|
|
|
(9,627
|
)
|
|
€
|
8.71
|
|
|
At December 31, 2019
|
|
2,519,294
|
|
|
€
|
12.11
|
|
|
2,066,503
|
|
|
€
|
8.08
|
|
|
79,526
|
|
|
€
|
8.71
|
|
|
(A)
|
For PSUs, the number of potential shares granted is presented using a vesting multiplier of
100%
.
|
|
(B)
|
When the achievement of TSR performance exceeds the vesting multiplier of
100%
, the additional potential shares are presented as over-performance shares.
|
|
(C)
|
For potential shares related to PSUs,
84,380
were forfeited following the departure of certain beneficiaries and
none
were forfeited in relation to the non-fulfilment of performance conditions.
|
|
Entity
|
|
Country
|
|
% Group Interest
|
|
Consolidation
Method |
|
|
Cross Operating Segment
|
|
|
|
|
|
|
|
|
Constellium Singen GmbH (AS&I and P&ARP)
|
|
Germany
|
|
100
|
%
|
|
Full
|
|
Constellium Valais S.A. (AS&I and A&T)
|
|
Switzerland
|
|
100
|
%
|
|
Full
|
|
AS&I
|
|
|
|
|
|
|
|
|
Constellium Automotive USA, LLC
|
|
U.S.
|
|
100
|
%
|
|
Full
|
|
Constellium Engley (Changchun) Automotive Structures Co Ltd.
|
|
China
|
|
54
|
%
|
|
Full
|
|
Constellium Extrusions Decin S.r.o.
|
|
Czech Republic
|
|
100
|
%
|
|
Full
|
|
Constellium Extrusions Deutschland GmbH
|
|
Germany
|
|
100
|
%
|
|
Full
|
|
Constellium Extrusions Landau GmbH
|
|
Germany
|
|
100
|
%
|
|
Full
|
|
Constellium Extrusions Burg GmbH
|
|
Germany
|
|
100
|
%
|
|
Full
|
|
Constellium Extrusions France S.A.S.
|
|
France
|
|
100
|
%
|
|
Full
|
|
Constellium Extrusions Levice S.r.o.
|
|
Slovakia
|
|
100
|
%
|
|
Full
|
|
Constellium Automotive Mexico, S. DE R.L. DE C.V.
|
|
Mexico
|
|
100
|
%
|
|
Full
|
|
Constellium Automotive Mexico Trading, S. DE R.L. DE C.V.
|
|
Mexico
|
|
100
|
%
|
|
Full
|
|
Astrex Inc
|
|
Canada
|
|
50
|
%
|
|
Full
|
|
Constellium Automotive Zilina S.r.o.
|
|
Slovakia
|
|
100
|
%
|
|
Full
|
|
Constellium Automotive Nanjing Co Ltd
|
|
China
|
|
100
|
%
|
|
Full
|
|
Constellium Automotive Spain SL
|
|
Spain
|
|
100
|
%
|
|
Full
|
|
A&T
|
|
|
|
|
|
|
|
|
Constellium Issoire S.A.S.
|
|
France
|
|
100
|
%
|
|
Full
|
|
Constellium Montreuil Juigné S.A.S.
|
|
France
|
|
100
|
%
|
|
Full
|
|
Constellium China Limited
|
|
China
|
|
100
|
%
|
|
Full
|
|
Constellium Japan KK
|
|
Japan
|
|
100
|
%
|
|
Full
|
|
Constellium Rolled Products Ravenswood, LLC
|
|
U.S.
|
|
100
|
%
|
|
Full
|
|
Constellium Southeast Asia PTE LTD
|
|
Singapore
|
|
100
|
%
|
|
Full
|
|
Constellium Ussel S.A.S.
|
|
France
|
|
100
|
%
|
|
Full
|
|
AluInfra Services SA (A)
|
|
Switzerland
|
|
50
|
%
|
|
Full
|
|
P&ARP
|
|
|
|
|
|
|
|
|
Constellium Deutschland GmbH
|
|
Germany
|
|
100
|
%
|
|
Full
|
|
Constellium Rolled Products Singen GmbH KG
|
|
Germany
|
|
100
|
%
|
|
Full
|
|
Constellium Property and Equipment Company, LLC
|
|
U.S.
|
|
100
|
%
|
|
Full
|
|
Constellium Neuf Brisach S.A.S.
|
|
France
|
|
100
|
%
|
|
Full
|
|
Constellium Muscle Shoals LLC
|
|
U.S.
|
|
100
|
%
|
|
Full
|
|
Constellium Holding Muscle Shoals LLC
|
|
U.S.
|
|
100
|
%
|
|
Full
|
|
Constellium Muscle Shoals Funding II LLC
|
|
U.S.
|
|
100
|
%
|
|
Full
|
|
Listerhill Total Maintenance Center LLC
|
|
U.S.
|
|
100
|
%
|
|
Full
|
|
Constellium Metal Procurement LLC
|
|
U.S.
|
|
100
|
%
|
|
Full
|
|
Constellium Bowling Green LLC
|
|
U.S.
|
|
100
|
%
|
|
Full
|
|
Rhenaroll
|
|
France
|
|
50
|
%
|
|
Equity
|
|
Holdings & Corporate
|
|
|
|
|
|
|
|
|
C-TEC Constellium Technology Center S.A.S.
|
|
France
|
|
100
|
%
|
|
Full
|
|
Constellium Finance S.A.S.
|
|
France
|
|
100
|
%
|
|
Full
|
|
Constellium France III
|
|
France
|
|
100
|
%
|
|
Full
|
|
Constellium France Holdco S.A.S.
|
|
France
|
|
100
|
%
|
|
Full
|
|
Constellium International
|
|
France
|
|
100
|
%
|
|
Full
|
|
Constellium Paris S.A.S
|
|
France
|
|
100
|
%
|
|
Full
|
|
Constellium Germany Holdco GmbH & Co. KG
|
|
Germany
|
|
100
|
%
|
|
Full
|
|
Constellium Germany Verwaltungs GmbH
|
|
Germany
|
|
100
|
%
|
|
Full
|
|
Constellium UK Limited
|
|
United Kingdom
|
|
100
|
%
|
|
Full
|
|
Constellium U.S. Holdings I, LLC
|
|
U.S.
|
|
100
|
%
|
|
Full
|
|
Constellium Switzerland AG
|
|
Switzerland
|
|
100
|
%
|
|
Full
|
|
Constellium W S.A.S.
|
|
France
|
|
100
|
%
|
|
Full
|
|
Constellium Treuhand UG
|
|
Germany
|
|
100
|
%
|
|
Full
|
|
Engineered Products International S.A.S.
|
|
France
|
|
100
|
%
|
|
Full
|
|
(A)
|
AluInfra Services SA, the joint venture created with Novelis in July 2018, is consolidated as a joint operation and is immaterial to the Group Consolidated Financial Statements.
|
|
(in millions of Euros)
|
|
At December 31, 2019
|
|
At December 31, 2018
|
||
|
Assets
|
|
|
|
|
||
|
Current assets
|
|
|
|
|
||
|
Cash and cash equivalents
|
|
—
|
|
|
—
|
|
|
Trade receivables and other
|
|
200
|
|
|
109
|
|
|
Other financial assets
|
|
37
|
|
|
38
|
|
|
|
|
237
|
|
|
147
|
|
|
Non-current assets
|
|
|
|
|
||
|
Property, plant and equipment
|
|
—
|
|
|
—
|
|
|
Financial assets
|
|
2,002
|
|
|
2,106
|
|
|
Investments in subsidiaries
|
|
159
|
|
|
144
|
|
|
Trade receivables and other
|
|
27
|
|
|
—
|
|
|
Deferred income tax assets
|
|
1
|
|
|
2
|
|
|
|
|
2,189
|
|
|
2,252
|
|
|
Total Assets
|
|
2,426
|
|
|
2,399
|
|
|
Liabilities
|
|
|
|
|
||
|
Current liabilities
|
|
|
|
|
||
|
Trade payables and other
|
|
6
|
|
|
5
|
|
|
Income tax payable
|
|
45
|
|
|
21
|
|
|
Other financial liabilities
|
|
33
|
|
|
33
|
|
|
|
|
84
|
|
|
59
|
|
|
Non-current liabilities
|
|
|
|
|
||
|
Borrowings
|
|
1,954
|
|
|
2,022
|
|
|
Income tax payable
|
|
19
|
|
|
—
|
|
|
|
|
1,973
|
|
|
2,022
|
|
|
Total Liabilities
|
|
2,057
|
|
|
2,081
|
|
|
Equity
|
|
|
|
|
||
|
Share capital
|
|
3
|
|
|
3
|
|
|
Share premium
|
|
429
|
|
|
429
|
|
|
Accumulated retained earnings
|
|
(153
|
)
|
|
(239
|
)
|
|
Other reserves
|
|
53
|
|
|
38
|
|
|
Net income
|
|
37
|
|
|
87
|
|
|
Total Equity
|
|
369
|
|
|
318
|
|
|
Total Equity and Liabilities
|
|
2,426
|
|
|
2,399
|
|
|
(in millions of Euros)
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Revenue
|
|
3
|
|
|
3
|
|
|
1
|
|
|
Gross profit
|
|
3
|
|
|
3
|
|
|
1
|
|
|
Selling and administrative expenses
|
|
(19
|
)
|
|
(15
|
)
|
|
(5
|
)
|
|
Employee benefit expenses
|
|
(3
|
)
|
|
(3
|
)
|
|
(1
|
)
|
|
Loss from recurring operations
|
|
(19
|
)
|
|
(15
|
)
|
|
(5
|
)
|
|
Other income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Other expense
|
|
(3
|
)
|
|
(3
|
)
|
|
—
|
|
|
Loss from operations
|
|
(22
|
)
|
|
(18
|
)
|
|
(5
|
)
|
|
Financial result - net
|
|
41
|
|
|
80
|
|
|
(65
|
)
|
|
Income / (loss) before income tax
|
|
19
|
|
|
62
|
|
|
(70
|
)
|
|
Income tax
|
|
18
|
|
|
25
|
|
|
—
|
|
|
Net income / (loss)
|
|
37
|
|
|
87
|
|
|
(70
|
)
|
|
Other comprehensive income / (loss)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Total comprehensive income / (loss)
|
|
37
|
|
|
87
|
|
|
(70
|
)
|
|
(in millions of Euros)
|
|
Year ended December 31, 2019
|
|
Year ended December 31, 2018
|
|
Year ended December 31, 2017
|
|||
|
Net income / (loss)
|
|
37
|
|
|
87
|
|
|
(70
|
)
|
|
Adjustments
|
|
|
|
|
|
|
|||
|
Finance cost - net
|
|
(41
|
)
|
|
(80
|
)
|
|
65
|
|
|
Dividend received
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Income tax
|
|
(18
|
)
|
|
(25
|
)
|
|
—
|
|
|
Interest paid
|
|
(115
|
)
|
|
(102
|
)
|
|
(148
|
)
|
|
Interest received
|
|
143
|
|
|
134
|
|
|
149
|
|
|
Changes in working capital
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Trade receivables and other
|
|
27
|
|
|
—
|
|
|
(1
|
)
|
|
Income tax paid
|
|
50
|
|
|
—
|
|
|
—
|
|
|
Trade payables and other
|
|
2
|
|
|
—
|
|
|
2
|
|
|
Net cash flows from / (used in) operating activities
|
|
85
|
|
|
14
|
|
|
(3
|
)
|
|
Investments in subsidiaries
|
|
—
|
|
|
(1
|
)
|
|
(11
|
)
|
|
Current account with subsidiaries and related parties
|
|
(135
|
)
|
|
(13
|
)
|
|
180
|
|
|
Loans granted to subsidiaries and related parties
|
|
—
|
|
|
—
|
|
|
(1,640
|
)
|
|
Repayment of loans granted to subsidiaries and related parties
|
|
150
|
|
|
—
|
|
|
823
|
|
|
Exit fees received from subsidiaries
|
|
—
|
|
|
—
|
|
|
9
|
|
|
Net cash flows from / (used in) investing activities
|
|
15
|
|
|
(14
|
)
|
|
(639
|
)
|
|
Net proceeds received from issuance of shares
|
|
—
|
|
|
—
|
|
|
259
|
|
|
Proceeds from issuance of Senior Notes
|
|
—
|
|
|
—
|
|
|
1,440
|
|
|
Payment of deferred financing costs
|
|
—
|
|
|
—
|
|
|
(29
|
)
|
|
Repayment of Senior Notes
|
|
(100
|
)
|
|
—
|
|
|
(949
|
)
|
|
Payment of exit fees
|
|
—
|
|
|
—
|
|
|
(61
|
)
|
|
Realized foreign exchange gains / (losses)
|
|
—
|
|
|
—
|
|
|
(17
|
)
|
|
Other
|
|
—
|
|
|
—
|
|
|
(1
|
)
|
|
Net cash flows (used in) / from financing activities
|
|
(100
|
)
|
|
—
|
|
|
642
|
|
|
Net increase in cash and cash equivalents
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Cash and cash equivalents - beginning of year
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Effect of exchange rate changes on cash and cash equivalents
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Cash and cash equivalents - end of year
|
|
—
|
|
|
—
|
|
|
—
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|